id	sid	tid	token	lemma	pos
iajs-1845	1	1	microsoft	microsoft	PROPN
iajs-1845	1	2	word	word	NOUN
iajs-1845	1	3	15	15	NUM
iajs-1845	1	4	-	-	SYM
iajs-1845	1	5	22	22	NUM
iajs-1845	1	6	  	  	SPACE
iajs-1845	1	7	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	NOUN
iajs-1845	1	8	biology	biology	NOUN
iajs-1845	1	9	|	|	ADV
iajs-1845	1	10	15	15	NUM
iajs-1845	1	11	2018)عام	2018)عام	NUM
iajs-1845	1	12	1العدد	1العدد	NUM
iajs-1845	1	13	(	(	PUNCT
iajs-1845	1	14	31مجلة	31مجلة	NUM
iajs-1845	1	15	إبن	إبن	VERB
iajs-1845	1	16	الهيثم	الهيثم	ADJ
iajs-1845	1	17	للعلوم	للعلوم	NOUN
iajs-1845	1	18	الصرفة	الصرفة	NOUN
iajs-1845	1	19	والتطبيقية	والتطبيقية	PRON
iajs-1845	1	20	المجلد	المجلد	VERB
iajs-1845	1	21	ibn	ibn	PROPN
iajs-1845	1	22	al	al	PROPN
iajs-1845	1	23	-	-	PUNCT
iajs-1845	1	24	haitham	haitham	PROPN
iajs-1845	1	25	jour	jour	X
iajs-1845	1	26	.	.	PROPN
iajs-1845	2	1	for	for	ADP
iajs-1845	2	2	pure	pure	ADJ
iajs-1845	2	3	&	&	CCONJ
iajs-1845	2	4	appl	appl	PROPN
iajs-1845	2	5	.	.	PUNCT
iajs-1845	3	1	sci	sci	PROPN
iajs-1845	3	2	.	.	PUNCT
iajs-1845	3	3	vol	vol	NOUN
iajs-1845	3	4	.	.	PROPN
iajs-1845	4	1	31	31	NUM
iajs-1845	4	2	(	(	PUNCT
iajs-1845	4	3	1	1	NUM
iajs-1845	4	4	)	)	SYM
iajs-1845	4	5	2018	2018	NUM
iajs-1845	4	6	urinary	urinary	ADJ
iajs-1845	4	7	vitamin	vitamin	NOUN
iajs-1845	4	8	-	-	PUNCT
iajs-1845	4	9	d	d	NOUN
iajs-1845	4	10	binding	bind	VERB
iajs-1845	4	11	protein	protein	NOUN
iajs-1845	4	12	as	as	ADP
iajs-1845	4	13	an	an	DET
iajs-1845	4	14	early	early	ADJ
iajs-1845	4	15	predictor	predictor	NOUN
iajs-1845	4	16	of	of	ADP
iajs-1845	4	17	diabetic	diabetic	ADJ
iajs-1845	4	18	nephropathyin	nephropathyin	PROPN
iajs-1845	4	19	type	type	NOUN
iajs-1845	4	20	1	1	NUM
iajs-1845	4	21	and	and	CCONJ
iajs-1845	4	22	type	type	NOUN
iajs-1845	4	23	2	2	NUM
iajs-1845	4	24	diabetes	diabetes	NOUN
iajs-1845	4	25	madha	madha	PROPN
iajs-1845	4	26	mohammed	mohammed	PROPN
iajs-1845	4	27	sheet	sheet	PROPN
iajs-1845	4	28	saleh	saleh	PROPN
iajs-1845	4	29	depat	depat	PROPN
iajs-1845	4	30	.	.	PUNCT
iajs-1845	4	31	of	of	ADP
iajs-1845	4	32	medical	medical	ADJ
iajs-1845	4	33	laboratory	laboratory	NOUN
iajs-1845	4	34	techniques	technique	NOUN
iajs-1845	4	35	/	/	SYM
iajs-1845	4	36	college	college	NOUN
iajs-1845	4	37	of	of	ADP
iajs-1845	4	38	health	health	NOUN
iajs-1845	4	39	and	and	CCONJ
iajs-1845	4	40	medical	medical	ADJ
iajs-1845	4	41	technology	technology	PROPN
iajs-1845	4	42	/	/	SYM
iajs-1845	4	43	baghdad	baghdad	PROPN
iajs-1845	4	44	madhataiz2004@yahoo.com	madhataiz2004@yahoo.com	X
iajs-1845	5	1	isam	isam	PROPN
iajs-1845	5	2	noori	noori	PROPN
iajs-1845	5	3	salman	salman	PROPN
iajs-1845	5	4	al	al	PROPN
iajs-1845	5	5	-	-	PUNCT
iajs-1845	5	6	karawi	karawi	PROPN
iajs-1845	5	7	national	national	ADJ
iajs-1845	5	8	center	center	NOUN
iajs-1845	5	9	for	for	ADP
iajs-1845	5	10	the	the	DET
iajs-1845	5	11	treatment	treatment	NOUN
iajs-1845	5	12	of	of	ADP
iajs-1845	5	13	diabetes	diabetes	NOUN
iajs-1845	5	14	and	and	CCONJ
iajs-1845	5	15	research	research	NOUN
iajs-1845	5	16	/	/	SYM
iajs-1845	5	17	collage	collage	NOUN
iajs-1845	5	18	of	of	ADP
iajs-1845	5	19	medicine	medicine	NOUN
iajs-1845	5	20	/	/	SYM
iajs-1845	5	21	al	al	PROPN
iajs-1845	5	22	-	-	PUNCT
iajs-1845	5	23	mustansiriyah	mustansiriyah	PROPN
iajs-1845	5	24	university	university	PROPN
iajs-1845	5	25	esam.kirwi@yahoo.com	esam.kirwi@yahoo.com	PROPN
iajs-1845	5	26	haael	haael	PROPN
iajs-1845	5	27	subhi	subhi	PROPN
iajs-1845	5	28	abbas	abbas	PROPN
iajs-1845	5	29	alkhafajy	alkhafajy	PROPN
iajs-1845	5	30	depat	depat	PROPN
iajs-1845	5	31	.	.	PUNCT
iajs-1845	6	1	of	of	ADP
iajs-1845	6	2	medical	medical	ADJ
iajs-1845	6	3	laboratory	laboratory	NOUN
iajs-1845	6	4	techniques	technique	NOUN
iajs-1845	6	5	/	/	SYM
iajs-1845	6	6	college	college	NOUN
iajs-1845	6	7	of	of	ADP
iajs-1845	6	8	health	health	NOUN
iajs-1845	6	9	and	and	CCONJ
iajs-1845	6	10	medical	medical	ADJ
iajs-1845	6	11	technology	technology	NOUN
iajs-1845	6	12	/	/	SYM
iajs-1845	6	13	baghdad	baghdad	PROPN
iajs-1845	6	14	haael16@gmail.com	haael16@gmail.com	PROPN
iajs-1845	6	15	received	receive	VERB
iajs-1845	6	16	in:27/	in:27/	NOUN
iajs-1845	6	17	august/2017	august/2017	ADV
iajs-1845	6	18	,	,	PUNCT
iajs-1845	6	19	accepted	accept	VERB
iajs-1845	6	20	in:5	in:5	PROPN
iajs-1845	6	21	/	/	SYM
iajs-1845	6	22	november/2017	november/2017	ADJ
iajs-1845	6	23	abstract	abstract	ADJ
iajs-1845	6	24	diabetic	diabetic	ADJ
iajs-1845	6	25	nephropathy	nephropathy	NOUN
iajs-1845	6	26	(	(	PUNCT
iajs-1845	6	27	dn	dn	NOUN
iajs-1845	6	28	)	)	PUNCT
iajs-1845	6	29	is	be	AUX
iajs-1845	6	30	the	the	DET
iajs-1845	6	31	most	most	ADV
iajs-1845	6	32	common	common	ADJ
iajs-1845	6	33	microvascular	microvascular	NOUN
iajs-1845	6	34	complication	complication	NOUN
iajs-1845	6	35	that	that	PRON
iajs-1845	6	36	may	may	AUX
iajs-1845	6	37	lead	lead	VERB
iajs-1845	6	38	to	to	ADP
iajs-1845	6	39	chronic	chronic	ADJ
iajs-1845	6	40	renal	renal	ADJ
iajs-1845	6	41	failure	failure	NOUN
iajs-1845	6	42	in	in	ADP
iajs-1845	6	43	diabetic	diabetic	ADJ
iajs-1845	6	44	patients	patient	NOUN
iajs-1845	6	45	.	.	PUNCT
iajs-1845	7	1	till	till	SCONJ
iajs-1845	7	2	now	now	ADV
iajs-1845	7	3	microalbuminuria	microalbuminuria	PROPN
iajs-1845	7	4	,	,	PUNCT
iajs-1845	7	5	with	with	ADP
iajs-1845	7	6	its	its	PRON
iajs-1845	7	7	restrictions	restriction	NOUN
iajs-1845	7	8	,	,	PUNCT
iajs-1845	7	9	is	be	AUX
iajs-1845	7	10	the	the	DET
iajs-1845	7	11	early	early	ADJ
iajs-1845	7	12	marker	marker	NOUN
iajs-1845	7	13	of	of	ADP
iajs-1845	7	14	dn	dn	PROPN
iajs-1845	7	15	,	,	PUNCT
iajs-1845	7	16	appeared	appear	VERB
iajs-1845	7	17	after	after	ADP
iajs-1845	7	18	the	the	DET
iajs-1845	7	19	disease	disease	NOUN
iajs-1845	7	20	exacerbation	exacerbation	NOUN
iajs-1845	7	21	.	.	PUNCT
iajs-1845	8	1	thus	thus	ADV
iajs-1845	8	2	,	,	PUNCT
iajs-1845	8	3	new	new	ADJ
iajs-1845	8	4	biomarkers	biomarker	NOUN
iajs-1845	8	5	are	be	AUX
iajs-1845	8	6	required	require	VERB
iajs-1845	8	7	to	to	PART
iajs-1845	8	8	predict	predict	VERB
iajs-1845	8	9	the	the	DET
iajs-1845	8	10	early	early	ADJ
iajs-1845	8	11	onset	onset	NOUN
iajs-1845	8	12	of	of	ADP
iajs-1845	8	13	dn	dn	NOUN
iajs-1845	8	14	before	before	ADP
iajs-1845	8	15	the	the	DET
iajs-1845	8	16	appearance	appearance	NOUN
iajs-1845	8	17	of	of	ADP
iajs-1845	8	18	microalbuminuria	microalbuminuria	PROPN
iajs-1845	8	19	.	.	PUNCT
iajs-1845	9	1	the	the	DET
iajs-1845	9	2	aim	aim	NOUN
iajs-1845	9	3	of	of	ADP
iajs-1845	9	4	this	this	DET
iajs-1845	9	5	study	study	NOUN
iajs-1845	9	6	is	be	AUX
iajs-1845	9	7	to	to	PART
iajs-1845	9	8	investigate	investigate	VERB
iajs-1845	9	9	the	the	DET
iajs-1845	9	10	possible	possible	ADJ
iajs-1845	9	11	use	use	NOUN
iajs-1845	9	12	of	of	ADP
iajs-1845	9	13	uvdbp	uvdbp	PROPN
iajs-1845	9	14	in	in	ADP
iajs-1845	9	15	the	the	DET
iajs-1845	9	16	early	early	ADJ
iajs-1845	9	17	prediction	prediction	NOUN
iajs-1845	9	18	of	of	ADP
iajs-1845	9	19	dn	dn	PROPN
iajs-1845	9	20	.	.	PROPN
iajs-1845	9	21	fifty	fifty	NUM
iajs-1845	9	22	diabetic	diabetic	ADJ
iajs-1845	9	23	patients	patient	NOUN
iajs-1845	9	24	with	with	ADP
iajs-1845	9	25	dn	dn	NOUN
iajs-1845	9	26	and	and	CCONJ
iajs-1845	9	27	40	40	NUM
iajs-1845	9	28	diabetic	diabetic	ADJ
iajs-1845	9	29	patients	patient	NOUN
iajs-1845	9	30	without	without	ADP
iajs-1845	9	31	dn	dn	NOUN
iajs-1845	9	32	for	for	ADP
iajs-1845	9	33	both	both	DET
iajs-1845	9	34	types	type	NOUN
iajs-1845	9	35	of	of	ADP
iajs-1845	9	36	diabetes	diabetes	NOUN
iajs-1845	9	37	were	be	AUX
iajs-1845	9	38	enrolled	enrol	VERB
iajs-1845	9	39	in	in	ADP
iajs-1845	9	40	this	this	DET
iajs-1845	9	41	study	study	NOUN
iajs-1845	9	42	.	.	PUNCT
iajs-1845	10	1	all	all	DET
iajs-1845	10	2	patients	patient	NOUN
iajs-1845	10	3	were	be	AUX
iajs-1845	10	4	tested	test	VERB
iajs-1845	10	5	for	for	ADP
iajs-1845	10	6	uacr	uacr	PROPN
iajs-1845	10	7	,	,	PUNCT
iajs-1845	10	8	uvdbp	uvdbp	PROPN
iajs-1845	10	9	(	(	PUNCT
iajs-1845	10	10	measured	measure	VERB
iajs-1845	10	11	by	by	ADP
iajs-1845	10	12	elisa	elisa	NOUN
iajs-1845	10	13	)	)	PUNCT
iajs-1845	10	14	,	,	PUNCT
iajs-1845	10	15	and	and	CCONJ
iajs-1845	10	16	blood	blood	NOUN
iajs-1845	10	17	hba1c	hba1c	PROPN
iajs-1845	10	18	.	.	PUNCT
iajs-1845	11	1	the	the	DET
iajs-1845	11	2	results	result	NOUN
iajs-1845	11	3	demonstrated	demonstrate	VERB
iajs-1845	11	4	a	a	DET
iajs-1845	11	5	highly	highly	ADV
iajs-1845	11	6	significant	significant	ADJ
iajs-1845	11	7	elevation	elevation	NOUN
iajs-1845	11	8	of	of	ADP
iajs-1845	11	9	uacr	uacr	PRON
iajs-1845	11	10	,	,	PUNCT
iajs-1845	11	11	hba1c	hba1c	PROPN
iajs-1845	11	12	and	and	CCONJ
iajs-1845	11	13	uvdbp	uvdbp	PROPN
iajs-1845	11	14	in	in	ADP
iajs-1845	11	15	diabetic	diabetic	ADJ
iajs-1845	11	16	patients	patient	NOUN
iajs-1845	11	17	with	with	ADP
iajs-1845	11	18	dn	dn	NOUN
iajs-1845	11	19	compared	compare	VERB
iajs-1845	11	20	to	to	ADP
iajs-1845	11	21	those	those	PRON
iajs-1845	11	22	without	without	ADP
iajs-1845	11	23	dn	dn	PROPN
iajs-1845	11	24	.	.	PROPN
iajs-1845	11	25	uvdbp	uvdbp	PROPN
iajs-1845	11	26	exhibited	exhibit	VERB
iajs-1845	11	27	a	a	DET
iajs-1845	11	28	strong	strong	ADJ
iajs-1845	11	29	positive	positive	ADJ
iajs-1845	11	30	correlation	correlation	NOUN
iajs-1845	11	31	with	with	ADP
iajs-1845	11	32	hba1c	hba1c	PROPN
iajs-1845	11	33	and	and	CCONJ
iajs-1845	11	34	uacr	uacr	VERB
iajs-1845	11	35	in	in	ADP
iajs-1845	11	36	dn	dn	PROPN
iajs-1845	11	37	patients	patient	NOUN
iajs-1845	11	38	.	.	PUNCT
iajs-1845	12	1	roc	roc	PROPN
iajs-1845	12	2	curve	curve	NOUN
iajs-1845	12	3	analysis	analysis	NOUN
iajs-1845	12	4	showed	show	VERB
iajs-1845	12	5	a	a	DET
iajs-1845	12	6	greater	great	ADJ
iajs-1845	12	7	auc	auc	NOUN
iajs-1845	12	8	(	(	PUNCT
iajs-1845	12	9	0.93	0.93	NUM
iajs-1845	12	10	)	)	PUNCT
iajs-1845	12	11	,	,	PUNCT
iajs-1845	12	12	and	and	CCONJ
iajs-1845	12	13	cutoff	cutoff	NOUN
iajs-1845	12	14	value	value	NOUN
iajs-1845	12	15	was	be	AUX
iajs-1845	12	16	>	>	X
iajs-1845	12	17	152	152	NUM
iajs-1845	12	18	ng	ng	PROPN
iajs-1845	12	19	/	/	SYM
iajs-1845	12	20	ml	ml	NOUN
iajs-1845	12	21	with	with	ADP
iajs-1845	12	22	94	94	NUM
iajs-1845	12	23	%	%	NOUN
iajs-1845	12	24	sensitivity	sensitivity	NOUN
iajs-1845	12	25	and	and	CCONJ
iajs-1845	12	26	82	82	NUM
iajs-1845	12	27	%	%	NOUN
iajs-1845	12	28	specificity	specificity	NOUN
iajs-1845	12	29	for	for	ADP
iajs-1845	12	30	early	early	ADJ
iajs-1845	12	31	detection	detection	NOUN
iajs-1845	12	32	of	of	ADP
iajs-1845	12	33	dn	dn	PROPN
iajs-1845	12	34	.	.	PUNCT
iajs-1845	13	1	these	these	DET
iajs-1845	13	2	findings	finding	NOUN
iajs-1845	13	3	suggesting	suggest	VERB
iajs-1845	13	4	the	the	DET
iajs-1845	13	5	sensitive	sensitive	ADJ
iajs-1845	13	6	and	and	CCONJ
iajs-1845	13	7	potential	potential	ADJ
iajs-1845	13	8	role	role	NOUN
iajs-1845	13	9	of	of	ADP
iajs-1845	13	10	uvdbp	uvdbp	PROPN
iajs-1845	13	11	in	in	ADP
iajs-1845	13	12	the	the	DET
iajs-1845	13	13	early	early	ADJ
iajs-1845	13	14	prediction	prediction	NOUN
iajs-1845	13	15	and	and	CCONJ
iajs-1845	13	16	diagnosis	diagnosis	NOUN
iajs-1845	13	17	of	of	ADP
iajs-1845	13	18	dn	dn	NOUN
iajs-1845	13	19	in	in	ADP
iajs-1845	13	20	type	type	NOUN
iajs-1845	13	21	1	1	NUM
iajs-1845	13	22	and	and	CCONJ
iajs-1845	13	23	type	type	NOUN
iajs-1845	13	24	2	2	NUM
iajs-1845	13	25	diabetes	diabetes	NOUN
iajs-1845	13	26	.	.	PUNCT
iajs-1845	14	1	keywords	keyword	NOUN
iajs-1845	14	2	:	:	PUNCT
iajs-1845	14	3	diabetic	diabetic	ADJ
iajs-1845	14	4	nephropathy	nephropathy	NOUN
iajs-1845	14	5	,	,	PUNCT
iajs-1845	14	6	vitamin	vitamin	NOUN
iajs-1845	14	7	d	d	NOUN
iajs-1845	14	8	binding	bind	VERB
iajs-1845	14	9	protein	protein	NOUN
iajs-1845	14	10	,	,	PUNCT
iajs-1845	14	11	urinary	urinary	ADJ
iajs-1845	14	12	albumin	albumin	NOUN
iajs-1845	14	13	/	/	SYM
iajs-1845	14	14	creatinine	creatinine	NOUN
iajs-1845	14	15	ratio	ratio	NOUN
iajs-1845	14	16	  	  	SPACE
iajs-1845	14	17	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	ADJ
iajs-1845	14	18	biology	biology	NOUN
iajs-1845	14	19	|	|	ADV
iajs-1845	14	20	16	16	NUM
iajs-1845	14	21	2018)عام	2018)عام	NUM
iajs-1845	14	22	1العدد	1العدد	NUM
iajs-1845	14	23	(	(	PUNCT
iajs-1845	14	24	31لمجلد	31لمجلد	NUM
iajs-1845	14	25	ا	ا	INTJ
iajs-1845	14	26	مجلة	مجلة	NOUN
iajs-1845	14	27	إبن	إبن	VERB
iajs-1845	14	28	الهيثم	الهيثم	ADJ
iajs-1845	14	29	للعلوم	للعلوم	NOUN
iajs-1845	14	30	الصرفة	الصرفة	NOUN
iajs-1845	14	31	والتطبيقية	والتطبيقية	VERB
iajs-1845	14	32	ibn	ibn	PROPN
iajs-1845	14	33	al	al	PROPN
iajs-1845	14	34	-	-	PUNCT
iajs-1845	14	35	haitham	haitham	PROPN
iajs-1845	14	36	jour	jour	X
iajs-1845	14	37	.	.	PROPN
iajs-1845	15	1	for	for	ADP
iajs-1845	15	2	pure	pure	ADJ
iajs-1845	15	3	&	&	CCONJ
iajs-1845	15	4	appl	appl	PROPN
iajs-1845	15	5	.	.	PUNCT
iajs-1845	16	1	sci	sci	PROPN
iajs-1845	16	2	.	.	PUNCT
iajs-1845	16	3	vol	vol	NOUN
iajs-1845	16	4	.	.	PROPN
iajs-1845	17	1	31	31	NUM
iajs-1845	17	2	(	(	PUNCT
iajs-1845	17	3	1	1	NUM
iajs-1845	17	4	)	)	SYM
iajs-1845	17	5	2018	2018	NUM
iajs-1845	17	6	introduction	introduction	NOUN
iajs-1845	17	7	diabetic	diabetic	ADJ
iajs-1845	17	8	nephropathy	nephropathy	NOUN
iajs-1845	17	9	(	(	PUNCT
iajs-1845	17	10	dn	dn	NOUN
iajs-1845	17	11	)	)	PUNCT
iajs-1845	17	12	is	be	AUX
iajs-1845	17	13	the	the	DET
iajs-1845	17	14	commonest	commonest	NOUN
iajs-1845	17	15	microvascular	microvascular	NOUN
iajs-1845	17	16	complication	complication	NOUN
iajs-1845	17	17	of	of	ADP
iajs-1845	17	18	diabetes	diabetes	NOUN
iajs-1845	17	19	mellitus	mellitus	NOUN
iajs-1845	17	20	(	(	PUNCT
iajs-1845	17	21	dm	dm	PROPN
iajs-1845	17	22	)	)	PUNCT
iajs-1845	17	23	,	,	PUNCT
iajs-1845	17	24	which	which	PRON
iajs-1845	17	25	is	be	AUX
iajs-1845	17	26	the	the	DET
iajs-1845	17	27	prime	prime	ADJ
iajs-1845	17	28	reason	reason	NOUN
iajs-1845	17	29	of	of	ADP
iajs-1845	17	30	renal	renal	ADJ
iajs-1845	17	31	failure	failure	NOUN
iajs-1845	17	32	globally	globally	ADV
iajs-1845	17	33	,	,	PUNCT
iajs-1845	17	34	and	and	CCONJ
iajs-1845	17	35	it	it	PRON
iajs-1845	17	36	is	be	AUX
iajs-1845	17	37	associated	associate	VERB
iajs-1845	17	38	with	with	ADP
iajs-1845	17	39	increased	increase	VERB
iajs-1845	17	40	cardiovascular	cardiovascular	ADJ
iajs-1845	17	41	mortality	mortality	NOUN
iajs-1845	18	1	[	[	X
iajs-1845	18	2	1	1	NUM
iajs-1845	18	3	]	]	PUNCT
iajs-1845	18	4	.	.	PUNCT
iajs-1845	19	1	the	the	DET
iajs-1845	19	2	prevalence	prevalence	NOUN
iajs-1845	19	3	of	of	ADP
iajs-1845	19	4	mortality	mortality	NOUN
iajs-1845	19	5	in	in	ADP
iajs-1845	19	6	diabetic	diabetic	ADJ
iajs-1845	19	7	patients	patient	NOUN
iajs-1845	19	8	with	with	ADP
iajs-1845	19	9	dn	dn	PROPN
iajs-1845	19	10	is	be	AUX
iajs-1845	19	11	nearly	nearly	ADV
iajs-1845	19	12	20	20	NUM
iajs-1845	19	13	-	-	SYM
iajs-1845	19	14	40	40	NUM
iajs-1845	19	15	times	time	NOUN
iajs-1845	19	16	higher	high	ADJ
iajs-1845	19	17	than	than	ADP
iajs-1845	19	18	those	those	DET
iajs-1845	19	19	patients	patient	NOUN
iajs-1845	19	20	without	without	ADP
iajs-1845	19	21	dn	dn	NOUN
iajs-1845	19	22	[	[	X
iajs-1845	19	23	2	2	NUM
iajs-1845	19	24	]	]	PUNCT
iajs-1845	19	25	.	.	PUNCT
iajs-1845	20	1	dn	dn	PROPN
iajs-1845	20	2	is	be	AUX
iajs-1845	20	3	a	a	DET
iajs-1845	20	4	progressive	progressive	ADJ
iajs-1845	20	5	disease	disease	NOUN
iajs-1845	20	6	or	or	CCONJ
iajs-1845	20	7	damage	damage	NOUN
iajs-1845	20	8	to	to	ADP
iajs-1845	20	9	the	the	DET
iajs-1845	20	10	kidneys	kidney	NOUN
iajs-1845	20	11	due	due	ADJ
iajs-1845	20	12	to	to	ADP
iajs-1845	20	13	hyperglycemia	hyperglycemia	NOUN
iajs-1845	20	14	-	-	PUNCT
iajs-1845	20	15	induced	induce	VERB
iajs-1845	20	16	metabolic	metabolic	NOUN
iajs-1845	20	17	and	and	CCONJ
iajs-1845	20	18	hemodynamic	hemodynamic	ADJ
iajs-1845	20	19	changes	change	NOUN
iajs-1845	20	20	resulted	result	VERB
iajs-1845	20	21	from	from	ADP
iajs-1845	20	22	dm	dm	PROPN
iajs-1845	20	23	[	[	X
iajs-1845	20	24	3	3	NUM
iajs-1845	20	25	]	]	PUNCT
iajs-1845	20	26	.	.	PUNCT
iajs-1845	21	1	microalbuminuria	microalbuminuria	PROPN
iajs-1845	21	2	(	(	PUNCT
iajs-1845	21	3	30	30	NUM
iajs-1845	21	4	-	-	SYM
iajs-1845	21	5	300	300	NUM
iajs-1845	21	6	mg	mg	PROPN
iajs-1845	21	7	/	/	SYM
iajs-1845	21	8	g	g	NOUN
iajs-1845	21	9	)	)	PUNCT
iajs-1845	21	10	,	,	PUNCT
iajs-1845	21	11	despite	despite	SCONJ
iajs-1845	21	12	its	its	PRON
iajs-1845	21	13	restrictions	restriction	NOUN
iajs-1845	21	14	,	,	PUNCT
iajs-1845	21	15	still	still	ADV
iajs-1845	21	16	the	the	DET
iajs-1845	21	17	early	early	ADJ
iajs-1845	21	18	marker	marker	NOUN
iajs-1845	21	19	of	of	ADP
iajs-1845	21	20	dn	dn	PROPN
iajs-1845	21	21	,	,	PUNCT
iajs-1845	21	22	which	which	PRON
iajs-1845	21	23	appears	appear	VERB
iajs-1845	21	24	after	after	ADP
iajs-1845	21	25	the	the	DET
iajs-1845	21	26	disease	disease	NOUN
iajs-1845	21	27	exacerbation	exacerbation	NOUN
iajs-1845	21	28	[	[	X
iajs-1845	21	29	4	4	NUM
iajs-1845	21	30	]	]	PUNCT
iajs-1845	21	31	.	.	PUNCT
iajs-1845	22	1	now	now	ADV
iajs-1845	22	2	,	,	PUNCT
iajs-1845	22	3	new	new	ADJ
iajs-1845	22	4	biomarkers	biomarker	NOUN
iajs-1845	22	5	have	have	AUX
iajs-1845	22	6	been	be	AUX
iajs-1845	22	7	found	find	VERB
iajs-1845	22	8	to	to	PART
iajs-1845	22	9	be	be	AUX
iajs-1845	22	10	early	early	ADJ
iajs-1845	22	11	predictors	predictor	NOUN
iajs-1845	22	12	of	of	ADP
iajs-1845	22	13	dn	dn	NOUN
iajs-1845	22	14	even	even	ADV
iajs-1845	22	15	in	in	ADP
iajs-1845	22	16	normoalbuminuric	normoalbuminuric	ADJ
iajs-1845	22	17	stage	stage	NOUN
iajs-1845	22	18	which	which	PRON
iajs-1845	22	19	precedes	precede	VERB
iajs-1845	22	20	mau	mau	PROPN
iajs-1845	22	21	onset	onset	NOUN
iajs-1845	22	22	,	,	PUNCT
iajs-1845	22	23	and	and	CCONJ
iajs-1845	22	24	these	these	DET
iajs-1845	22	25	biomarkers	biomarker	NOUN
iajs-1845	22	26	can	can	AUX
iajs-1845	22	27	also	also	ADV
iajs-1845	22	28	assess	assess	VERB
iajs-1845	22	29	renal	renal	ADJ
iajs-1845	22	30	functions	function	NOUN
iajs-1845	22	31	[	[	X
iajs-1845	22	32	5	5	NUM
iajs-1845	22	33	]	]	PUNCT
iajs-1845	22	34	.	.	PUNCT
iajs-1845	23	1	vitamin	vitamin	NOUN
iajs-1845	23	2	-	-	PUNCT
iajs-1845	23	3	d	d	NOUN
iajs-1845	23	4	binding	bind	VERB
iajs-1845	23	5	protein	protein	NOUN
iajs-1845	23	6	(	(	PUNCT
iajs-1845	23	7	vdbp	vdbp	NOUN
iajs-1845	23	8	)	)	PUNCT
iajs-1845	23	9	,	,	PUNCT
iajs-1845	23	10	also	also	ADV
iajs-1845	23	11	known	know	VERB
iajs-1845	23	12	as	as	ADP
iajs-1845	23	13	group	group	NOUN
iajs-1845	23	14	-	-	PUNCT
iajs-1845	23	15	specific	specific	ADJ
iajs-1845	23	16	component	component	NOUN
iajs-1845	23	17	(	(	PUNCT
iajs-1845	23	18	gc	gc	PROPN
iajs-1845	23	19	)	)	PUNCT
iajs-1845	23	20	globulin	globulin	NOUN
iajs-1845	23	21	,	,	PUNCT
iajs-1845	23	22	is	be	AUX
iajs-1845	23	23	a	a	DET
iajs-1845	23	24	multifunctional	multifunctional	ADJ
iajs-1845	23	25	circulating	circulate	VERB
iajs-1845	23	26	α	α	NOUN
iajs-1845	23	27	-	-	ADJ
iajs-1845	23	28	globulin	globulin	NOUN
iajs-1845	23	29	protein	protein	NOUN
iajs-1845	23	30	with	with	ADP
iajs-1845	23	31	58	58	NUM
iajs-1845	23	32	 	 	SPACE
iajs-1845	23	33	kda	kda	NOUN
iajs-1845	23	34	of	of	ADP
iajs-1845	23	35	molecular	molecular	ADJ
iajs-1845	23	36	weight	weight	NOUN
iajs-1845	23	37	[	[	X
iajs-1845	23	38	6	6	NUM
iajs-1845	23	39	]	]	PUNCT
iajs-1845	23	40	.	.	PUNCT
iajs-1845	24	1	it	it	PRON
iajs-1845	24	2	has	have	VERB
iajs-1845	24	3	various	various	ADJ
iajs-1845	24	4	functions	function	NOUN
iajs-1845	24	5	such	such	ADJ
iajs-1845	24	6	as	as	ADP
iajs-1845	24	7	transports	transport	NOUN
iajs-1845	24	8	vitamin	vitamin	NOUN
iajs-1845	24	9	-	-	PUNCT
iajs-1845	24	10	d	d	NOUN
iajs-1845	24	11	,	,	PUNCT
iajs-1845	24	12	fatty	fatty	ADJ
iajs-1845	24	13	acids	acid	NOUN
iajs-1845	24	14	and	and	CCONJ
iajs-1845	24	15	actin	actin	NOUN
iajs-1845	24	16	in	in	ADP
iajs-1845	24	17	the	the	DET
iajs-1845	24	18	body	body	NOUN
iajs-1845	24	19	,	,	PUNCT
iajs-1845	24	20	increases	increase	VERB
iajs-1845	24	21	complement	complement	NOUN
iajs-1845	24	22	5	5	NUM
iajs-1845	24	23	(	(	PUNCT
iajs-1845	24	24	c5	c5	PROPN
iajs-1845	24	25	)	)	PUNCT
iajs-1845	24	26	chemotactic	chemotactic	ADJ
iajs-1845	24	27	activity	activity	NOUN
iajs-1845	24	28	and	and	CCONJ
iajs-1845	24	29	promotes	promote	VERB
iajs-1845	24	30	macrophage	macrophage	ADJ
iajs-1845	24	31	activation	activation	NOUN
iajs-1845	24	32	[	[	X
iajs-1845	24	33	7	7	NUM
iajs-1845	24	34	]	]	PUNCT
iajs-1845	24	35	.	.	PUNCT
iajs-1845	25	1	it	it	PRON
iajs-1845	25	2	is	be	AUX
iajs-1845	25	3	produced	produce	VERB
iajs-1845	25	4	mainly	mainly	ADV
iajs-1845	25	5	by	by	ADP
iajs-1845	25	6	hepatocytes	hepatocyte	NOUN
iajs-1845	25	7	and	and	CCONJ
iajs-1845	25	8	found	find	VERB
iajs-1845	25	9	in	in	ADP
iajs-1845	25	10	plasma	plasma	NOUN
iajs-1845	25	11	,	,	PUNCT
iajs-1845	25	12	ascitic	ascitic	ADJ
iajs-1845	25	13	fluid	fluid	NOUN
iajs-1845	25	14	,	,	PUNCT
iajs-1845	25	15	cerebrospinal	cerebrospinal	ADJ
iajs-1845	25	16	fluid	fluid	NOUN
iajs-1845	25	17	and	and	CCONJ
iajs-1845	25	18	on	on	ADP
iajs-1845	25	19	the	the	DET
iajs-1845	25	20	surface	surface	NOUN
iajs-1845	25	21	of	of	ADP
iajs-1845	25	22	many	many	ADJ
iajs-1845	25	23	cell	cell	NOUN
iajs-1845	25	24	types	type	NOUN
iajs-1845	25	25	[	[	X
iajs-1845	25	26	8	8	NUM
iajs-1845	25	27	]	]	PUNCT
iajs-1845	25	28	.	.	PUNCT
iajs-1845	26	1	vitamin	vitamin	NOUN
iajs-1845	26	2	-	-	PUNCT
iajs-1845	26	3	d	d	NOUN
iajs-1845	26	4	circulate	circulate	AUX
iajs-1845	26	5	bound	bind	VERB
iajs-1845	26	6	to	to	PART
iajs-1845	26	7	vdbp	vdbp	VERB
iajs-1845	26	8	(	(	PUNCT
iajs-1845	26	9	85–90	85–90	NUM
iajs-1845	26	10	%	%	NOUN
iajs-1845	26	11	)	)	PUNCT
iajs-1845	26	12	and	and	CCONJ
iajs-1845	26	13	albumin	albumin	NOUN
iajs-1845	26	14	(	(	PUNCT
iajs-1845	26	15	10–15	10–15	NUM
iajs-1845	26	16	%	%	NOUN
iajs-1845	26	17	)	)	PUNCT
iajs-1845	26	18	,	,	PUNCT
iajs-1845	26	19	with	with	ADP
iajs-1845	26	20	<	<	X
iajs-1845	26	21	1	1	NUM
iajs-1845	26	22	%	%	NOUN
iajs-1845	26	23	exists	exist	VERB
iajs-1845	26	24	as	as	ADP
iajs-1845	26	25	free	free	ADJ
iajs-1845	26	26	form	form	NOUN
iajs-1845	26	27	[	[	X
iajs-1845	26	28	9	9	NUM
iajs-1845	26	29	]	]	PUNCT
iajs-1845	26	30	.	.	PUNCT
iajs-1845	27	1	there	there	PRON
iajs-1845	27	2	are	be	VERB
iajs-1845	27	3	three	three	NUM
iajs-1845	27	4	main	main	ADJ
iajs-1845	27	5	roles	role	NOUN
iajs-1845	27	6	of	of	ADP
iajs-1845	27	7	vdbp	vdbp	NOUN
iajs-1845	27	8	in	in	ADP
iajs-1845	27	9	vitamin	vitamin	NOUN
iajs-1845	27	10	d	d	NOUN
iajs-1845	27	11	physiology	physiology	NOUN
iajs-1845	27	12	;	;	PUNCT
iajs-1845	27	13	protecting	protect	VERB
iajs-1845	27	14	vitamin	vitamin	NOUN
iajs-1845	27	15	-	-	PUNCT
iajs-1845	27	16	d	d	NOUN
iajs-1845	27	17	from	from	ADP
iajs-1845	27	18	biodegradation	biodegradation	NOUN
iajs-1845	27	19	,	,	PUNCT
iajs-1845	27	20	limiting	limit	VERB
iajs-1845	27	21	its	its	PRON
iajs-1845	27	22	access	access	NOUN
iajs-1845	27	23	to	to	ADP
iajs-1845	27	24	target	target	NOUN
iajs-1845	27	25	tissues	tissue	NOUN
iajs-1845	27	26	,	,	PUNCT
iajs-1845	27	27	and	and	CCONJ
iajs-1845	27	28	reabsorbing	reabsorb	VERB
iajs-1845	27	29	vitamind	vitamind	NOUN
iajs-1845	27	30	in	in	ADP
iajs-1845	27	31	the	the	DET
iajs-1845	27	32	kidneys	kidney	NOUN
iajs-1845	27	33	[	[	X
iajs-1845	27	34	10	10	NUM
iajs-1845	27	35	]	]	PUNCT
iajs-1845	27	36	.	.	PUNCT
iajs-1845	28	1	the	the	DET
iajs-1845	28	2	vdbp/25(oh)d	vdbp/25(oh)d	PROPN
iajs-1845	28	3	(	(	PUNCT
iajs-1845	28	4	25	25	NUM
iajs-1845	28	5	-	-	PUNCT
iajs-1845	28	6	hydroxyvitamin	hydroxyvitamin	NOUN
iajs-1845	28	7	d	d	NOUN
iajs-1845	28	8	)	)	PUNCT
iajs-1845	28	9	complex	complex	NOUN
iajs-1845	28	10	is	be	AUX
iajs-1845	28	11	filtered	filter	VERB
iajs-1845	28	12	in	in	ADP
iajs-1845	28	13	the	the	DET
iajs-1845	28	14	glomerulus	glomerulus	NOUN
iajs-1845	28	15	and	and	CCONJ
iajs-1845	28	16	then	then	ADV
iajs-1845	28	17	reabsorbed	reabsorb	VERB
iajs-1845	28	18	by	by	ADP
iajs-1845	28	19	megalin	megalin	PROPN
iajs-1845	28	20	-	-	PUNCT
iajs-1845	28	21	cubilin	cubilin	ADJ
iajs-1845	28	22	receptors	receptor	NOUN
iajs-1845	28	23	of	of	ADP
iajs-1845	28	24	the	the	DET
iajs-1845	28	25	proximal	proximal	ADJ
iajs-1845	28	26	tubular	tubular	ADJ
iajs-1845	28	27	(	(	PUNCT
iajs-1845	28	28	pt	pt	NOUN
iajs-1845	28	29	)	)	PUNCT
iajs-1845	28	30	epithelial	epithelial	ADJ
iajs-1845	28	31	cells	cell	NOUN
iajs-1845	28	32	.	.	PUNCT
iajs-1845	29	1	the	the	DET
iajs-1845	29	2	carrier	carrier	NOUN
iajs-1845	29	3	vdbp	vdbp	NOUN
iajs-1845	29	4	is	be	AUX
iajs-1845	29	5	degraded	degrade	VERB
iajs-1845	29	6	in	in	ADP
iajs-1845	29	7	lysosomes	lysosome	NOUN
iajs-1845	29	8	,	,	PUNCT
iajs-1845	29	9	while	while	SCONJ
iajs-1845	29	10	25(oh)d	25(oh)d	NOUN
iajs-1845	29	11	is	be	AUX
iajs-1845	29	12	converted	convert	VERB
iajs-1845	29	13	into	into	ADP
iajs-1845	29	14	biologically	biologically	ADV
iajs-1845	29	15	active	active	ADJ
iajs-1845	29	16	1,25(oh)2d	1,25(oh)2d	NUM
iajs-1845	29	17	(	(	PUNCT
iajs-1845	29	18	calcitriol	calcitriol	NOUN
iajs-1845	29	19	)	)	PUNCT
iajs-1845	29	20	via	via	ADP
iajs-1845	29	21	1α	1α	NUM
iajs-1845	29	22	-	-	PUNCT
iajs-1845	29	23	hydroxylase	hydroxylase	NOUN
iajs-1845	29	24	inside	inside	ADP
iajs-1845	29	25	these	these	DET
iajs-1845	29	26	cells	cell	NOUN
iajs-1845	29	27	,	,	PUNCT
iajs-1845	29	28	and	and	CCONJ
iajs-1845	29	29	resecreted	resecrete	VERB
iajs-1845	29	30	into	into	ADP
iajs-1845	29	31	the	the	DET
iajs-1845	29	32	circulation	circulation	NOUN
iajs-1845	29	33	[	[	X
iajs-1845	29	34	11	11	NUM
iajs-1845	29	35	]	]	PUNCT
iajs-1845	29	36	.	.	PUNCT
iajs-1845	30	1	therefore	therefore	ADV
iajs-1845	30	2	,	,	PUNCT
iajs-1845	30	3	in	in	ADP
iajs-1845	30	4	dn	dn	NOUN
iajs-1845	30	5	,	,	PUNCT
iajs-1845	30	6	hyperglycemia	hyperglycemia	NOUN
iajs-1845	30	7	induces	induce	VERB
iajs-1845	30	8	ros	ros	PROPN
iajs-1845	30	9	(	(	PUNCT
iajs-1845	30	10	reactive	reactive	ADJ
iajs-1845	30	11	oxygen	oxygen	NOUN
iajs-1845	30	12	species	specie	NOUN
iajs-1845	30	13	)	)	PUNCT
iajs-1845	30	14	and	and	CCONJ
iajs-1845	30	15	tgf	tgf	PROPN
iajs-1845	30	16	-	-	PUNCT
iajs-1845	30	17	β	β	PROPN
iajs-1845	30	18	(	(	PUNCT
iajs-1845	30	19	transforming	transform	VERB
iajs-1845	30	20	growth	growth	NOUN
iajs-1845	30	21	factor	factor	NOUN
iajs-1845	30	22	-	-	PUNCT
iajs-1845	30	23	beta	beta	NOUN
iajs-1845	30	24	)	)	PUNCT
iajs-1845	30	25	production	production	NOUN
iajs-1845	30	26	,	,	PUNCT
iajs-1845	30	27	as	as	ADV
iajs-1845	30	28	well	well	ADV
iajs-1845	30	29	as	as	ADP
iajs-1845	30	30	,	,	PUNCT
iajs-1845	30	31	induces	induce	VERB
iajs-1845	30	32	proinflammatory	proinflammatory	ADJ
iajs-1845	30	33	cytokines	cytokine	NOUN
iajs-1845	30	34	secretion	secretion	NOUN
iajs-1845	30	35	(	(	PUNCT
iajs-1845	30	36	such	such	ADJ
iajs-1845	30	37	as	as	ADP
iajs-1845	30	38	interleukin-18	interleukin-18	PROPN
iajs-1845	30	39	)	)	PUNCT
iajs-1845	30	40	from	from	ADP
iajs-1845	30	41	podocytes	podocyte	NOUN
iajs-1845	30	42	[	[	X
iajs-1845	30	43	12	12	NUM
iajs-1845	30	44	]	]	PUNCT
iajs-1845	30	45	.	.	PUNCT
iajs-1845	31	1	these	these	PRON
iajs-1845	31	2	directly	directly	ADV
iajs-1845	31	3	and	and	CCONJ
iajs-1845	31	4	indirectly	indirectly	ADV
iajs-1845	31	5	causing	cause	VERB
iajs-1845	31	6	renal	renal	ADJ
iajs-1845	31	7	tubular	tubular	ADJ
iajs-1845	31	8	damage	damage	NOUN
iajs-1845	31	9	with	with	ADP
iajs-1845	31	10	destruction	destruction	NOUN
iajs-1845	31	11	of	of	ADP
iajs-1845	31	12	megalin	megalin	PROPN
iajs-1845	31	13	/	/	SYM
iajs-1845	31	14	cubilin	cubilin	ADJ
iajs-1845	31	15	receptors	receptor	NOUN
iajs-1845	31	16	in	in	ADP
iajs-1845	31	17	pt	pt	PRON
iajs-1845	31	18	epithelial	epithelial	ADJ
iajs-1845	31	19	cells	cell	NOUN
iajs-1845	31	20	that	that	PRON
iajs-1845	31	21	responsible	responsible	ADJ
iajs-1845	31	22	for	for	ADP
iajs-1845	31	23	vdbp	vdbp	NOUN
iajs-1845	31	24	uptake	uptake	NOUN
iajs-1845	31	25	leading	lead	VERB
iajs-1845	31	26	to	to	ADP
iajs-1845	31	27	excretion	excretion	NOUN
iajs-1845	31	28	of	of	ADP
iajs-1845	31	29	vdbp	vdbp	NOUN
iajs-1845	31	30	in	in	ADP
iajs-1845	31	31	urine	urine	NOUN
iajs-1845	31	32	[	[	X
iajs-1845	31	33	13	13	NUM
iajs-1845	31	34	]	]	PUNCT
iajs-1845	31	35	.	.	PUNCT
iajs-1845	32	1	the	the	DET
iajs-1845	32	2	aim	aim	NOUN
iajs-1845	32	3	of	of	ADP
iajs-1845	32	4	this	this	DET
iajs-1845	32	5	study	study	NOUN
iajs-1845	32	6	was	be	AUX
iajs-1845	32	7	to	to	PART
iajs-1845	32	8	find	find	VERB
iajs-1845	32	9	out	out	ADP
iajs-1845	32	10	the	the	DET
iajs-1845	32	11	possible	possible	ADJ
iajs-1845	32	12	use	use	NOUN
iajs-1845	32	13	of	of	ADP
iajs-1845	32	14	urinary	urinary	ADJ
iajs-1845	32	15	vdbp	vdbp	NOUN
iajs-1845	32	16	(	(	PUNCT
iajs-1845	32	17	uvdbp	uvdbp	PROPN
iajs-1845	32	18	)	)	PUNCT
iajs-1845	32	19	as	as	ADP
iajs-1845	32	20	a	a	DET
iajs-1845	32	21	sensitive	sensitive	ADJ
iajs-1845	32	22	marker	marker	NOUN
iajs-1845	32	23	for	for	ADP
iajs-1845	32	24	early	early	ADJ
iajs-1845	32	25	prediction	prediction	NOUN
iajs-1845	32	26	of	of	ADP
iajs-1845	32	27	dn	dn	PROPN
iajs-1845	32	28	in	in	ADP
iajs-1845	32	29	diabetic	diabetic	ADJ
iajs-1845	32	30	iraqi	iraqi	ADJ
iajs-1845	32	31	patients	patient	NOUN
iajs-1845	32	32	.	.	PUNCT
iajs-1845	33	1	materials	material	NOUN
iajs-1845	33	2	and	and	CCONJ
iajs-1845	33	3	methods	method	NOUN
iajs-1845	33	4	patient	patient	VERB
iajs-1845	33	5	:	:	PUNCT
iajs-1845	33	6	ninety	ninety	NUM
iajs-1845	33	7	type	type	NOUN
iajs-1845	33	8	1	1	NUM
iajs-1845	33	9	(	(	PUNCT
iajs-1845	33	10	t1d	t1d	NOUN
iajs-1845	33	11	)	)	PUNCT
iajs-1845	33	12	and	and	CCONJ
iajs-1845	33	13	type	type	NOUN
iajs-1845	33	14	2	2	NUM
iajs-1845	33	15	(	(	PUNCT
iajs-1845	33	16	t2d	t2d	NOUN
iajs-1845	33	17	)	)	PUNCT
iajs-1845	33	18	diabetic	diabetic	ADJ
iajs-1845	33	19	iraqi	iraqi	ADJ
iajs-1845	33	20	patients	patient	NOUN
iajs-1845	33	21	,	,	PUNCT
iajs-1845	33	22	with	with	ADP
iajs-1845	33	23	(	(	PUNCT
iajs-1845	33	24	50	50	NUM
iajs-1845	33	25	patients	patient	NOUN
iajs-1845	33	26	)	)	PUNCT
iajs-1845	33	27	and	and	CCONJ
iajs-1845	33	28	without	without	ADP
iajs-1845	33	29	(	(	PUNCT
iajs-1845	33	30	40	40	NUM
iajs-1845	33	31	patients	patient	NOUN
iajs-1845	33	32	)	)	PUNCT
iajs-1845	33	33	nephropathy	nephropathy	NOUN
iajs-1845	33	34	,	,	PUNCT
iajs-1845	33	35	were	be	AUX
iajs-1845	33	36	enrolled	enrol	VERB
iajs-1845	33	37	in	in	ADP
iajs-1845	33	38	this	this	DET
iajs-1845	33	39	study	study	NOUN
iajs-1845	33	40	with	with	ADP
iajs-1845	33	41	diabetic	diabetic	ADJ
iajs-1845	33	42	duration	duration	NOUN
iajs-1845	33	43	≥5	≥5	NUM
iajs-1845	33	44	years	year	NOUN
iajs-1845	33	45	and	and	CCONJ
iajs-1845	33	46	age	age	NOUN
iajs-1845	33	47	range	range	NOUN
iajs-1845	33	48	between	between	ADP
iajs-1845	33	49	(	(	PUNCT
iajs-1845	33	50	6	6	NUM
iajs-1845	33	51	-	-	SYM
iajs-1845	33	52	25	25	NUM
iajs-1845	33	53	)	)	PUNCT
iajs-1845	33	54	for	for	ADP
iajs-1845	33	55	t1d	t1d	PROPN
iajs-1845	33	56	and	and	CCONJ
iajs-1845	33	57	(	(	PUNCT
iajs-1845	33	58	35	35	NUM
iajs-1845	33	59	-	-	SYM
iajs-1845	33	60	60	60	NUM
iajs-1845	33	61	)	)	PUNCT
iajs-1845	33	62	for	for	ADP
iajs-1845	33	63	t2d	t2d	NOUN
iajs-1845	33	64	,	,	PUNCT
iajs-1845	33	65	selected	select	VERB
iajs-1845	33	66	from	from	ADP
iajs-1845	33	67	the	the	DET
iajs-1845	33	68	specialized	specialized	ADJ
iajs-1845	33	69	center	center	NOUN
iajs-1845	33	70	for	for	ADP
iajs-1845	33	71	endocrinology	endocrinology	NOUN
iajs-1845	33	72	and	and	CCONJ
iajs-1845	33	73	diabetes	diabetes	NOUN
iajs-1845	33	74	/	/	SYM
iajs-1845	33	75	baghdad	baghdad	PROPN
iajs-1845	33	76	and	and	CCONJ
iajs-1845	33	77	the	the	DET
iajs-1845	33	78	national	national	ADJ
iajs-1845	33	79	center	center	NOUN
iajs-1845	33	80	for	for	ADP
iajs-1845	33	81	the	the	DET
iajs-1845	33	82	treatment	treatment	NOUN
iajs-1845	33	83	of	of	ADP
iajs-1845	33	84	diabetes	diabetes	NOUN
iajs-1845	33	85	and	and	CCONJ
iajs-1845	33	86	research	research	NOUN
iajs-1845	33	87	/	/	SYM
iajs-1845	33	88	al	al	PROPN
iajs-1845	33	89	-	-	PUNCT
iajs-1845	33	90	mustansiriyah	mustansiriyah	PROPN
iajs-1845	33	91	university	university	NOUN
iajs-1845	33	92	during	during	ADP
iajs-1845	33	93	the	the	DET
iajs-1845	33	94	period	period	NOUN
iajs-1845	33	95	from	from	ADP
iajs-1845	33	96	october	october	PROPN
iajs-1845	33	97	2016	2016	NUM
iajs-1845	33	98	to	to	ADP
iajs-1845	33	99	march	march	PROPN
iajs-1845	33	100	2017	2017	NUM
iajs-1845	33	101	.	.	PUNCT
iajs-1845	34	1	the	the	DET
iajs-1845	34	2	presence	presence	NOUN
iajs-1845	34	3	or	or	CCONJ
iajs-1845	34	4	absence	absence	NOUN
iajs-1845	34	5	of	of	ADP
iajs-1845	34	6	dn	dn	NOUN
iajs-1845	34	7	was	be	AUX
iajs-1845	34	8	defined	define	VERB
iajs-1845	34	9	by	by	ADP
iajs-1845	34	10	the	the	DET
iajs-1845	34	11	detection	detection	NOUN
iajs-1845	34	12	of	of	ADP
iajs-1845	34	13	microalbuminuria	microalbuminuria	PROPN
iajs-1845	34	14	(	(	PUNCT
iajs-1845	34	15	30	30	NUM
iajs-1845	34	16	-	-	SYM
iajs-1845	34	17	300	300	NUM
iajs-1845	34	18	mg	mg	PROPN
iajs-1845	34	19	/	/	SYM
iajs-1845	34	20	g	g	NOUN
iajs-1845	34	21	)	)	PUNCT
iajs-1845	34	22	using	use	VERB
iajs-1845	34	23	urinary	urinary	ADJ
iajs-1845	34	24	albumin	albumin	ADJ
iajs-1845	34	25	/	/	SYM
iajs-1845	34	26	creatinine	creatinine	NOUN
iajs-1845	34	27	ration	ration	NOUN
iajs-1845	34	28	(	(	PUNCT
iajs-1845	34	29	uacr	uacr	INTJ
iajs-1845	34	30	)	)	PUNCT
iajs-1845	34	31	.	.	PUNCT
iajs-1845	35	1	all	all	DET
iajs-1845	35	2	subjects	subject	NOUN
iajs-1845	35	3	were	be	AUX
iajs-1845	35	4	screened	screen	VERB
iajs-1845	35	5	for	for	ADP
iajs-1845	35	6	their	their	PRON
iajs-1845	35	7	urine	urine	NOUN
iajs-1845	35	8	microalbumin	microalbumin	NOUN
iajs-1845	35	9	,	,	PUNCT
iajs-1845	35	10	creatinine	creatinine	NOUN
iajs-1845	35	11	and	and	CCONJ
iajs-1845	35	12	vdbp	vdbp	NOUN
iajs-1845	35	13	,	,	PUNCT
iajs-1845	35	14	and	and	CCONJ
iajs-1845	35	15	for	for	ADP
iajs-1845	35	16	their	their	PRON
iajs-1845	35	17	blood	blood	NOUN
iajs-1845	35	18	hba1c	hba1c	PROPN
iajs-1845	35	19	(	(	PUNCT
iajs-1845	35	20	glycated	glycate	VERB
iajs-1845	35	21	hemoglobin	hemoglobin	NOUN
iajs-1845	35	22	)	)	PUNCT
iajs-1845	35	23	.	.	PUNCT
iajs-1845	36	1	also	also	ADV
iajs-1845	36	2	,	,	PUNCT
iajs-1845	36	3	all	all	DET
iajs-1845	36	4	subjects	subject	NOUN
iajs-1845	36	5	were	be	AUX
iajs-1845	36	6	excluded	exclude	VERB
iajs-1845	36	7	from	from	ADP
iajs-1845	36	8	other	other	ADJ
iajs-1845	36	9	chronic	chronic	ADJ
iajs-1845	36	10	liver	liver	NOUN
iajs-1845	36	11	,	,	PUNCT
iajs-1845	36	12	kidney	kidney	NOUN
iajs-1845	36	13	or	or	CCONJ
iajs-1845	36	14	heart	heart	NOUN
iajs-1845	36	15	diseases	disease	NOUN
iajs-1845	36	16	,	,	PUNCT
iajs-1845	36	17	urinary	urinary	ADJ
iajs-1845	36	18	tract	tract	NOUN
iajs-1845	36	19	infections	infection	NOUN
iajs-1845	36	20	,	,	PUNCT
iajs-1845	36	21	smoking	smoking	NOUN
iajs-1845	36	22	,	,	PUNCT
iajs-1845	36	23	and	and	CCONJ
iajs-1845	36	24	pregnancy	pregnancy	NOUN
iajs-1845	36	25	.	.	PUNCT
iajs-1845	37	1	materials	material	NOUN
iajs-1845	37	2	and	and	CCONJ
iajs-1845	37	3	methods	method	NOUN
iajs-1845	37	4	:	:	PUNCT
iajs-1845	37	5	blood	blood	NOUN
iajs-1845	37	6	and	and	CCONJ
iajs-1845	37	7	random	random	ADJ
iajs-1845	37	8	-	-	PUNCT
iajs-1845	37	9	spot	spot	NOUN
iajs-1845	37	10	urine	urine	NOUN
iajs-1845	37	11	specimens	specimen	NOUN
iajs-1845	37	12	were	be	AUX
iajs-1845	37	13	collected	collect	VERB
iajs-1845	37	14	from	from	ADP
iajs-1845	37	15	each	each	DET
iajs-1845	37	16	subject	subject	NOUN
iajs-1845	37	17	;	;	PUNCT
iajs-1845	37	18	uncentrifuged	uncentrifuged	ADJ
iajs-1845	37	19	urine	urine	NOUN
iajs-1845	37	20	was	be	AUX
iajs-1845	37	21	immediately	immediately	ADV
iajs-1845	37	22	tested	test	VERB
iajs-1845	37	23	for	for	ADP
iajs-1845	37	24	urinary	urinary	ADJ
iajs-1845	37	25	albumin	albumin	ADJ
iajs-1845	37	26	/	/	SYM
iajs-1845	37	27	creatinine	creatinine	NOUN
iajs-1845	37	28	ratio	ratio	NOUN
iajs-1845	37	29	(	(	PUNCT
iajs-1845	37	30	uacr	uacr	INTJ
iajs-1845	37	31	)	)	PUNCT
iajs-1845	37	32	using	use	VERB
iajs-1845	37	33	microalbuminuria	microalbuminuria	ADJ
iajs-1845	37	34	test	test	NOUN
iajs-1845	37	35	strips	strip	NOUN
iajs-1845	37	36	calledcombina	calledcombina	NOUN
iajs-1845	37	37	13	13	NUM
iajs-1845	37	38	(	(	PUNCT
iajs-1845	37	39	human	human	PROPN
iajs-1845	37	40	,	,	PUNCT
iajs-1845	37	41	germany	germany	PROPN
iajs-1845	37	42	)	)	PUNCT
iajs-1845	37	43	to	to	PART
iajs-1845	37	44	detect	detect	VERB
iajs-1845	37	45	urine	urine	NOUN
iajs-1845	37	46	microalbumin	microalbumin	NOUN
iajs-1845	37	47	and	and	CCONJ
iajs-1845	37	48	creatinine	creatinine	NOUN
iajs-1845	37	49	,	,	PUNCT
iajs-1845	37	50	then	then	ADV
iajs-1845	37	51	the	the	DET
iajs-1845	37	52	strips	strip	NOUN
iajs-1845	37	53	were	be	AUX
iajs-1845	37	54	read	read	VERB
iajs-1845	37	55	using	use	VERB
iajs-1845	37	56	combilyzer	combilyzer	NOUN
iajs-1845	37	57	13	13	NUM
iajs-1845	37	58	(	(	PUNCT
iajs-1845	37	59	human	human	PROPN
iajs-1845	37	60	,	,	PUNCT
iajs-1845	37	61	germany	germany	PROPN
iajs-1845	37	62	)	)	PUNCT
iajs-1845	37	63	instrument	instrument	NOUN
iajs-1845	38	1	[	[	X
iajs-1845	38	2	14	14	NUM
iajs-1845	38	3	]	]	PUNCT
iajs-1845	38	4	.	.	PUNCT
iajs-1845	39	1	whereas	whereas	SCONJ
iajs-1845	39	2	centrifuged	centrifuged	ADJ
iajs-1845	39	3	urine	urine	NOUN
iajs-1845	39	4	was	be	AUX
iajs-1845	39	5	frozen	freeze	VERB
iajs-1845	39	6	-20	-20	PUNCT
iajs-1845	39	7	°	°	NUM
iajs-1845	39	8	c	c	NOUN
iajs-1845	39	9	until	until	SCONJ
iajs-1845	39	10	used	use	VERB
iajs-1845	39	11	for	for	ADP
iajs-1845	39	12	  	  	SPACE
iajs-1845	39	13	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	ADJ
iajs-1845	39	14	biology	biology	NOUN
iajs-1845	39	15	|	|	ADV
iajs-1845	39	16	17	17	NUM
iajs-1845	39	17	2018)عام	2018)عام	NUM
iajs-1845	39	18	1العدد	1العدد	NUM
iajs-1845	39	19	(	(	PUNCT
iajs-1845	39	20	31لمجلد	31لمجلد	NUM
iajs-1845	39	21	ا	ا	INTJ
iajs-1845	39	22	مجلة	مجلة	NOUN
iajs-1845	39	23	إبن	إبن	VERB
iajs-1845	39	24	الهيثم	الهيثم	ADJ
iajs-1845	39	25	للعلوم	للعلوم	NOUN
iajs-1845	39	26	الصرفة	الصرفة	NOUN
iajs-1845	39	27	والتطبيقية	والتطبيقية	VERB
iajs-1845	39	28	ibn	ibn	PROPN
iajs-1845	39	29	al	al	PROPN
iajs-1845	39	30	-	-	PUNCT
iajs-1845	39	31	haitham	haitham	PROPN
iajs-1845	39	32	jour	jour	X
iajs-1845	39	33	.	.	PROPN
iajs-1845	40	1	for	for	ADP
iajs-1845	40	2	pure	pure	ADJ
iajs-1845	40	3	&	&	CCONJ
iajs-1845	40	4	appl	appl	PROPN
iajs-1845	40	5	.	.	PUNCT
iajs-1845	41	1	sci	sci	PROPN
iajs-1845	41	2	.	.	PUNCT
iajs-1845	41	3	vol	vol	NOUN
iajs-1845	41	4	.	.	PROPN
iajs-1845	42	1	31	31	NUM
iajs-1845	42	2	(	(	PUNCT
iajs-1845	42	3	1	1	NUM
iajs-1845	42	4	)	)	SYM
iajs-1845	42	5	2018	2018	NUM
iajs-1845	42	6	detection	detection	NOUN
iajs-1845	42	7	of	of	ADP
iajs-1845	42	8	uvdbp	uvdbp	NOUN
iajs-1845	42	9	using	use	VERB
iajs-1845	42	10	sandwich	sandwich	NOUN
iajs-1845	42	11	elisa	elisa	PROPN
iajs-1845	42	12	kit	kit	PROPN
iajs-1845	42	13	(	(	PUNCT
iajs-1845	42	14	mybiosource	mybiosource	PROPN
iajs-1845	42	15	,	,	PUNCT
iajs-1845	42	16	usa	usa	PROPN
iajs-1845	42	17	)	)	PUNCT
iajs-1845	42	18	which	which	PRON
iajs-1845	42	19	based	base	VERB
iajs-1845	42	20	on	on	ADP
iajs-1845	42	21	the	the	DET
iajs-1845	42	22	reaction	reaction	NOUN
iajs-1845	42	23	of	of	ADP
iajs-1845	42	24	vdbp	vdbp	NOUN
iajs-1845	42	25	in	in	ADP
iajs-1845	42	26	patient	patient	NOUN
iajs-1845	42	27	's	's	PART
iajs-1845	42	28	urine	urine	NOUN
iajs-1845	42	29	with	with	ADP
iajs-1845	42	30	anti	anti	ADJ
iajs-1845	42	31	-	-	ADJ
iajs-1845	42	32	vdbp	vdbp	ADJ
iajs-1845	42	33	antibody	antibody	NOUN
iajs-1845	42	34	pre	pre	VERB
iajs-1845	42	35	-	-	VERB
iajs-1845	42	36	coated	coated	ADJ
iajs-1845	42	37	onto	onto	ADP
iajs-1845	42	38	microwell	microwell	NOUN
iajs-1845	42	39	plate	plate	NOUN
iajs-1845	42	40	giving	give	VERB
iajs-1845	42	41	a	a	DET
iajs-1845	42	42	color	color	NOUN
iajs-1845	42	43	change	change	NOUN
iajs-1845	42	44	proportional	proportional	ADJ
iajs-1845	42	45	directly	directly	ADV
iajs-1845	42	46	with	with	ADP
iajs-1845	42	47	vdbp	vdbp	ADJ
iajs-1845	42	48	concentration	concentration	NOUN
iajs-1845	42	49	in	in	ADP
iajs-1845	42	50	patient	patient	NOUN
iajs-1845	42	51	's	's	PART
iajs-1845	42	52	urine	urine	NOUN
iajs-1845	42	53	[	[	X
iajs-1845	42	54	15	15	NUM
iajs-1845	42	55	]	]	PUNCT
iajs-1845	42	56	.	.	PUNCT
iajs-1845	43	1	whole	whole	ADJ
iajs-1845	43	2	blood	blood	NOUN
iajs-1845	43	3	was	be	AUX
iajs-1845	43	4	used	use	VERB
iajs-1845	43	5	to	to	PART
iajs-1845	43	6	estimate	estimate	VERB
iajs-1845	43	7	hba1c	hba1c	NOUN
iajs-1845	43	8	using	use	VERB
iajs-1845	43	9	fully	fully	ADV
iajs-1845	43	10	automated	automate	VERB
iajs-1845	43	11	clover	clover	NOUN
iajs-1845	43	12	a1cinstrument	a1cinstrument	NOUN
iajs-1845	43	13	(	(	PUNCT
iajs-1845	43	14	infopia	infopia	PROPN
iajs-1845	43	15	,	,	PUNCT
iajs-1845	43	16	korea	korea	PROPN
iajs-1845	43	17	)	)	PUNCT
iajs-1845	43	18	based	base	VERB
iajs-1845	43	19	on	on	ADP
iajs-1845	43	20	boronate	boronate	NOUN
iajs-1845	43	21	affinity	affinity	NOUN
iajs-1845	43	22	chromatography	chromatography	NOUN
iajs-1845	43	23	technique	technique	NOUN
iajs-1845	43	24	[	[	X
iajs-1845	43	25	16	16	NUM
iajs-1845	43	26	]	]	PUNCT
iajs-1845	43	27	.	.	PUNCT
iajs-1845	44	1	all	all	DET
iajs-1845	44	2	results	result	NOUN
iajs-1845	44	3	were	be	AUX
iajs-1845	44	4	statistically	statistically	ADV
iajs-1845	44	5	analyzed	analyze	VERB
iajs-1845	44	6	using	use	VERB
iajs-1845	44	7	spss	spss	PROPN
iajs-1845	44	8	(	(	PUNCT
iajs-1845	44	9	version	version	NOUN
iajs-1845	44	10	18.0	18.0	NUM
iajs-1845	44	11	)	)	PUNCT
iajs-1845	44	12	,	,	PUNCT
iajs-1845	44	13	a	a	DET
iajs-1845	44	14	significant	significant	NOUN
iajs-1845	44	15	of	of	ADP
iajs-1845	44	16	difference	difference	NOUN
iajs-1845	44	17	was	be	AUX
iajs-1845	44	18	tested	test	VERB
iajs-1845	44	19	by	by	ADP
iajs-1845	44	20	student	student	NOUN
iajs-1845	44	21	's	's	PART
iajs-1845	44	22	t	t	NOUN
iajs-1845	44	23	test	test	NOUN
iajs-1845	44	24	,	,	PUNCT
iajs-1845	44	25	and	and	CCONJ
iajs-1845	44	26	the	the	DET
iajs-1845	44	27	correlation	correlation	NOUN
iajs-1845	44	28	between	between	ADP
iajs-1845	44	29	parameters	parameter	NOUN
iajs-1845	44	30	was	be	AUX
iajs-1845	44	31	obtained	obtain	VERB
iajs-1845	44	32	by	by	ADP
iajs-1845	44	33	pearson	pearson	PROPN
iajs-1845	44	34	's	's	PART
iajs-1845	44	35	correlation	correlation	NOUN
iajs-1845	44	36	(	(	PUNCT
iajs-1845	44	37	r	r	NOUN
iajs-1845	44	38	)	)	PUNCT
iajs-1845	44	39	,	,	PUNCT
iajs-1845	44	40	the	the	DET
iajs-1845	44	41	values	value	NOUN
iajs-1845	44	42	of	of	ADP
iajs-1845	44	43	>	>	X
iajs-1845	44	44	0.05	0.05	NUM
iajs-1845	44	45	,	,	PUNCT
iajs-1845	44	46	≤0.5	≤0.5	NOUN
iajs-1845	44	47	,	,	PUNCT
iajs-1845	44	48	and	and	CCONJ
iajs-1845	44	49	≤0.01	≤0.01	NOUN
iajs-1845	44	50	were	be	AUX
iajs-1845	44	51	considered	consider	VERB
iajs-1845	44	52	non	non	ADJ
iajs-1845	44	53	-	-	ADJ
iajs-1845	44	54	significant	significant	ADJ
iajs-1845	44	55	,	,	PUNCT
iajs-1845	44	56	significant	significant	ADJ
iajs-1845	44	57	and	and	CCONJ
iajs-1845	44	58	highly	highly	ADV
iajs-1845	44	59	significant	significant	ADJ
iajs-1845	44	60	.	.	PUNCT
iajs-1845	45	1	roc	roc	NOUN
iajs-1845	45	2	(	(	PUNCT
iajs-1845	45	3	receiver	receiver	ADV
iajs-1845	45	4	operating	operate	VERB
iajs-1845	45	5	characteristic	characteristic	NOUN
iajs-1845	45	6	)	)	PUNCT
iajs-1845	45	7	curve	curve	NOUN
iajs-1845	45	8	was	be	AUX
iajs-1845	45	9	used	use	VERB
iajs-1845	45	10	to	to	PART
iajs-1845	45	11	detect	detect	VERB
iajs-1845	45	12	the	the	DET
iajs-1845	45	13	diagnostic	diagnostic	ADJ
iajs-1845	45	14	predictivity	predictivity	NOUN
iajs-1845	45	15	of	of	ADP
iajs-1845	45	16	urinary	urinary	ADJ
iajs-1845	45	17	vdbp	vdbp	NOUN
iajs-1845	45	18	using	use	VERB
iajs-1845	45	19	medcalc	medcalc	ADJ
iajs-1845	45	20	software	software	NOUN
iajs-1845	45	21	(	(	PUNCT
iajs-1845	45	22	version	version	NOUN
iajs-1845	45	23	17.8	17.8	NUM
iajs-1845	45	24	)	)	PUNCT
iajs-1845	45	25	,	,	PUNCT
iajs-1845	45	26	a	a	DET
iajs-1845	45	27	value	value	NOUN
iajs-1845	45	28	<	<	X
iajs-1845	45	29	0.5	0.5	NUM
iajs-1845	45	30	of	of	ADP
iajs-1845	45	31	auc	auc	NOUN
iajs-1845	45	32	(	(	PUNCT
iajs-1845	45	33	area	area	NOUN
iajs-1845	45	34	under	under	ADP
iajs-1845	45	35	the	the	DET
iajs-1845	45	36	curve	curve	NOUN
iajs-1845	45	37	)	)	PUNCT
iajs-1845	45	38	was	be	AUX
iajs-1845	45	39	considered	consider	VERB
iajs-1845	45	40	statistically	statistically	ADV
iajs-1845	45	41	significant	significant	ADJ
iajs-1845	45	42	.	.	PUNCT
iajs-1845	46	1	results	result	NOUN
iajs-1845	46	2	table	table	NOUN
iajs-1845	46	3	(	(	PUNCT
iajs-1845	46	4	1	1	X
iajs-1845	46	5	)	)	PUNCT
iajs-1845	46	6	revealed	reveal	VERB
iajs-1845	46	7	a	a	DET
iajs-1845	46	8	significant	significant	ADJ
iajs-1845	46	9	difference	difference	NOUN
iajs-1845	46	10	in	in	ADP
iajs-1845	46	11	t1d	t1d	PROPN
iajs-1845	46	12	patients	patient	NOUN
iajs-1845	46	13	with	with	ADP
iajs-1845	46	14	dn	dn	NOUN
iajs-1845	46	15	than	than	ADP
iajs-1845	46	16	those	those	PRON
iajs-1845	46	17	without	without	ADP
iajs-1845	46	18	dn	dn	NOUN
iajs-1845	46	19	for	for	ADP
iajs-1845	46	20	uacr	uacr	PROPN
iajs-1845	46	21	(	(	PUNCT
iajs-1845	46	22	97.0	97.0	NUM
iajs-1845	46	23	vs.	vs.	ADP
iajs-1845	46	24	14.0	14.0	NUM
iajs-1845	46	25	mg	mg	NUM
iajs-1845	46	26	/	/	SYM
iajs-1845	46	27	g	g	NOUN
iajs-1845	46	28	)	)	PUNCT
iajs-1845	46	29	,	,	PUNCT
iajs-1845	46	30	hba1c	hba1c	PROPN
iajs-1845	46	31	(	(	PUNCT
iajs-1845	46	32	11.0	11.0	NUM
iajs-1845	46	33	vs.	vs.	ADP
iajs-1845	46	34	9.5	9.5	NUM
iajs-1845	46	35	%	%	NOUN
iajs-1845	46	36	)	)	PUNCT
iajs-1845	46	37	,	,	PUNCT
iajs-1845	46	38	and	and	CCONJ
iajs-1845	46	39	uvdbp	uvdbp	PROPN
iajs-1845	46	40	(	(	PUNCT
iajs-1845	46	41	347.2	347.2	NUM
iajs-1845	46	42	vs.	vs.	ADP
iajs-1845	46	43	127.9	127.9	NUM
iajs-1845	46	44	ng	ng	PROPN
iajs-1845	46	45	/	/	SYM
iajs-1845	46	46	ml	ml	PROPN
iajs-1845	46	47	)	)	PUNCT
iajs-1845	46	48	;	;	PUNCT
iajs-1845	46	49	also	also	ADV
iajs-1845	46	50	a	a	DET
iajs-1845	46	51	significant	significant	ADJ
iajs-1845	46	52	difference	difference	NOUN
iajs-1845	46	53	in	in	ADP
iajs-1845	46	54	t2d	t2d	NOUN
iajs-1845	46	55	patients	patient	NOUN
iajs-1845	46	56	with	with	ADP
iajs-1845	46	57	compared	compare	VERB
iajs-1845	46	58	to	to	ADP
iajs-1845	46	59	without	without	ADP
iajs-1845	46	60	dn	dn	NOUN
iajs-1845	46	61	for	for	ADP
iajs-1845	46	62	uacr	uacr	PROPN
iajs-1845	46	63	(	(	PUNCT
iajs-1845	46	64	74.7	74.7	NUM
iajs-1845	46	65	vs.	vs.	ADP
iajs-1845	46	66	16.7	16.7	NUM
iajs-1845	46	67	mg	mg	NUM
iajs-1845	46	68	/	/	SYM
iajs-1845	46	69	g	g	NOUN
iajs-1845	46	70	)	)	PUNCT
iajs-1845	46	71	,	,	PUNCT
iajs-1845	46	72	hba1c	hba1c	PROPN
iajs-1845	46	73	(	(	PUNCT
iajs-1845	46	74	11.5	11.5	NUM
iajs-1845	46	75	vs.	vs.	ADP
iajs-1845	46	76	8.6	8.6	NUM
iajs-1845	46	77	%	%	NOUN
iajs-1845	46	78	)	)	PUNCT
iajs-1845	46	79	,	,	PUNCT
iajs-1845	46	80	and	and	CCONJ
iajs-1845	46	81	(	(	PUNCT
iajs-1845	46	82	248.2	248.2	NUM
iajs-1845	46	83	vs.	vs.	ADP
iajs-1845	46	84	105.3	105.3	NUM
iajs-1845	46	85	ng	ng	NOUN
iajs-1845	46	86	/	/	SYM
iajs-1845	46	87	ml	ml	PROPN
iajs-1845	46	88	)	)	PUNCT
iajs-1845	46	89	.	.	PUNCT
iajs-1845	47	1	additionally	additionally	ADV
iajs-1845	47	2	,	,	PUNCT
iajs-1845	47	3	a	a	DET
iajs-1845	47	4	highly	highly	ADV
iajs-1845	47	5	significant	significant	ADJ
iajs-1845	47	6	difference	difference	NOUN
iajs-1845	47	7	(	(	PUNCT
iajs-1845	47	8	p<0.01	p<0.01	PROPN
iajs-1845	47	9	)	)	PUNCT
iajs-1845	47	10	in	in	ADP
iajs-1845	47	11	diabetic	diabetic	ADJ
iajs-1845	47	12	patients	patient	NOUN
iajs-1845	47	13	with	with	ADP
iajs-1845	47	14	dn	dn	NOUN
iajs-1845	47	15	compared	compare	VERB
iajs-1845	47	16	to	to	ADP
iajs-1845	47	17	those	those	PRON
iajs-1845	47	18	without	without	ADP
iajs-1845	47	19	dn	dn	NOUN
iajs-1845	47	20	for	for	ADP
iajs-1845	47	21	uacr	uacr	PROPN
iajs-1845	47	22	(	(	PUNCT
iajs-1845	47	23	171.7	171.7	NUM
iajs-1845	47	24	vs.	vs.	ADP
iajs-1845	47	25	30.7	30.7	NUM
iajs-1845	47	26	mg	mg	NUM
iajs-1845	47	27	/	/	SYM
iajs-1845	47	28	g	g	NOUN
iajs-1845	47	29	)	)	PUNCT
iajs-1845	47	30	,	,	PUNCT
iajs-1845	47	31	hba1c	hba1c	PROPN
iajs-1845	47	32	(	(	PUNCT
iajs-1845	47	33	22.5	22.5	NUM
iajs-1845	47	34	vs.18.1	vs.18.1	NOUN
iajs-1845	47	35	%	%	NOUN
iajs-1845	47	36	)	)	PUNCT
iajs-1845	47	37	and	and	CCONJ
iajs-1845	47	38	(	(	PUNCT
iajs-1845	47	39	495.4	495.4	NUM
iajs-1845	47	40	vs.	vs.	ADP
iajs-1845	47	41	233.2	233.2	NUM
iajs-1845	47	42	ng	ng	PROPN
iajs-1845	47	43	/	/	SYM
iajs-1845	47	44	ml	ml	PROPN
iajs-1845	47	45	)	)	PUNCT
iajs-1845	47	46	(	(	PUNCT
iajs-1845	47	47	data	datum	NOUN
iajs-1845	47	48	not	not	PART
iajs-1845	47	49	shown	show	VERB
iajs-1845	47	50	in	in	ADP
iajs-1845	47	51	table	table	NOUN
iajs-1845	47	52	(	(	PUNCT
iajs-1845	47	53	1	1	NUM
iajs-1845	47	54	)	)	PUNCT
iajs-1845	47	55	)	)	PUNCT
iajs-1845	47	56	.	.	PUNCT
iajs-1845	48	1	table	table	NOUN
iajs-1845	48	2	(	(	PUNCT
iajs-1845	48	3	1	1	NUM
iajs-1845	48	4	):	):	PUNCT
iajs-1845	48	5	comparison	comparison	NOUN
iajs-1845	48	6	of	of	ADP
iajs-1845	48	7	the	the	DET
iajs-1845	48	8	mean	mean	ADJ
iajs-1845	48	9	levels	level	NOUN
iajs-1845	48	10	of	of	ADP
iajs-1845	48	11	biochemical	biochemical	ADJ
iajs-1845	48	12	and	and	CCONJ
iajs-1845	48	13	uvdbp	uvdbp	PROPN
iajs-1845	48	14	markers	marker	NOUN
iajs-1845	48	15	in	in	ADP
iajs-1845	48	16	the	the	DET
iajs-1845	48	17	diabetic	diabetic	ADJ
iajs-1845	48	18	patients	patient	NOUN
iajs-1845	48	19	with	with	ADP
iajs-1845	48	20	and	and	CCONJ
iajs-1845	48	21	without	without	ADP
iajs-1845	48	22	nephropathy	nephropathy	NOUN
iajs-1845	48	23	.	.	PUNCT
iajs-1845	49	1	parameters	parameter	NOUN
iajs-1845	49	2	statistics	statistic	NOUN
iajs-1845	49	3	groups	group	NOUN
iajs-1845	49	4	dps	dps	VERB
iajs-1845	49	5	with	with	ADP
iajs-1845	49	6	dn	dn	NOUN
iajs-1845	49	7	vs.	vs.	ADP
iajs-1845	49	8	without	without	ADP
iajs-1845	49	9	dn	dn	PROPN
iajs-1845	49	10	t1d	t1d	PROPN
iajs-1845	49	11	t2d	t2d	PROPN
iajs-1845	49	12	with	with	ADP
iajs-1845	49	13	dn	dn	PROPN
iajs-1845	49	14	(	(	PUNCT
iajs-1845	49	15	n=25	n=25	NOUN
iajs-1845	49	16	)	)	PUNCT
iajs-1845	49	17	without	without	ADP
iajs-1845	49	18	dn	dn	PROPN
iajs-1845	49	19	(	(	PUNCT
iajs-1845	49	20	n=20	n=20	PROPN
iajs-1845	49	21	)	)	PUNCT
iajs-1845	49	22	with	with	ADP
iajs-1845	49	23	dn	dn	PROPN
iajs-1845	49	24	(	(	PUNCT
iajs-1845	49	25	n=25	n=25	NOUN
iajs-1845	49	26	)	)	PUNCT
iajs-1845	49	27	without	without	ADP
iajs-1845	49	28	dn	dn	PROPN
iajs-1845	49	29	(	(	PUNCT
iajs-1845	49	30	n=20	n=20	PROPN
iajs-1845	49	31	)	)	PUNCT
iajs-1845	50	1	uacr	uacr	INTJ
iajs-1845	50	2	(	(	PUNCT
iajs-1845	50	3	mg	mg	PROPN
iajs-1845	50	4	/	/	SYM
iajs-1845	50	5	g	g	NOUN
iajs-1845	50	6	)	)	PUNCT
iajs-1845	50	7	mean	mean	VERB
iajs-1845	50	8	97.0	97.0	NUM
iajs-1845	50	9	14.0	14.0	NUM
iajs-1845	50	10	74.7	74.7	NUM
iajs-1845	50	11	16.7	16.7	NUM
iajs-1845	50	12	0.000	0.000	NUM
iajs-1845	50	13	(	(	PUNCT
iajs-1845	50	14	hs	hs	X
iajs-1845	50	15	)	)	PUNCT
iajs-1845	50	16	sd	sd	ADP
iajs-1845	50	17	34.0	34.0	NUM
iajs-1845	50	18	7.1	7.1	NUM
iajs-1845	50	19	29.0	29.0	NUM
iajs-1845	50	20	7.3	7.3	NUM
iajs-1845	50	21	range	range	NOUN
iajs-1845	50	22	40	40	NUM
iajs-1845	50	23	-	-	SYM
iajs-1845	50	24	150	150	NUM
iajs-1845	50	25	5	5	NUM
iajs-1845	50	26	-	-	SYM
iajs-1845	50	27	30	30	NUM
iajs-1845	50	28	35	35	NUM
iajs-1845	50	29	-	-	SYM
iajs-1845	50	30	150	150	NUM
iajs-1845	50	31	10	10	NUM
iajs-1845	50	32	-	-	SYM
iajs-1845	50	33	30	30	NUM
iajs-1845	50	34	p	p	NOUN
iajs-1845	50	35	-	-	PUNCT
iajs-1845	50	36	value	value	NOUN
iajs-1845	51	1	0.000	0.000	NUM
iajs-1845	51	2	(	(	PUNCT
iajs-1845	51	3	hs	hs	X
iajs-1845	51	4	)	)	PUNCT
iajs-1845	51	5	0.000	0.000	NUM
iajs-1845	51	6	(	(	PUNCT
iajs-1845	51	7	hs	hs	X
iajs-1845	51	8	)	)	PUNCT
iajs-1845	51	9	hba1c	hba1c	PROPN
iajs-1845	51	10	(	(	PUNCT
iajs-1845	51	11	%	%	INTJ
iajs-1845	51	12	)	)	PUNCT
iajs-1845	51	13	mean	mean	NOUN
iajs-1845	51	14	11.0	11.0	NUM
iajs-1845	51	15	9.5	9.5	NUM
iajs-1845	51	16	11.5	11.5	NUM
iajs-1845	51	17	8.6	8.6	NUM
iajs-1845	51	18	0.001	0.001	NUM
iajs-1845	51	19	(	(	PUNCT
iajs-1845	51	20	hs	hs	X
iajs-1845	51	21	)	)	PUNCT
iajs-1845	51	22	sd	sd	ADP
iajs-1845	51	23	1.9	1.9	NUM
iajs-1845	51	24	1.9	1.9	NUM
iajs-1845	51	25	1.8	1.8	NUM
iajs-1845	51	26	1.7	1.7	NUM
iajs-1845	51	27	range	range	NOUN
iajs-1845	51	28	8	8	NUM
iajs-1845	51	29	-	-	SYM
iajs-1845	51	30	14	14	NUM
iajs-1845	51	31	7	7	NUM
iajs-1845	51	32	-	-	SYM
iajs-1845	51	33	13	13	NUM
iajs-1845	51	34	8	8	NUM
iajs-1845	51	35	-	-	SYM
iajs-1845	51	36	14	14	NUM
iajs-1845	51	37	6	6	NUM
iajs-1845	51	38	-	-	SYM
iajs-1845	51	39	13	13	NUM
iajs-1845	51	40	p	p	NOUN
iajs-1845	51	41	-	-	PUNCT
iajs-1845	51	42	value	value	NOUN
iajs-1845	51	43	0.020	0.020	NUM
iajs-1845	51	44	(	(	PUNCT
iajs-1845	51	45	s	s	NOUN
iajs-1845	51	46	)	)	PUNCT
iajs-1845	51	47	0.003	0.003	NUM
iajs-1845	51	48	(	(	PUNCT
iajs-1845	51	49	hs	hs	PROPN
iajs-1845	51	50	)	)	PUNCT
iajs-1845	51	51	uvdbp	uvdbp	PROPN
iajs-1845	51	52	(	(	PUNCT
iajs-1845	51	53	ng	ng	PROPN
iajs-1845	51	54	/	/	SYM
iajs-1845	51	55	ml	ml	NOUN
iajs-1845	51	56	)	)	PUNCT
iajs-1845	51	57	mean	mean	VERB
iajs-1845	52	1	347.2	347.2	NUM
iajs-1845	52	2	127.9	127.9	NUM
iajs-1845	52	3	248.2	248.2	NUM
iajs-1845	52	4	105.3	105.3	NUM
iajs-1845	52	5	0.000	0.000	NUM
iajs-1845	52	6	(	(	PUNCT
iajs-1845	52	7	hs	hs	X
iajs-1845	52	8	)	)	PUNCT
iajs-1845	52	9	sd	sd	ADP
iajs-1845	52	10	150.3	150.3	NUM
iajs-1845	52	11	61.5	61.5	NUM
iajs-1845	52	12	97.8	97.8	NUM
iajs-1845	52	13	59.9	59.9	NUM
iajs-1845	52	14	range	range	NOUN
iajs-1845	52	15	182	182	NUM
iajs-1845	52	16	-	-	SYM
iajs-1845	52	17	713	713	NUM
iajs-1845	52	18	85	85	NUM
iajs-1845	52	19	-	-	SYM
iajs-1845	52	20	336	336	NUM
iajs-1845	52	21	140	140	NUM
iajs-1845	52	22	-	-	SYM
iajs-1845	52	23	454	454	NUM
iajs-1845	52	24	30	30	NUM
iajs-1845	52	25	-	-	SYM
iajs-1845	52	26	219	219	NUM
iajs-1845	52	27	p	p	NOUN
iajs-1845	52	28	-	-	PUNCT
iajs-1845	52	29	value	value	NOUN
iajs-1845	52	30	0.000	0.000	NUM
iajs-1845	52	31	(	(	PUNCT
iajs-1845	52	32	hs	hs	X
iajs-1845	52	33	)	)	PUNCT
iajs-1845	52	34	0.000	0.000	NUM
iajs-1845	52	35	(	(	PUNCT
iajs-1845	52	36	hs	hs	INTJ
iajs-1845	52	37	)	)	PUNCT
iajs-1845	52	38	t1d=	t1d=	NOUN
iajs-1845	52	39	type	type	NOUN
iajs-1845	52	40	1	1	NUM
iajs-1845	52	41	diabetes	diabete	NOUN
iajs-1845	52	42	,	,	PUNCT
iajs-1845	52	43	t2d=	t2d=	DET
iajs-1845	52	44	type	type	NOUN
iajs-1845	52	45	2	2	NUM
iajs-1845	52	46	diabetes	diabetes	NOUN
iajs-1845	52	47	,	,	PUNCT
iajs-1845	52	48	dn=	dn=	NOUN
iajs-1845	52	49	diabetic	diabetic	ADJ
iajs-1845	52	50	nephropathy	nephropathy	NOUN
iajs-1845	52	51	,	,	PUNCT
iajs-1845	52	52	dps=	dps=	ADJ
iajs-1845	52	53	diabetic	diabetic	ADJ
iajs-1845	52	54	patients	patient	NOUN
iajs-1845	52	55	,	,	PUNCT
iajs-1845	52	56	uacr=	uacr=	NUM
iajs-1845	52	57	urinary	urinary	ADJ
iajs-1845	52	58	albumin	albumin	NOUN
iajs-1845	52	59	to	to	ADP
iajs-1845	52	60	creatinine	creatinine	NOUN
iajs-1845	52	61	ratio	ratio	NOUN
iajs-1845	52	62	,	,	PUNCT
iajs-1845	52	63	hba1c=	hba1c=	PROPN
iajs-1845	52	64	glycated	glycate	VERB
iajs-1845	52	65	hemoglobin	hemoglobin	NOUN
iajs-1845	52	66	,	,	PUNCT
iajs-1845	52	67	uvdbp=	uvdbp=	ADJ
iajs-1845	52	68	urinary	urinary	ADJ
iajs-1845	52	69	vitamin	vitamin	NOUN
iajs-1845	52	70	d	d	NOUN
iajs-1845	52	71	binding	bind	VERB
iajs-1845	52	72	protein	protein	NOUN
iajs-1845	52	73	sd	sd	NOUN
iajs-1845	52	74	=	=	NOUN
iajs-1845	52	75	standard	standard	ADJ
iajs-1845	52	76	deviation	deviation	NOUN
iajs-1845	52	77	,	,	PUNCT
iajs-1845	52	78	s=	s=	NOUN
iajs-1845	52	79	significant	significant	ADJ
iajs-1845	52	80	,	,	PUNCT
iajs-1845	52	81	hs=	hs=	ADV
iajs-1845	52	82	highly	highly	ADV
iajs-1845	52	83	significant	significant	ADJ
iajs-1845	52	84	table	table	NOUN
iajs-1845	52	85	(	(	PUNCT
iajs-1845	52	86	2	2	NUM
iajs-1845	52	87	)	)	PUNCT
iajs-1845	52	88	exhibited	exhibit	VERB
iajs-1845	52	89	a	a	DET
iajs-1845	52	90	strong	strong	ADJ
iajs-1845	52	91	positive	positive	ADJ
iajs-1845	52	92	correlation	correlation	NOUN
iajs-1845	52	93	of	of	ADP
iajs-1845	52	94	uvdbp	uvdbp	PROPN
iajs-1845	52	95	with	with	ADP
iajs-1845	52	96	uacr	uacr	PRON
iajs-1845	52	97	in	in	ADP
iajs-1845	52	98	dn	dn	PROPN
iajs-1845	52	99	patients	patient	NOUN
iajs-1845	52	100	(	(	PUNCT
iajs-1845	52	101	r=0.540	r=0.540	PROPN
iajs-1845	52	102	with	with	ADP
iajs-1845	52	103	p=0.000	p=0.000	NUM
iajs-1845	52	104	)	)	PUNCT
iajs-1845	52	105	compared	compare	VERB
iajs-1845	52	106	to	to	ADP
iajs-1845	52	107	non	non	ADJ
iajs-1845	52	108	-	-	ADJ
iajs-1845	52	109	significant	significant	ADJ
iajs-1845	52	110	relation	relation	NOUN
iajs-1845	52	111	in	in	ADP
iajs-1845	52	112	diabetic	diabetic	ADJ
iajs-1845	52	113	patients	patient	NOUN
iajs-1845	52	114	without	without	ADP
iajs-1845	52	115	dn	dn	PROPN
iajs-1845	52	116	(	(	PUNCT
iajs-1845	52	117	r=-0.061	r=-0.061	NOUN
iajs-1845	52	118	with	with	ADP
iajs-1845	52	119	p=0.708	p=0.708	NUM
iajs-1845	52	120	)	)	PUNCT
iajs-1845	52	121	.	.	PUNCT
iajs-1845	53	1	whereas	whereas	SCONJ
iajs-1845	53	2	a	a	DET
iajs-1845	53	3	strong	strong	ADJ
iajs-1845	53	4	positive	positive	ADJ
iajs-1845	53	5	correlation	correlation	NOUN
iajs-1845	53	6	of	of	ADP
iajs-1845	53	7	uvdbp	uvdbp	PROPN
iajs-1845	53	8	with	with	ADP
iajs-1845	53	9	hba1c	hba1c	PROPN
iajs-1845	53	10	was	be	AUX
iajs-1845	53	11	seen	see	VERB
iajs-1845	53	12	in	in	ADP
iajs-1845	53	13	both	both	CCONJ
iajs-1845	53	14	diabetic	diabetic	ADJ
iajs-1845	53	15	patients	patient	NOUN
iajs-1845	53	16	with	with	ADP
iajs-1845	53	17	and	and	CCONJ
iajs-1845	53	18	without	without	ADP
iajs-1845	53	19	dn	dn	PROPN
iajs-1845	53	20	(	(	PUNCT
iajs-1845	53	21	r=0.560	r=0.560	NOUN
iajs-1845	53	22	with	with	ADP
iajs-1845	53	23	p=0.000	p=0.000	NUM
iajs-1845	53	24	and	and	CCONJ
iajs-1845	53	25	r=0.694	r=0.694	NOUN
iajs-1845	53	26	with	with	ADP
iajs-1845	53	27	p=0.000	p=0.000	NUM
iajs-1845	53	28	,	,	PUNCT
iajs-1845	53	29	respectively	respectively	ADV
iajs-1845	53	30	)	)	PUNCT
iajs-1845	53	31	.	.	PUNCT
iajs-1845	53	32	  	  	SPACE
iajs-1845	54	1	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	ADJ
iajs-1845	54	2	biology	biology	NOUN
iajs-1845	54	3	|	|	ADV
iajs-1845	54	4	18	18	NUM
iajs-1845	54	5	2018)عام	2018)عام	NUM
iajs-1845	54	6	1العدد	1العدد	NUM
iajs-1845	54	7	(	(	PUNCT
iajs-1845	54	8	31لمجلد	31لمجلد	NUM
iajs-1845	54	9	ا	ا	INTJ
iajs-1845	54	10	مجلة	مجلة	NOUN
iajs-1845	54	11	إبن	إبن	VERB
iajs-1845	54	12	الهيثم	الهيثم	ADJ
iajs-1845	54	13	للعلوم	للعلوم	NOUN
iajs-1845	54	14	الصرفة	الصرفة	NOUN
iajs-1845	54	15	والتطبيقية	والتطبيقية	VERB
iajs-1845	54	16	ibn	ibn	PROPN
iajs-1845	54	17	al	al	PROPN
iajs-1845	54	18	-	-	PUNCT
iajs-1845	54	19	haitham	haitham	PROPN
iajs-1845	54	20	jour	jour	X
iajs-1845	54	21	.	.	PROPN
iajs-1845	54	22	for	for	ADP
iajs-1845	54	23	pure	pure	ADJ
iajs-1845	54	24	&	&	CCONJ
iajs-1845	54	25	appl	appl	PROPN
iajs-1845	54	26	.	.	PUNCT
iajs-1845	55	1	sci	sci	PROPN
iajs-1845	55	2	.	.	PUNCT
iajs-1845	55	3	vol	vol	NOUN
iajs-1845	55	4	.	.	PROPN
iajs-1845	56	1	31	31	NUM
iajs-1845	56	2	(	(	PUNCT
iajs-1845	56	3	1	1	NUM
iajs-1845	56	4	)	)	SYM
iajs-1845	56	5	2018	2018	NUM
iajs-1845	56	6	table	table	NOUN
iajs-1845	56	7	(	(	PUNCT
iajs-1845	56	8	2	2	NUM
iajs-1845	56	9	):	):	PUNCT
iajs-1845	56	10	correlation	correlation	NOUN
iajs-1845	56	11	of	of	ADP
iajs-1845	56	12	uvdbp	uvdbp	PROPN
iajs-1845	56	13	with	with	ADP
iajs-1845	56	14	uacr	uacr	PROPN
iajs-1845	56	15	and	and	CCONJ
iajs-1845	56	16	hba1c	hba1c	PROPN
iajs-1845	56	17	in	in	ADP
iajs-1845	56	18	diabetic	diabetic	ADJ
iajs-1845	56	19	patients	patient	NOUN
iajs-1845	56	20	with	with	ADP
iajs-1845	56	21	and	and	CCONJ
iajs-1845	56	22	without	without	ADP
iajs-1845	56	23	nephropathy	nephropathy	NOUN
iajs-1845	56	24	.	.	PUNCT
iajs-1845	57	1	parameters	parameter	NOUN
iajs-1845	57	2	uvdbp(ng	uvdbp(ng	ADJ
iajs-1845	57	3	/	/	SYM
iajs-1845	57	4	ml	ml	NOUN
iajs-1845	57	5	)	)	PUNCT
iajs-1845	57	6	diabetic	diabetic	ADJ
iajs-1845	57	7	patients	patient	NOUN
iajs-1845	57	8	with	with	ADP
iajs-1845	57	9	dn	dn	PROPN
iajs-1845	57	10	diabetic	diabetic	ADJ
iajs-1845	57	11	patients	patient	NOUN
iajs-1845	57	12	without	without	ADP
iajs-1845	57	13	dn	dn	ADP
iajs-1845	57	14	uacr	uacr	ADV
iajs-1845	57	15	(	(	PUNCT
iajs-1845	57	16	mg	mg	PROPN
iajs-1845	57	17	/	/	SYM
iajs-1845	57	18	g	g	NOUN
iajs-1845	57	19	)	)	PUNCT
iajs-1845	57	20	r	r	NOUN
iajs-1845	57	21	0.540	0.540	NUM
iajs-1845	57	22	r	r	NOUN
iajs-1845	57	23	-0.061	-0.061	NOUN
iajs-1845	57	24	p	p	NOUN
iajs-1845	57	25	-	-	PUNCT
iajs-1845	57	26	value	value	NOUN
iajs-1845	57	27	0.000	0.000	NUM
iajs-1845	57	28	(	(	PUNCT
iajs-1845	57	29	hs	hs	NOUN
iajs-1845	57	30	)	)	PUNCT
iajs-1845	57	31	p	p	NOUN
iajs-1845	57	32	-	-	PUNCT
iajs-1845	57	33	value	value	NOUN
iajs-1845	57	34	0.708	0.708	NUM
iajs-1845	57	35	(	(	PUNCT
iajs-1845	57	36	ns	ns	NUM
iajs-1845	57	37	)	)	PUNCT
iajs-1845	57	38	hba1c	hba1c	PROPN
iajs-1845	57	39	(	(	PUNCT
iajs-1845	57	40	%	%	INTJ
iajs-1845	57	41	)	)	PUNCT
iajs-1845	57	42	r	r	NOUN
iajs-1845	57	43	0.560	0.560	NUM
iajs-1845	57	44	r	r	NOUN
iajs-1845	57	45	0.694	0.694	NUM
iajs-1845	57	46	p	p	ADJ
iajs-1845	57	47	-	-	PUNCT
iajs-1845	57	48	value	value	NOUN
iajs-1845	57	49	0.000	0.000	NUM
iajs-1845	57	50	(	(	PUNCT
iajs-1845	57	51	hs	hs	NOUN
iajs-1845	57	52	)	)	PUNCT
iajs-1845	57	53	p	p	NOUN
iajs-1845	57	54	-	-	PUNCT
iajs-1845	57	55	value	value	NOUN
iajs-1845	57	56	0.000	0.000	NUM
iajs-1845	57	57	(	(	PUNCT
iajs-1845	57	58	hs	hs	NOUN
iajs-1845	57	59	)	)	PUNCT
iajs-1845	57	60	r=	r=	PROPN
iajs-1845	57	61	pearson	pearson	PROPN
iajs-1845	57	62	's	's	PART
iajs-1845	57	63	correlation	correlation	NOUN
iajs-1845	57	64	,	,	PUNCT
iajs-1845	57	65	ns=	ns=	ADJ
iajs-1845	57	66	non	non	ADJ
iajs-1845	57	67	-	-	ADJ
iajs-1845	57	68	significant	significant	ADJ
iajs-1845	57	69	table	table	NOUN
iajs-1845	57	70	(	(	PUNCT
iajs-1845	57	71	3	3	NUM
iajs-1845	57	72	)	)	PUNCT
iajs-1845	57	73	and	and	CCONJ
iajs-1845	57	74	figure	figure	NOUN
iajs-1845	57	75	(	(	PUNCT
iajs-1845	57	76	1	1	X
iajs-1845	57	77	)	)	PUNCT
iajs-1845	57	78	showed	show	VERB
iajs-1845	57	79	roc	roc	PROPN
iajs-1845	57	80	curve	curve	NOUN
iajs-1845	57	81	characteristics	characteristic	NOUN
iajs-1845	57	82	of	of	ADP
iajs-1845	57	83	uvdbp	uvdbp	PROPN
iajs-1845	57	84	with	with	ADP
iajs-1845	57	85	highly	highly	ADV
iajs-1845	57	86	significant	significant	ADJ
iajs-1845	57	87	auc	auc	NOUN
iajs-1845	57	88	(	(	PUNCT
iajs-1845	57	89	0.935	0.935	NUM
iajs-1845	57	90	)	)	PUNCT
iajs-1845	57	91	.	.	PUNCT
iajs-1845	58	1	urinary	urinary	ADJ
iajs-1845	58	2	vdbp	vdbp	NOUN
iajs-1845	58	3	showed	show	VERB
iajs-1845	58	4	a	a	DET
iajs-1845	58	5	diagnostic	diagnostic	ADJ
iajs-1845	58	6	cutoff	cutoff	NOUN
iajs-1845	58	7	value	value	NOUN
iajs-1845	58	8	of	of	ADP
iajs-1845	58	9	>	>	SYM
iajs-1845	58	10	152	152	NUM
iajs-1845	58	11	ng	ng	PROPN
iajs-1845	58	12	/	/	SYM
iajs-1845	58	13	ml	ml	NOUN
iajs-1845	58	14	with	with	ADP
iajs-1845	58	15	94	94	NUM
iajs-1845	58	16	%	%	NOUN
iajs-1845	58	17	,	,	PUNCT
iajs-1845	58	18	82	82	NUM
iajs-1845	58	19	%	%	NOUN
iajs-1845	58	20	,	,	PUNCT
iajs-1845	58	21	87	87	NUM
iajs-1845	58	22	%	%	NOUN
iajs-1845	58	23	,	,	PUNCT
iajs-1845	58	24	and	and	CCONJ
iajs-1845	58	25	92	92	NUM
iajs-1845	58	26	%	%	NOUN
iajs-1845	58	27	of	of	ADP
iajs-1845	58	28	sensitivity	sensitivity	NOUN
iajs-1845	58	29	,	,	PUNCT
iajs-1845	58	30	specificity	specificity	NOUN
iajs-1845	58	31	,	,	PUNCT
iajs-1845	58	32	ppv	ppv	NOUN
iajs-1845	58	33	(	(	PUNCT
iajs-1845	58	34	positive	positive	ADJ
iajs-1845	58	35	predictive	predictive	ADJ
iajs-1845	58	36	value	value	NOUN
iajs-1845	58	37	)	)	PUNCT
iajs-1845	58	38	,	,	PUNCT
iajs-1845	58	39	and	and	CCONJ
iajs-1845	58	40	npv	npv	NOUN
iajs-1845	58	41	(	(	PUNCT
iajs-1845	58	42	negative	negative	ADJ
iajs-1845	58	43	predictive	predictive	ADJ
iajs-1845	58	44	value	value	NOUN
iajs-1845	58	45	)	)	PUNCT
iajs-1845	58	46	respectively	respectively	ADV
iajs-1845	58	47	.	.	PUNCT
iajs-1845	59	1	table	table	NOUN
iajs-1845	59	2	(	(	PUNCT
iajs-1845	59	3	3	3	NUM
iajs-1845	59	4	):	):	PUNCT
iajs-1845	59	5	roc	roc	PROPN
iajs-1845	59	6	curve	curve	NOUN
iajs-1845	59	7	characteristics	characteristic	NOUN
iajs-1845	59	8	of	of	ADP
iajs-1845	59	9	uvdbp	uvdbp	PROPN
iajs-1845	59	10	in	in	ADP
iajs-1845	59	11	diabetic	diabetic	ADJ
iajs-1845	59	12	patients	patient	NOUN
iajs-1845	59	13	with	with	ADP
iajs-1845	59	14	and	and	CCONJ
iajs-1845	59	15	without	without	ADP
iajs-1845	59	16	nephropathy	nephropathy	NOUN
iajs-1845	59	17	.	.	PUNCT
iajs-1845	60	1	roc=	roc=	ADJ
iajs-1845	60	2	receiver	receiver	NOUN
iajs-1845	60	3	operating	operate	VERB
iajs-1845	60	4	characteristic	characteristic	NOUN
iajs-1845	60	5	,	,	PUNCT
iajs-1845	60	6	auc=	auc=	ADJ
iajs-1845	60	7	area	area	NOUN
iajs-1845	60	8	under	under	ADP
iajs-1845	60	9	the	the	DET
iajs-1845	60	10	curve	curve	NOUN
iajs-1845	60	11	,	,	PUNCT
iajs-1845	60	12	ppv=	ppv=	ADV
iajs-1845	60	13	positive	positive	ADJ
iajs-1845	60	14	predictive	predictive	ADJ
iajs-1845	60	15	value	value	NOUN
iajs-1845	60	16	,	,	PUNCT
iajs-1845	60	17	npv=	npv=	ADV
iajs-1845	60	18	negative	negative	ADJ
iajs-1845	60	19	predictive	predictive	ADJ
iajs-1845	60	20	value	value	NOUN
iajs-1845	60	21	.	.	PUNCT
iajs-1845	61	1	figure	figure	NOUN
iajs-1845	61	2	(	(	PUNCT
iajs-1845	61	3	1	1	NUM
iajs-1845	61	4	):	):	PUNCT
iajs-1845	61	5	receiver	receiver	ADJ
iajs-1845	61	6	operating	operate	VERB
iajs-1845	61	7	characteristic	characteristic	NOUN
iajs-1845	61	8	(	(	PUNCT
iajs-1845	61	9	roc	roc	PROPN
iajs-1845	61	10	)	)	PUNCT
iajs-1845	61	11	curve	curve	NOUN
iajs-1845	61	12	analysis	analysis	NOUN
iajs-1845	61	13	of	of	ADP
iajs-1845	61	14	uvdbp	uvdbp	PROPN
iajs-1845	61	15	in	in	ADP
iajs-1845	61	16	diabetic	diabetic	ADJ
iajs-1845	61	17	patients	patient	NOUN
iajs-1845	61	18	with	with	ADP
iajs-1845	61	19	and	and	CCONJ
iajs-1845	61	20	without	without	ADP
iajs-1845	61	21	nephropathy	nephropathy	ADJ
iajs-1845	61	22	discussion	discussion	NOUN
iajs-1845	61	23	in	in	ADP
iajs-1845	61	24	the	the	DET
iajs-1845	61	25	current	current	ADJ
iajs-1845	61	26	study	study	NOUN
iajs-1845	61	27	,	,	PUNCT
iajs-1845	61	28	diabetic	diabetic	ADJ
iajs-1845	61	29	patients	patient	NOUN
iajs-1845	61	30	with	with	ADP
iajs-1845	61	31	nephropathy	nephropathy	NOUN
iajs-1845	61	32	demonstrated	demonstrate	VERB
iajs-1845	61	33	a	a	DET
iajs-1845	61	34	significantly	significantly	ADV
iajs-1845	61	35	elevated	elevated	ADJ
iajs-1845	61	36	levels	level	NOUN
iajs-1845	61	37	of	of	ADP
iajs-1845	61	38	uacr	uacr	NOUN
iajs-1845	61	39	,	,	PUNCT
iajs-1845	61	40	hba1c	hba1c	PROPN
iajs-1845	61	41	and	and	CCONJ
iajs-1845	61	42	uvdbp	uvdbp	PROPN
iajs-1845	61	43	compared	compare	VERB
iajs-1845	61	44	to	to	ADP
iajs-1845	61	45	diabetic	diabetic	ADJ
iajs-1845	61	46	patients	patient	NOUN
iajs-1845	61	47	without	without	ADP
iajs-1845	61	48	nephropathy	nephropathy	NOUN
iajs-1845	61	49	(	(	PUNCT
iajs-1845	61	50	table	table	NOUN
iajs-1845	61	51	1	1	NUM
iajs-1845	61	52	)	)	PUNCT
iajs-1845	61	53	.	.	PUNCT
iajs-1845	62	1	these	these	DET
iajs-1845	62	2	results	result	NOUN
iajs-1845	62	3	were	be	AUX
iajs-1845	62	4	consistent	consistent	ADJ
iajs-1845	62	5	with	with	ADP
iajs-1845	62	6	a	a	DET
iajs-1845	62	7	study	study	NOUN
iajs-1845	62	8	in	in	ADP
iajs-1845	62	9	morocco	morocco	PROPN
iajs-1845	62	10	that	that	PRON
iajs-1845	62	11	revealed	reveal	VERB
iajs-1845	62	12	a	a	DET
iajs-1845	62	13	higher	high	ADJ
iajs-1845	62	14	significant	significant	ADJ
iajs-1845	62	15	levels	level	NOUN
iajs-1845	62	16	of	of	ADP
iajs-1845	62	17	albuminuria	albuminuria	NOUN
iajs-1845	62	18	were	be	AUX
iajs-1845	62	19	seen	see	VERB
iajs-1845	62	20	in	in	ADP
iajs-1845	62	21	t2d	t2d	NOUN
iajs-1845	62	22	patients	patient	NOUN
iajs-1845	62	23	with	with	ADP
iajs-1845	62	24	mau	mau	PROPN
iajs-1845	62	25	compared	compare	VERB
iajs-1845	62	26	to	to	ADP
iajs-1845	62	27	tests	test	NOUN
iajs-1845	62	28	roc	roc	PROPN
iajs-1845	62	29	curve	curve	NOUN
iajs-1845	62	30	characteristics	characteristic	NOUN
iajs-1845	62	31	auc	auc	VERB
iajs-1845	62	32	p	p	NOUN
iajs-1845	62	33	-	-	PUNCT
iajs-1845	62	34	valve	valve	NOUN
iajs-1845	62	35	cutoff	cutoff	NOUN
iajs-1845	62	36	sensitivity	sensitivity	NOUN
iajs-1845	62	37	specificity	specificity	NOUN
iajs-1845	62	38	ppv	ppv	NOUN
iajs-1845	62	39	npv	npv	PROPN
iajs-1845	62	40	uvdbp	uvdbp	PROPN
iajs-1845	62	41	(	(	PUNCT
iajs-1845	62	42	ng	ng	PROPN
iajs-1845	62	43	/	/	SYM
iajs-1845	62	44	ml	ml	PROPN
iajs-1845	62	45	)	)	PUNCT
iajs-1845	62	46	0.935	0.935	NUM
iajs-1845	62	47	0.000	0.000	NUM
iajs-1845	62	48	(	(	PUNCT
iajs-1845	62	49	hs	hs	X
iajs-1845	62	50	)	)	PUNCT
iajs-1845	62	51	>	>	NOUN
iajs-1845	62	52	152	152	NUM
iajs-1845	62	53	94	94	NUM
iajs-1845	62	54	%	%	NOUN
iajs-1845	62	55	82	82	NUM
iajs-1845	62	56	%	%	NOUN
iajs-1845	62	57	87	87	NUM
iajs-1845	62	58	%	%	NOUN
iajs-1845	62	59	92	92	NUM
iajs-1845	62	60	%	%	NOUN
iajs-1845	62	61	  	  	SPACE
iajs-1845	62	62	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	ADJ
iajs-1845	62	63	biology	biology	NOUN
iajs-1845	62	64	|	|	ADV
iajs-1845	62	65	19	19	NUM
iajs-1845	62	66	2018)عام	2018)عام	NUM
iajs-1845	62	67	1العدد	1العدد	NUM
iajs-1845	62	68	(	(	PUNCT
iajs-1845	62	69	31لمجلد	31لمجلد	NUM
iajs-1845	62	70	ا	ا	INTJ
iajs-1845	62	71	مجلة	مجلة	NOUN
iajs-1845	62	72	إبن	إبن	VERB
iajs-1845	62	73	الهيثم	الهيثم	ADJ
iajs-1845	62	74	للعلوم	للعلوم	NOUN
iajs-1845	62	75	الصرفة	الصرفة	NOUN
iajs-1845	62	76	والتطبيقية	والتطبيقية	VERB
iajs-1845	62	77	ibn	ibn	PROPN
iajs-1845	62	78	al	al	PROPN
iajs-1845	62	79	-	-	PUNCT
iajs-1845	62	80	haitham	haitham	PROPN
iajs-1845	62	81	jour	jour	X
iajs-1845	62	82	.	.	PROPN
iajs-1845	63	1	for	for	ADP
iajs-1845	63	2	pure	pure	ADJ
iajs-1845	63	3	&	&	CCONJ
iajs-1845	63	4	appl	appl	PROPN
iajs-1845	63	5	.	.	PUNCT
iajs-1845	64	1	sci	sci	PROPN
iajs-1845	64	2	.	.	PUNCT
iajs-1845	64	3	vol	vol	NOUN
iajs-1845	64	4	.	.	PROPN
iajs-1845	65	1	31	31	NUM
iajs-1845	65	2	(	(	PUNCT
iajs-1845	65	3	1	1	NUM
iajs-1845	65	4	)	)	PUNCT
iajs-1845	65	5	2018	2018	NUM
iajs-1845	65	6	those	those	PRON
iajs-1845	65	7	with	with	ADP
iajs-1845	65	8	normoalbuminuria	normoalbuminuria	PROPN
iajs-1845	65	9	[	[	X
iajs-1845	65	10	17	17	NUM
iajs-1845	65	11	]	]	PUNCT
iajs-1845	65	12	,	,	PUNCT
iajs-1845	65	13	also	also	ADV
iajs-1845	65	14	a	a	DET
iajs-1845	65	15	study	study	NOUN
iajs-1845	65	16	in	in	ADP
iajs-1845	65	17	egypt	egypt	PROPN
iajs-1845	65	18	showed	show	VERB
iajs-1845	65	19	that	that	SCONJ
iajs-1845	65	20	there	there	PRON
iajs-1845	65	21	was	be	VERB
iajs-1845	65	22	a	a	DET
iajs-1845	65	23	significant	significant	ADJ
iajs-1845	65	24	higher	high	ADJ
iajs-1845	65	25	percentage	percentage	NOUN
iajs-1845	65	26	of	of	ADP
iajs-1845	65	27	mau	mau	PROPN
iajs-1845	65	28	(	(	PUNCT
iajs-1845	65	29	89	89	NUM
iajs-1845	65	30	%	%	NOUN
iajs-1845	65	31	)	)	PUNCT
iajs-1845	65	32	in	in	ADP
iajs-1845	65	33	t1d	t1d	PROPN
iajs-1845	65	34	patients	patient	NOUN
iajs-1845	65	35	with	with	ADP
iajs-1845	65	36	poor	poor	ADJ
iajs-1845	65	37	glycemic	glycemic	ADJ
iajs-1845	65	38	control	control	NOUN
iajs-1845	65	39	(	(	PUNCT
iajs-1845	65	40	hba1c	hba1c	X
iajs-1845	65	41	>	>	X
iajs-1845	65	42	8.0	8.0	NUM
iajs-1845	65	43	%	%	NOUN
iajs-1845	65	44	)	)	PUNCT
iajs-1845	65	45	and	and	CCONJ
iajs-1845	65	46	disease	disease	NOUN
iajs-1845	65	47	duration	duration	NOUN
iajs-1845	65	48	>	>	NOUN
iajs-1845	65	49	10	10	NUM
iajs-1845	65	50	years	year	NOUN
iajs-1845	66	1	[	[	X
iajs-1845	66	2	18	18	NUM
iajs-1845	66	3	]	]	PUNCT
iajs-1845	66	4	.	.	PUNCT
iajs-1845	67	1	ufuomaet	ufuomaet	PROPN
iajs-1845	68	1	al	al	PROPN
iajs-1845	68	2	.	.	PROPN
iajs-1845	69	1	(	(	PUNCT
iajs-1845	69	2	2016	2016	NUM
iajs-1845	69	3	)	)	PUNCT
iajs-1845	69	4	mentioned	mention	VERB
iajs-1845	69	5	that	that	SCONJ
iajs-1845	69	6	hba1c	hba1c	PROPN
iajs-1845	69	7	levels	level	NOUN
iajs-1845	69	8	were	be	AUX
iajs-1845	69	9	significantly	significantly	ADV
iajs-1845	69	10	higher	high	ADJ
iajs-1845	69	11	(	(	PUNCT
iajs-1845	69	12	p<0.001	p<0.001	X
iajs-1845	69	13	)	)	PUNCT
iajs-1845	69	14	in	in	ADP
iajs-1845	69	15	t2d	t2d	NOUN
iajs-1845	69	16	patients	patient	NOUN
iajs-1845	69	17	with	with	ADP
iajs-1845	69	18	mau	mau	PROPN
iajs-1845	69	19	than	than	ADP
iajs-1845	69	20	those	those	PRON
iajs-1845	69	21	without	without	ADP
iajs-1845	69	22	mau	mau	PROPN
iajs-1845	70	1	[	[	X
iajs-1845	70	2	19	19	NUM
iajs-1845	70	3	]	]	PUNCT
iajs-1845	70	4	,	,	PUNCT
iajs-1845	70	5	and	and	CCONJ
iajs-1845	70	6	al	al	PROPN
iajs-1845	70	7	-	-	PUNCT
iajs-1845	70	8	eisaet	eisaet	PROPN
iajs-1845	70	9	al	al	PROPN
iajs-1845	70	10	.	.	PROPN
iajs-1845	70	11	(	(	PUNCT
iajs-1845	70	12	2017	2017	NUM
iajs-1845	70	13	)	)	PUNCT
iajs-1845	70	14	also	also	ADV
iajs-1845	70	15	agreed	agree	VERB
iajs-1845	70	16	with	with	ADP
iajs-1845	70	17	our	our	PRON
iajs-1845	70	18	results	result	NOUN
iajs-1845	70	19	that	that	SCONJ
iajs-1845	70	20	the	the	DET
iajs-1845	70	21	mean	mean	ADJ
iajs-1845	70	22	hba1c	hba1c	PROPN
iajs-1845	70	23	levels	level	NOUN
iajs-1845	70	24	were	be	AUX
iajs-1845	70	25	higher	high	ADJ
iajs-1845	70	26	significantly	significantly	ADV
iajs-1845	70	27	in	in	ADP
iajs-1845	70	28	t1d	t1d	PROPN
iajs-1845	70	29	with	with	ADP
iajs-1845	70	30	dn	dn	NOUN
iajs-1845	70	31	vs.	vs.	ADP
iajs-1845	70	32	without	without	ADP
iajs-1845	70	33	dn	dn	PROPN
iajs-1845	70	34	[	[	X
iajs-1845	70	35	20	20	NUM
iajs-1845	70	36	]	]	PUNCT
iajs-1845	70	37	.	.	PUNCT
iajs-1845	71	1	however	however	ADV
iajs-1845	71	2	,	,	PUNCT
iajs-1845	71	3	our	our	PRON
iajs-1845	71	4	results	result	NOUN
iajs-1845	71	5	were	be	AUX
iajs-1845	71	6	inconsistent	inconsistent	ADJ
iajs-1845	71	7	with	with	ADP
iajs-1845	71	8	a	a	DET
iajs-1845	71	9	study	study	NOUN
iajs-1845	71	10	which	which	PRON
iajs-1845	71	11	stated	state	VERB
iajs-1845	71	12	that	that	SCONJ
iajs-1845	71	13	there	there	PRON
iajs-1845	71	14	was	be	VERB
iajs-1845	71	15	no	no	DET
iajs-1845	71	16	significant	significant	ADJ
iajs-1845	71	17	difference	difference	NOUN
iajs-1845	71	18	in	in	ADP
iajs-1845	71	19	hba1c	hba1c	PROPN
iajs-1845	71	20	levels	level	NOUN
iajs-1845	71	21	in	in	ADP
iajs-1845	71	22	diabetic	diabetic	ADJ
iajs-1845	71	23	patients	patient	NOUN
iajs-1845	71	24	with	with	ADP
iajs-1845	71	25	micro	micro	NOUN
iajs-1845	71	26	and	and	CCONJ
iajs-1845	71	27	macroalbuminuria	macroalbuminuria	PROPN
iajs-1845	71	28	,	,	PUNCT
iajs-1845	71	29	and	and	CCONJ
iajs-1845	71	30	those	those	PRON
iajs-1845	71	31	with	with	ADP
iajs-1845	71	32	normoalbuminuria	normoalbuminuria	PROPN
iajs-1845	71	33	for	for	ADP
iajs-1845	71	34	both	both	DET
iajs-1845	71	35	types	type	NOUN
iajs-1845	71	36	of	of	ADP
iajs-1845	71	37	diabetes	diabetes	NOUN
iajs-1845	71	38	[	[	X
iajs-1845	71	39	21	21	NUM
iajs-1845	71	40	]	]	PUNCT
iajs-1845	71	41	.	.	PUNCT
iajs-1845	72	1	the	the	DET
iajs-1845	72	2	possible	possible	ADJ
iajs-1845	72	3	explanation	explanation	NOUN
iajs-1845	72	4	of	of	ADP
iajs-1845	72	5	increased	increase	VERB
iajs-1845	72	6	uacr	uacr	ADV
iajs-1845	72	7	and	and	CCONJ
iajs-1845	72	8	hba1c	hba1c	PROPN
iajs-1845	72	9	in	in	ADP
iajs-1845	72	10	dn	dn	NOUN
iajs-1845	72	11	patients	patient	NOUN
iajs-1845	72	12	was	be	AUX
iajs-1845	72	13	due	due	ADJ
iajs-1845	72	14	to	to	ADP
iajs-1845	72	15	hyperglycemia	hyperglycemia	NOUN
iajs-1845	72	16	.	.	PUNCT
iajs-1845	73	1	hyperglycemia	hyperglycemia	NOUN
iajs-1845	73	2	causes	cause	VERB
iajs-1845	73	3	hyperproduction	hyperproduction	NOUN
iajs-1845	73	4	of	of	ADP
iajs-1845	73	5	tgf	tgf	PROPN
iajs-1845	73	6	-	-	PUNCT
iajs-1845	73	7	β	β	PROPN
iajs-1845	73	8	and	and	CCONJ
iajs-1845	73	9	ros	ros	PROPN
iajs-1845	73	10	,	,	PUNCT
iajs-1845	73	11	which	which	PRON
iajs-1845	73	12	directly	directly	ADV
iajs-1845	73	13	damage	damage	VERB
iajs-1845	73	14	the	the	DET
iajs-1845	73	15	glomerular	glomerular	ADJ
iajs-1845	73	16	endothelium	endothelium	NOUN
iajs-1845	73	17	.	.	PUNCT
iajs-1845	74	1	hyperglycemia	hyperglycemia	NOUN
iajs-1845	74	2	also	also	ADV
iajs-1845	74	3	stimulates	stimulate	VERB
iajs-1845	74	4	the	the	DET
iajs-1845	74	5	production	production	NOUN
iajs-1845	74	6	of	of	ADP
iajs-1845	74	7	vegf	vegf	PROPN
iajs-1845	74	8	-	-	PUNCT
iajs-1845	74	9	a	a	PRON
iajs-1845	74	10	that	that	PRON
iajs-1845	74	11	induce	induce	VERB
iajs-1845	74	12	glomerular	glomerular	ADJ
iajs-1845	74	13	hyperpermeability	hyperpermeability	NOUN
iajs-1845	74	14	[	[	X
iajs-1845	74	15	12	12	NUM
iajs-1845	74	16	]	]	PUNCT
iajs-1845	74	17	and	and	CCONJ
iajs-1845	74	18	inflammatory	inflammatory	ADJ
iajs-1845	74	19	cytokines	cytokine	NOUN
iajs-1845	74	20	that	that	PRON
iajs-1845	74	21	destruct	destruct	VERB
iajs-1845	74	22	megalin	megalin	PROPN
iajs-1845	74	23	-	-	PUNCT
iajs-1845	74	24	cubilin	cubilin	ADJ
iajs-1845	74	25	receptors	receptor	NOUN
iajs-1845	74	26	involved	involve	VERB
iajs-1845	74	27	in	in	ADP
iajs-1845	74	28	albumin	albumin	ADJ
iajs-1845	74	29	reabsorption	reabsorption	NOUN
iajs-1845	74	30	in	in	ADP
iajs-1845	74	31	renal	renal	ADJ
iajs-1845	74	32	tubules	tubule	NOUN
iajs-1845	74	33	,	,	PUNCT
iajs-1845	74	34	leading	lead	VERB
iajs-1845	74	35	to	to	ADP
iajs-1845	74	36	the	the	DET
iajs-1845	74	37	appearance	appearance	NOUN
iajs-1845	74	38	of	of	ADP
iajs-1845	74	39	mau	mau	PROPN
iajs-1845	75	1	[	[	X
iajs-1845	75	2	22	22	NUM
iajs-1845	75	3	]	]	PUNCT
iajs-1845	75	4	,	,	PUNCT
iajs-1845	75	5	indicating	indicate	VERB
iajs-1845	75	6	that	that	SCONJ
iajs-1845	75	7	poor	poor	ADJ
iajs-1845	75	8	glycemic	glycemic	ADJ
iajs-1845	75	9	control	control	NOUN
iajs-1845	75	10	could	could	AUX
iajs-1845	75	11	be	be	AUX
iajs-1845	75	12	an	an	DET
iajs-1845	75	13	important	important	ADJ
iajs-1845	75	14	risk	risk	NOUN
iajs-1845	75	15	factor	factor	NOUN
iajs-1845	75	16	for	for	ADP
iajs-1845	75	17	dn	dn	PROPN
iajs-1845	75	18	initiation	initiation	NOUN
iajs-1845	75	19	and	and	CCONJ
iajs-1845	75	20	progression	progression	NOUN
iajs-1845	75	21	.	.	PUNCT
iajs-1845	76	1	concerning	concern	VERB
iajs-1845	76	2	to	to	ADP
iajs-1845	76	3	uvdbp	uvdbp	PROPN
iajs-1845	76	4	which	which	PRON
iajs-1845	76	5	was	be	AUX
iajs-1845	76	6	elevated	elevate	VERB
iajs-1845	76	7	significantly	significantly	ADV
iajs-1845	76	8	in	in	ADP
iajs-1845	76	9	dn	dn	PROPN
iajs-1845	76	10	patients	patient	NOUN
iajs-1845	76	11	than	than	ADP
iajs-1845	76	12	those	those	DET
iajs-1845	76	13	patients	patient	NOUN
iajs-1845	76	14	without	without	ADP
iajs-1845	76	15	dn	dn	PROPN
iajs-1845	76	16	,	,	PUNCT
iajs-1845	76	17	these	these	DET
iajs-1845	76	18	finding	finding	NOUN
iajs-1845	76	19	were	be	AUX
iajs-1845	76	20	in	in	ADP
iajs-1845	76	21	agreement	agreement	NOUN
iajs-1845	76	22	with	with	ADP
iajs-1845	76	23	studies	study	NOUN
iajs-1845	76	24	which	which	PRON
iajs-1845	76	25	reported	report	VERB
iajs-1845	76	26	that	that	SCONJ
iajs-1845	76	27	uvdbp	uvdbp	PROPN
iajs-1845	76	28	levels	level	NOUN
iajs-1845	76	29	were	be	AUX
iajs-1845	76	30	significantly	significantly	ADV
iajs-1845	76	31	higher	high	ADJ
iajs-1845	76	32	(	(	PUNCT
iajs-1845	76	33	p=0.004	p=0.004	NOUN
iajs-1845	76	34	)	)	PUNCT
iajs-1845	76	35	in	in	ADP
iajs-1845	76	36	diabetic	diabetic	ADJ
iajs-1845	76	37	patients	patient	NOUN
iajs-1845	76	38	with	with	ADP
iajs-1845	76	39	micro	micro	NOUN
iajs-1845	76	40	and	and	CCONJ
iajs-1845	76	41	macroalbuminuria	macroalbuminuria	PROPN
iajs-1845	76	42	compared	compare	VERB
iajs-1845	76	43	to	to	ADP
iajs-1845	76	44	diabetic	diabetic	ADJ
iajs-1845	76	45	patients	patient	NOUN
iajs-1845	76	46	with	with	ADP
iajs-1845	76	47	normoalbuminuria	normoalbuminuria	PROPN
iajs-1845	76	48	[	[	X
iajs-1845	76	49	23	23	NUM
iajs-1845	76	50	,	,	PUNCT
iajs-1845	76	51	24	24	NUM
iajs-1845	76	52	]	]	PUNCT
iajs-1845	76	53	,	,	PUNCT
iajs-1845	76	54	whereas	whereas	SCONJ
iajs-1845	76	55	another	another	DET
iajs-1845	76	56	study	study	NOUN
iajs-1845	76	57	noticed	notice	VERB
iajs-1845	76	58	that	that	SCONJ
iajs-1845	76	59	uvdbp	uvdbp	PROPN
iajs-1845	76	60	was	be	AUX
iajs-1845	76	61	higher	high	ADJ
iajs-1845	76	62	in	in	ADP
iajs-1845	76	63	microalbuminuric	microalbuminuric	ADJ
iajs-1845	76	64	patients	patient	NOUN
iajs-1845	76	65	than	than	ADP
iajs-1845	76	66	normoalbuminuric	normoalbuminuric	ADJ
iajs-1845	76	67	patients	patient	NOUN
iajs-1845	76	68	with	with	ADP
iajs-1845	76	69	non	non	ADJ
iajs-1845	76	70	-	-	ADJ
iajs-1845	76	71	diabetic	diabetic	ADJ
iajs-1845	76	72	chronic	chronic	ADJ
iajs-1845	76	73	kidney	kidney	NOUN
iajs-1845	76	74	disease	disease	NOUN
iajs-1845	76	75	(	(	PUNCT
iajs-1845	76	76	ckd	ckd	NOUN
iajs-1845	76	77	)	)	PUNCT
iajs-1845	77	1	[	[	X
iajs-1845	77	2	25	25	NUM
iajs-1845	77	3	]	]	PUNCT
iajs-1845	77	4	.	.	PUNCT
iajs-1845	78	1	the	the	DET
iajs-1845	78	2	possible	possible	ADJ
iajs-1845	78	3	explanation	explanation	NOUN
iajs-1845	78	4	of	of	ADP
iajs-1845	78	5	elevated	elevated	ADJ
iajs-1845	78	6	uvdbp	uvdbp	NOUN
iajs-1845	78	7	in	in	ADP
iajs-1845	78	8	dn	dn	PROPN
iajs-1845	78	9	patients	patient	NOUN
iajs-1845	78	10	was	be	AUX
iajs-1845	78	11	resulted	result	VERB
iajs-1845	78	12	from	from	ADP
iajs-1845	78	13	hyperglycemia	hyperglycemia	NOUN
iajs-1845	78	14	-	-	PUNCT
iajs-1845	78	15	induced	induce	VERB
iajs-1845	78	16	ros	ros	PROPN
iajs-1845	78	17	,	,	PUNCT
iajs-1845	78	18	tgf	tgf	PROPN
iajs-1845	78	19	-	-	PUNCT
iajs-1845	78	20	β	β	X
iajs-1845	78	21	and	and	CCONJ
iajs-1845	78	22	proinflammatory	proinflammatory	ADJ
iajs-1845	78	23	cytokines	cytokine	NOUN
iajs-1845	78	24	(	(	PUNCT
iajs-1845	78	25	il-18	il-18	NUM
iajs-1845	78	26	)	)	PUNCT
iajs-1845	78	27	production	production	NOUN
iajs-1845	78	28	from	from	ADP
iajs-1845	78	29	podocytes	podocyte	NOUN
iajs-1845	78	30	[	[	X
iajs-1845	78	31	12	12	NUM
iajs-1845	78	32	]	]	PUNCT
iajs-1845	78	33	causing	cause	VERB
iajs-1845	78	34	renal	renal	ADJ
iajs-1845	78	35	tubular	tubular	ADJ
iajs-1845	78	36	damage	damage	NOUN
iajs-1845	78	37	with	with	ADP
iajs-1845	78	38	destruction	destruction	NOUN
iajs-1845	78	39	of	of	ADP
iajs-1845	78	40	megalin	megalin	PROPN
iajs-1845	78	41	/	/	SYM
iajs-1845	78	42	cubilin	cubilin	ADJ
iajs-1845	78	43	receptors	receptor	NOUN
iajs-1845	78	44	in	in	ADP
iajs-1845	78	45	pt	pt	PRON
iajs-1845	78	46	epithelial	epithelial	ADJ
iajs-1845	78	47	cells	cell	NOUN
iajs-1845	78	48	that	that	PRON
iajs-1845	78	49	responsible	responsible	ADJ
iajs-1845	78	50	for	for	ADP
iajs-1845	78	51	vdbp	vdbp	NOUN
iajs-1845	78	52	reabsorption	reabsorption	NOUN
iajs-1845	78	53	leading	lead	VERB
iajs-1845	78	54	to	to	ADP
iajs-1845	78	55	urinary	urinary	ADJ
iajs-1845	78	56	excretion	excretion	NOUN
iajs-1845	78	57	of	of	ADP
iajs-1845	78	58	vdbp	vdbp	NOUN
iajs-1845	78	59	[	[	X
iajs-1845	78	60	13	13	NUM
iajs-1845	78	61	]	]	PUNCT
iajs-1845	78	62	.	.	PUNCT
iajs-1845	79	1	furthermore	furthermore	ADV
iajs-1845	79	2	,	,	PUNCT
iajs-1845	79	3	a	a	DET
iajs-1845	79	4	significant	significant	ADJ
iajs-1845	79	5	positive	positive	ADJ
iajs-1845	79	6	association	association	NOUN
iajs-1845	79	7	of	of	ADP
iajs-1845	79	8	uvdbp	uvdbp	PROPN
iajs-1845	79	9	with	with	ADP
iajs-1845	79	10	uacr	uacr	PROPN
iajs-1845	79	11	and	and	CCONJ
iajs-1845	79	12	hba1c	hba1c	PROPN
iajs-1845	79	13	was	be	AUX
iajs-1845	79	14	manifested	manifest	VERB
iajs-1845	79	15	in	in	ADP
iajs-1845	79	16	diabetic	diabetic	ADJ
iajs-1845	79	17	patients	patient	NOUN
iajs-1845	79	18	with	with	ADP
iajs-1845	79	19	nephropathy	nephropathy	NOUN
iajs-1845	79	20	(	(	PUNCT
iajs-1845	79	21	table	table	NOUN
iajs-1845	79	22	2	2	NUM
iajs-1845	79	23	)	)	PUNCT
iajs-1845	79	24	.	.	PUNCT
iajs-1845	80	1	these	these	DET
iajs-1845	80	2	results	result	NOUN
iajs-1845	80	3	were	be	AUX
iajs-1845	80	4	similar	similar	ADJ
iajs-1845	80	5	to	to	ADP
iajs-1845	80	6	thrailkillet	thrailkillet	PROPN
iajs-1845	80	7	al	al	PROPN
iajs-1845	80	8	.	.	PROPN
iajs-1845	81	1	(	(	PUNCT
iajs-1845	81	2	2011	2011	NUM
iajs-1845	81	3	)	)	PUNCT
iajs-1845	81	4	and	and	CCONJ
iajs-1845	81	5	mohamed	mohamed	PROPN
iajs-1845	81	6	(	(	PUNCT
iajs-1845	81	7	2016	2016	NUM
iajs-1845	81	8	)	)	PUNCT
iajs-1845	81	9	studies	study	NOUN
iajs-1845	81	10	,	,	PUNCT
iajs-1845	81	11	who	who	PRON
iajs-1845	81	12	found	find	VERB
iajs-1845	81	13	that	that	SCONJ
iajs-1845	81	14	uvdbp	uvdbp	PROPN
iajs-1845	81	15	was	be	AUX
iajs-1845	81	16	strongly	strongly	ADV
iajs-1845	81	17	positively	positively	ADV
iajs-1845	81	18	associated	associate	VERB
iajs-1845	81	19	(	(	PUNCT
iajs-1845	81	20	p<0.001	p<0.001	X
iajs-1845	81	21	)	)	PUNCT
iajs-1845	81	22	with	with	ADP
iajs-1845	81	23	elevated	elevated	ADJ
iajs-1845	81	24	hba1c	hba1c	PROPN
iajs-1845	81	25	levels	level	NOUN
iajs-1845	81	26	in	in	ADP
iajs-1845	81	27	t1d	t1d	PROPN
iajs-1845	81	28	and	and	CCONJ
iajs-1845	81	29	t2d	t2d	NOUN
iajs-1845	81	30	patients	patient	NOUN
iajs-1845	81	31	(	(	PUNCT
iajs-1845	81	32	respectively	respectively	ADV
iajs-1845	81	33	)	)	PUNCT
iajs-1845	81	34	with	with	ADP
iajs-1845	81	35	normo	normo	NOUN
iajs-1845	81	36	and	and	CCONJ
iajs-1845	81	37	microalbuminuria	microalbuminuria	PROPN
iajs-1845	82	1	[	[	X
iajs-1845	82	2	23	23	NUM
iajs-1845	82	3	,	,	PUNCT
iajs-1845	82	4	26	26	NUM
iajs-1845	82	5	]	]	PUNCT
iajs-1845	82	6	.	.	PUNCT
iajs-1845	83	1	other	other	ADJ
iajs-1845	83	2	studies	study	NOUN
iajs-1845	83	3	also	also	ADV
iajs-1845	83	4	agreed	agree	VERB
iajs-1845	83	5	with	with	ADP
iajs-1845	83	6	our	our	PRON
iajs-1845	83	7	finding	finding	NOUN
iajs-1845	83	8	,	,	PUNCT
iajs-1845	83	9	which	which	PRON
iajs-1845	83	10	demonstrated	demonstrate	VERB
iajs-1845	83	11	a	a	DET
iajs-1845	83	12	strong	strong	ADJ
iajs-1845	83	13	positive	positive	ADJ
iajs-1845	83	14	correlation	correlation	NOUN
iajs-1845	83	15	(	(	PUNCT
iajs-1845	83	16	p<0.001	p<0.001	PROPN
iajs-1845	83	17	)	)	PUNCT
iajs-1845	83	18	between	between	ADP
iajs-1845	83	19	uvdbp	uvdbp	PROPN
iajs-1845	83	20	and	and	CCONJ
iajs-1845	83	21	uacr	uacr	PROPN
iajs-1845	83	22	was	be	AUX
iajs-1845	83	23	seen	see	VERB
iajs-1845	83	24	in	in	ADP
iajs-1845	83	25	dn	dn	NOUN
iajs-1845	83	26	patients	patient	NOUN
iajs-1845	83	27	,	,	PUNCT
iajs-1845	83	28	and	and	CCONJ
iajs-1845	83	29	uvdbp	uvdbp	PROPN
iajs-1845	83	30	levels	level	NOUN
iajs-1845	83	31	were	be	AUX
iajs-1845	83	32	directly	directly	ADV
iajs-1845	83	33	proportional	proportional	ADJ
iajs-1845	83	34	with	with	ADP
iajs-1845	83	35	increased	increase	VERB
iajs-1845	83	36	uacr	uacr	NOUN
iajs-1845	83	37	levels	level	NOUN
iajs-1845	83	38	[	[	X
iajs-1845	83	39	27	27	NUM
iajs-1845	83	40	,	,	PUNCT
iajs-1845	83	41	28	28	NUM
iajs-1845	83	42	]	]	PUNCT
iajs-1845	83	43	.	.	PUNCT
iajs-1845	84	1	however	however	ADV
iajs-1845	84	2	,	,	PUNCT
iajs-1845	84	3	another	another	DET
iajs-1845	84	4	study	study	NOUN
iajs-1845	84	5	reported	report	VERB
iajs-1845	84	6	that	that	SCONJ
iajs-1845	84	7	there	there	PRON
iajs-1845	84	8	was	be	VERB
iajs-1845	84	9	no	no	DET
iajs-1845	84	10	significant	significant	ADJ
iajs-1845	84	11	relation	relation	NOUN
iajs-1845	84	12	between	between	ADP
iajs-1845	84	13	uvdbp	uvdbp	PROPN
iajs-1845	84	14	and	and	CCONJ
iajs-1845	84	15	uacr	uacr	VERB
iajs-1845	84	16	in	in	ADP
iajs-1845	84	17	microalbuminuric	microalbuminuric	ADJ
iajs-1845	84	18	diabetic	diabetic	ADJ
iajs-1845	84	19	patients	patient	NOUN
iajs-1845	84	20	,	,	PUNCT
iajs-1845	84	21	but	but	CCONJ
iajs-1845	84	22	only	only	ADV
iajs-1845	84	23	in	in	ADP
iajs-1845	84	24	diabetic	diabetic	ADJ
iajs-1845	84	25	patients	patient	NOUN
iajs-1845	84	26	with	with	ADP
iajs-1845	84	27	macroalbuminuria	macroalbuminuria	PROPN
iajs-1845	85	1	[	[	X
iajs-1845	85	2	29	29	NUM
iajs-1845	85	3	]	]	PUNCT
iajs-1845	85	4	.	.	PUNCT
iajs-1845	86	1	these	these	DET
iajs-1845	86	2	inconsistent	inconsistent	ADJ
iajs-1845	86	3	results	result	NOUN
iajs-1845	86	4	might	might	AUX
iajs-1845	86	5	be	be	AUX
iajs-1845	86	6	due	due	ADJ
iajs-1845	86	7	to	to	ADP
iajs-1845	86	8	different	different	ADJ
iajs-1845	86	9	study	study	NOUN
iajs-1845	86	10	designs	design	NOUN
iajs-1845	86	11	,	,	PUNCT
iajs-1845	86	12	different	different	ADJ
iajs-1845	86	13	stages	stage	NOUN
iajs-1845	86	14	of	of	ADP
iajs-1845	86	15	dn	dn	NOUN
iajs-1845	86	16	,	,	PUNCT
iajs-1845	86	17	and	and	CCONJ
iajs-1845	86	18	different	different	ADJ
iajs-1845	86	19	populations	population	NOUN
iajs-1845	86	20	that	that	PRON
iajs-1845	86	21	had	have	AUX
iajs-1845	86	22	been	be	AUX
iajs-1845	86	23	studied	study	VERB
iajs-1845	86	24	.	.	PUNCT
iajs-1845	87	1	roc	roc	PROPN
iajs-1845	87	2	curve	curve	NOUN
iajs-1845	87	3	analysis	analysis	NOUN
iajs-1845	87	4	exhibited	exhibit	VERB
iajs-1845	87	5	a	a	DET
iajs-1845	87	6	greater	great	ADJ
iajs-1845	87	7	auc	auc	NOUN
iajs-1845	87	8	(	(	PUNCT
iajs-1845	87	9	0.935	0.935	NUM
iajs-1845	87	10	)	)	PUNCT
iajs-1845	87	11	for	for	ADP
iajs-1845	87	12	uvdbp	uvdbp	PROPN
iajs-1845	87	13	with	with	ADP
iajs-1845	87	14	cutoff	cutoff	NOUN
iajs-1845	87	15	value	value	NOUN
iajs-1845	87	16	(	(	PUNCT
iajs-1845	87	17	>	>	X
iajs-1845	87	18	125	125	NUM
iajs-1845	87	19	ng	ng	NOUN
iajs-1845	87	20	/	/	SYM
iajs-1845	87	21	ml	ml	PROPN
iajs-1845	87	22	)	)	PUNCT
iajs-1845	87	23	,	,	PUNCT
iajs-1845	87	24	this	this	DET
iajs-1845	87	25	value	value	NOUN
iajs-1845	87	26	has	have	VERB
iajs-1845	87	27	sensitivity	sensitivity	NOUN
iajs-1845	87	28	(	(	PUNCT
iajs-1845	87	29	94	94	NUM
iajs-1845	87	30	%	%	NOUN
iajs-1845	87	31	)	)	PUNCT
iajs-1845	87	32	,	,	PUNCT
iajs-1845	87	33	specificity	specificity	NOUN
iajs-1845	87	34	(	(	PUNCT
iajs-1845	87	35	82	82	NUM
iajs-1845	87	36	%	%	NOUN
iajs-1845	87	37	)	)	PUNCT
iajs-1845	87	38	,	,	PUNCT
iajs-1845	87	39	ppv	ppv	NOUN
iajs-1845	87	40	(	(	PUNCT
iajs-1845	87	41	87	87	NUM
iajs-1845	87	42	%	%	NOUN
iajs-1845	87	43	)	)	PUNCT
iajs-1845	87	44	,	,	PUNCT
iajs-1845	87	45	and	and	CCONJ
iajs-1845	87	46	npv	npv	NOUN
iajs-1845	87	47	(	(	PUNCT
iajs-1845	87	48	92	92	NUM
iajs-1845	87	49	%	%	NOUN
iajs-1845	87	50	)	)	PUNCT
iajs-1845	87	51	as	as	SCONJ
iajs-1845	87	52	shown	show	VERB
iajs-1845	87	53	in	in	ADP
iajs-1845	87	54	table	table	NOUN
iajs-1845	87	55	(	(	PUNCT
iajs-1845	87	56	3	3	NUM
iajs-1845	87	57	)	)	PUNCT
iajs-1845	87	58	and	and	CCONJ
iajs-1845	87	59	figure	figure	NOUN
iajs-1845	87	60	(	(	PUNCT
iajs-1845	87	61	1	1	NUM
iajs-1845	87	62	)	)	PUNCT
iajs-1845	87	63	.	.	PUNCT
iajs-1845	88	1	these	these	DET
iajs-1845	88	2	findings	finding	NOUN
iajs-1845	88	3	were	be	AUX
iajs-1845	88	4	concurred	concur	VERB
iajs-1845	88	5	with	with	ADP
iajs-1845	88	6	many	many	ADJ
iajs-1845	88	7	studies	study	NOUN
iajs-1845	88	8	which	which	PRON
iajs-1845	88	9	revealed	reveal	VERB
iajs-1845	88	10	a	a	DET
iajs-1845	88	11	higher	high	ADJ
iajs-1845	88	12	auc	auc	NOUN
iajs-1845	88	13	(	(	PUNCT
iajs-1845	88	14	0.96	0.96	NUM
iajs-1845	88	15	)	)	PUNCT
iajs-1845	88	16	of	of	ADP
iajs-1845	88	17	uvdbp	uvdbp	PROPN
iajs-1845	88	18	with	with	ADP
iajs-1845	88	19	90	90	NUM
iajs-1845	88	20	%	%	NOUN
iajs-1845	88	21	sensitivity	sensitivity	NOUN
iajs-1845	88	22	,	,	PUNCT
iajs-1845	88	23	77	77	NUM
iajs-1845	88	24	%	%	NOUN
iajs-1845	88	25	specificity	specificity	NOUN
iajs-1845	88	26	,	,	PUNCT
iajs-1845	88	27	79	79	NUM
iajs-1845	88	28	%	%	NOUN
iajs-1845	88	29	ppv	ppv	NOUN
iajs-1845	88	30	,	,	PUNCT
iajs-1845	88	31	and	and	CCONJ
iajs-1845	88	32	88	88	NUM
iajs-1845	88	33	%	%	NOUN
iajs-1845	88	34	npv	npv	NOUN
iajs-1845	88	35	[	[	X
iajs-1845	88	36	27,29	27,29	NUM
iajs-1845	88	37	,	,	PUNCT
iajs-1845	88	38	30	30	NUM
iajs-1845	88	39	]	]	PUNCT
iajs-1845	88	40	,	,	PUNCT
iajs-1845	88	41	suggesting	suggest	VERB
iajs-1845	88	42	a	a	DET
iajs-1845	88	43	sensitive	sensitive	ADJ
iajs-1845	88	44	and	and	CCONJ
iajs-1845	88	45	potential	potential	ADJ
iajs-1845	88	46	role	role	NOUN
iajs-1845	88	47	of	of	ADP
iajs-1845	88	48	urinary	urinary	ADJ
iajs-1845	88	49	vdbp	vdbp	NOUN
iajs-1845	88	50	in	in	ADP
iajs-1845	88	51	the	the	DET
iajs-1845	88	52	early	early	ADJ
iajs-1845	88	53	prediction	prediction	NOUN
iajs-1845	88	54	,	,	PUNCT
iajs-1845	88	55	diagnosis	diagnosis	NOUN
iajs-1845	88	56	and	and	CCONJ
iajs-1845	88	57	assessment	assessment	NOUN
iajs-1845	88	58	of	of	ADP
iajs-1845	88	59	dn	dn	NOUN
iajs-1845	88	60	in	in	ADP
iajs-1845	88	61	diabetic	diabetic	ADJ
iajs-1845	88	62	patients	patient	NOUN
iajs-1845	88	63	.	.	PUNCT
iajs-1845	89	1	in	in	ADP
iajs-1845	89	2	conclusion	conclusion	NOUN
iajs-1845	89	3	,	,	PUNCT
iajs-1845	89	4	poor	poor	ADJ
iajs-1845	89	5	glycemic	glycemic	ADJ
iajs-1845	89	6	control	control	NOUN
iajs-1845	89	7	is	be	AUX
iajs-1845	89	8	an	an	DET
iajs-1845	89	9	important	important	ADJ
iajs-1845	89	10	risk	risk	NOUN
iajs-1845	89	11	factor	factor	NOUN
iajs-1845	89	12	for	for	ADP
iajs-1845	89	13	the	the	DET
iajs-1845	89	14	initiation	initiation	NOUN
iajs-1845	89	15	and	and	CCONJ
iajs-1845	89	16	development	development	NOUN
iajs-1845	89	17	of	of	ADP
iajs-1845	89	18	dn	dn	PROPN
iajs-1845	89	19	,	,	PUNCT
iajs-1845	89	20	uvdbp	uvdbp	PROPN
iajs-1845	89	21	levels	level	NOUN
iajs-1845	89	22	were	be	AUX
iajs-1845	89	23	significantly	significantly	ADV
iajs-1845	89	24	elevated	elevate	VERB
iajs-1845	89	25	in	in	ADP
iajs-1845	89	26	dn	dn	NOUN
iajs-1845	89	27	patients	patient	NOUN
iajs-1845	89	28	and	and	CCONJ
iajs-1845	89	29	positively	positively	ADV
iajs-1845	89	30	associated	associate	VERB
iajs-1845	89	31	with	with	ADP
iajs-1845	89	32	higher	high	ADJ
iajs-1845	89	33	hba1c	hba1c	PROPN
iajs-1845	89	34	and	and	CCONJ
iajs-1845	89	35	uacr	uacr	INTJ
iajs-1845	89	36	,	,	PUNCT
iajs-1845	89	37	therefore	therefore	ADV
iajs-1845	89	38	it	it	PRON
iajs-1845	89	39	can	can	AUX
iajs-1845	89	40	be	be	AUX
iajs-1845	89	41	used	use	VERB
iajs-1845	89	42	as	as	ADP
iajs-1845	89	43	an	an	DET
iajs-1845	89	44	early	early	ADJ
iajs-1845	89	45	predictor	predictor	NOUN
iajs-1845	89	46	for	for	ADP
iajs-1845	89	47	the	the	DET
iajs-1845	89	48	detection	detection	NOUN
iajs-1845	89	49	and	and	CCONJ
iajs-1845	89	50	may	may	AUX
iajs-1845	89	51	prevent	prevent	VERB
iajs-1845	89	52	the	the	DET
iajs-1845	89	53	early	early	ADJ
iajs-1845	89	54	onset	onset	NOUN
iajs-1845	89	55	of	of	ADP
iajs-1845	89	56	dn	dn	PROPN
iajs-1845	89	57	in	in	ADP
iajs-1845	89	58	iraqi	iraqi	ADJ
iajs-1845	89	59	diabetic	diabetic	ADJ
iajs-1845	89	60	patients	patient	NOUN
iajs-1845	89	61	.	.	PUNCT
iajs-1845	89	62	  	  	SPACE
iajs-1845	90	1	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	ADJ
iajs-1845	90	2	biology	biology	NOUN
iajs-1845	90	3	|	|	ADV
iajs-1845	90	4	20	20	NUM
iajs-1845	90	5	2018)عام	2018)عام	NUM
iajs-1845	90	6	1العدد	1العدد	NUM
iajs-1845	90	7	(	(	PUNCT
iajs-1845	90	8	31لمجلد	31لمجلد	NUM
iajs-1845	90	9	ا	ا	INTJ
iajs-1845	90	10	مجلة	مجلة	NOUN
iajs-1845	90	11	إبن	إبن	VERB
iajs-1845	90	12	الهيثم	الهيثم	ADJ
iajs-1845	90	13	للعلوم	للعلوم	NOUN
iajs-1845	90	14	الصرفة	الصرفة	NOUN
iajs-1845	90	15	والتطبيقية	والتطبيقية	VERB
iajs-1845	90	16	ibn	ibn	PROPN
iajs-1845	90	17	al	al	PROPN
iajs-1845	90	18	-	-	PUNCT
iajs-1845	90	19	haitham	haitham	PROPN
iajs-1845	90	20	jour	jour	X
iajs-1845	90	21	.	.	PROPN
iajs-1845	90	22	for	for	ADP
iajs-1845	90	23	pure	pure	ADJ
iajs-1845	90	24	&	&	CCONJ
iajs-1845	90	25	appl	appl	PROPN
iajs-1845	90	26	.	.	PUNCT
iajs-1845	91	1	sci	sci	PROPN
iajs-1845	91	2	.	.	PUNCT
iajs-1845	91	3	vol	vol	NOUN
iajs-1845	91	4	.	.	PROPN
iajs-1845	92	1	31	31	NUM
iajs-1845	92	2	(	(	PUNCT
iajs-1845	92	3	1	1	NUM
iajs-1845	92	4	)	)	SYM
iajs-1845	92	5	2018	2018	NUM
iajs-1845	92	6	references	reference	NOUN
iajs-1845	92	7	[	[	X
iajs-1845	92	8	1	1	NUM
iajs-1845	92	9	]	]	PUNCT
iajs-1845	92	10	c.	c.	PROPN
iajs-1845	92	11	wang	wang	PROPN
iajs-1845	92	12	;	;	PUNCT
iajs-1845	92	13	c.	c.	PROPN
iajs-1845	92	14	li	li	PROPN
iajs-1845	92	15	;	;	PUNCT
iajs-1845	92	16	w.	w.	PROPN
iajs-1845	92	17	gong	gong	PROPN
iajs-1845	92	18	,	,	PUNCT
iajs-1845	92	19	and	and	CCONJ
iajs-1845	92	20	t.	t.	PROPN
iajs-1845	92	21	lou	lou	PROPN
iajs-1845	92	22	,	,	PUNCT
iajs-1845	92	23	new	new	ADJ
iajs-1845	92	24	urinary	urinary	ADJ
iajs-1845	92	25	biomarkers	biomarker	NOUN
iajs-1845	92	26	for	for	ADP
iajs-1845	92	27	diabetic	diabetic	ADJ
iajs-1845	92	28	kidney	kidney	NOUN
iajs-1845	92	29	disease	disease	NOUN
iajs-1845	92	30	.	.	PUNCT
iajs-1845	93	1	biomarker	biomarker	NOUN
iajs-1845	93	2	research	research	NOUN
iajs-1845	93	3	,	,	PUNCT
iajs-1845	93	4	1(1	1(1	NUM
iajs-1845	93	5	):	):	PUNCT
iajs-1845	93	6	9	9	NUM
iajs-1845	93	7	.	.	X
iajs-1845	93	8	url	url	PROPN
iajs-1845	93	9	:	:	PUNCT
iajs-1845	93	10	https://doi.org/10.1186/2050-7771-1-9	https://doi.org/10.1186/2050-7771-1-9	NOUN
iajs-1845	93	11	.	.	PUNCT
iajs-1845	94	1	2013	2013	NUM
iajs-1845	95	1	[	[	X
iajs-1845	95	2	2	2	X
iajs-1845	95	3	]	]	PUNCT
iajs-1845	95	4	s.	s.	PROPN
iajs-1845	95	5	thomas	thomas	PROPN
iajs-1845	95	6	,	,	PUNCT
iajs-1845	95	7	and	and	CCONJ
iajs-1845	95	8	j.	j.	PROPN
iajs-1845	95	9	karalliedde	karalliedde	PROPN
iajs-1845	95	10	,	,	PUNCT
iajs-1845	95	11	diabetic	diabetic	ADJ
iajs-1845	95	12	nephropathy	nephropathy	NOUN
iajs-1845	95	13	.	.	PUNCT
iajs-1845	96	1	medicine	medicine	NOUN
iajs-1845	96	2	,	,	PUNCT
iajs-1845	96	3	43(1	43(1	NUM
iajs-1845	96	4	):	):	PUNCT
iajs-1845	96	5	20	20	NUM
iajs-1845	96	6	-	-	SYM
iajs-1845	96	7	25	25	NUM
iajs-1845	96	8	.	.	PUNCT
iajs-1845	96	9	url	url	PROPN
iajs-1845	96	10	:	:	PUNCT
iajs-1845	96	11	https://doi.org/10.1016/j.mpmed.2014.10.007	https://doi.org/10.1016/j.mpmed.2014.10.007	VERB
iajs-1845	96	12	.	.	PUNCT
iajs-1845	97	1	2015	2015	NUM
iajs-1845	98	1	[	[	X
iajs-1845	98	2	3	3	X
iajs-1845	98	3	]	]	X
iajs-1845	98	4	k.r	k.r	PROPN
iajs-1845	98	5	.	.	PROPN
iajs-1845	98	6	tuttle	tuttle	PROPN
iajs-1845	98	7	;	;	PUNCT
iajs-1845	98	8	g.l	g.l	PROPN
iajs-1845	98	9	.	.	PROPN
iajs-1845	98	10	bakris	bakris	PROPN
iajs-1845	98	11	;	;	PUNCT
iajs-1845	98	12	r.w	r.w	PROPN
iajs-1845	98	13	.	.	PROPN
iajs-1845	98	14	bilous	bilous	PROPN
iajs-1845	98	15	;	;	PUNCT
iajs-1845	98	16	j.l	j.l	PROPN
iajs-1845	98	17	.	.	PROPN
iajs-1845	98	18	chiang	chiang	PROPN
iajs-1845	98	19	;	;	PUNCT
iajs-1845	98	20	i.h	i.h	PROPN
iajs-1845	98	21	.	.	PROPN
iajs-1845	98	22	de	de	PROPN
iajs-1845	98	23	boer	boer	PROPN
iajs-1845	98	24	;	;	PUNCT
iajs-1845	98	25	j.	j.	PROPN
iajs-1845	98	26	goldstein	goldstein	PROPN
iajs-1845	98	27	-	-	PUNCT
iajs-1845	98	28	fuchs	fuchs	PROPN
iajs-1845	98	29	;	;	PUNCT
iajs-1845	98	30	i.b	i.b	PROPN
iajs-1845	98	31	.	.	PROPN
iajs-1845	98	32	hirsch	hirsch	PROPN
iajs-1845	98	33	;	;	PUNCT
iajs-1845	98	34	k.	k.	PROPN
iajs-1845	98	35	kalantar	kalantar	PROPN
iajs-1845	98	36	-	-	PUNCT
iajs-1845	98	37	zadeh	zadeh	PROPN
iajs-1845	98	38	;	;	PUNCT
iajs-1845	98	39	a.s	a.s	PROPN
iajs-1845	98	40	.	.	PROPN
iajs-1845	98	41	narva	narva	PROPN
iajs-1845	98	42	;	;	PUNCT
iajs-1845	98	43	s.d	s.d	PROPN
iajs-1845	98	44	.	.	PROPN
iajs-1845	98	45	navaneethan	navaneethan	PROPN
iajs-1845	98	46	,	,	PUNCT
iajs-1845	98	47	and	and	CCONJ
iajs-1845	98	48	j.j	j.j	PROPN
iajs-1845	98	49	.	.	PROPN
iajs-1845	98	50	neumiller	neumiller	PROPN
iajs-1845	98	51	,	,	PUNCT
iajs-1845	98	52	diabetic	diabetic	ADJ
iajs-1845	98	53	kidney	kidney	NOUN
iajs-1845	98	54	disease	disease	NOUN
iajs-1845	98	55	:	:	PUNCT
iajs-1845	98	56	a	a	DET
iajs-1845	98	57	report	report	NOUN
iajs-1845	98	58	from	from	ADP
iajs-1845	98	59	an	an	DET
iajs-1845	98	60	ada	ada	PROPN
iajs-1845	98	61	consensus	consensus	NOUN
iajs-1845	98	62	conference	conference	NOUN
iajs-1845	98	63	.	.	PUNCT
iajs-1845	99	1	american	american	PROPN
iajs-1845	99	2	journal	journal	PROPN
iajs-1845	99	3	of	of	ADP
iajs-1845	99	4	kidney	kidney	NOUN
iajs-1845	99	5	diseases	disease	NOUN
iajs-1845	99	6	,	,	PUNCT
iajs-1845	99	7	64(4	64(4	NOUN
iajs-1845	99	8	):	):	PUNCT
iajs-1845	99	9	510	510	NUM
iajs-1845	99	10	-	-	SYM
iajs-1845	99	11	533	533	NUM
iajs-1845	99	12	.	.	NUM
iajs-1845	99	13	2014	2014	NUM
iajs-1845	100	1	[	[	X
iajs-1845	100	2	4	4	NUM
iajs-1845	100	3	]	]	X
iajs-1845	100	4	c.h	c.h	PROPN
iajs-1845	100	5	.	.	PROPN
iajs-1845	100	6	lin	lin	PROPN
iajs-1845	100	7	;	;	PUNCT
iajs-1845	100	8	y.c	y.c	PROPN
iajs-1845	100	9	.	.	PROPN
iajs-1845	100	10	chang	chang	PROPN
iajs-1845	100	11	,	,	PUNCT
iajs-1845	100	12	and	and	CCONJ
iajs-1845	100	13	l.m	l.m	PROPN
iajs-1845	100	14	.	.	PROPN
iajs-1845	100	15	chuang	chuang	PROPN
iajs-1845	100	16	,	,	PUNCT
iajs-1845	100	17	early	early	ADJ
iajs-1845	100	18	detection	detection	NOUN
iajs-1845	100	19	of	of	ADP
iajs-1845	100	20	diabetic	diabetic	ADJ
iajs-1845	100	21	kidney	kidney	NOUN
iajs-1845	100	22	disease	disease	NOUN
iajs-1845	100	23	:	:	PUNCT
iajs-1845	100	24	present	present	ADJ
iajs-1845	100	25	limitations	limitation	NOUN
iajs-1845	100	26	and	and	CCONJ
iajs-1845	100	27	future	future	ADJ
iajs-1845	100	28	perspectives	perspective	NOUN
iajs-1845	100	29	.	.	PUNCT
iajs-1845	101	1	world	world	PROPN
iajs-1845	101	2	journal	journal	PROPN
iajs-1845	101	3	of	of	ADP
iajs-1845	101	4	diabetes	diabetes	NOUN
iajs-1845	101	5	,	,	PUNCT
iajs-1845	101	6	7(14	7(14	NUM
iajs-1845	101	7	):	):	PUNCT
iajs-1845	101	8	290	290	NUM
iajs-1845	101	9	-	-	SYM
iajs-1845	101	10	301	301	NUM
iajs-1845	101	11	.	.	PUNCT
iajs-1845	101	12	url	url	PROPN
iajs-1845	101	13	:	:	PUNCT
iajs-1845	101	14	http://doi	http://doi	NOUN
iajs-1845	101	15	:	:	PUNCT
iajs-1845	101	16	10.4239	10.4239	NUM
iajs-1845	101	17	/	/	SYM
iajs-1845	101	18	wjd.v7.i14.290	wjd.v7.i14.290	PROPN
iajs-1845	101	19	.	.	PUNCT
iajs-1845	101	20	2016	2016	NUM
iajs-1845	102	1	[	[	X
iajs-1845	102	2	5	5	NUM
iajs-1845	102	3	]	]	PUNCT
iajs-1845	102	4	c.	c.	NOUN
iajs-1845	102	5	gluhovschi	gluhovschi	PROPN
iajs-1845	102	6	;	;	PUNCT
iajs-1845	102	7	g.	g.	PROPN
iajs-1845	102	8	gluhovschi	gluhovschi	PROPN
iajs-1845	102	9	;	;	PUNCT
iajs-1845	102	10	l.	l.	PROPN
iajs-1845	102	11	petrica	petrica	PROPN
iajs-1845	102	12	;	;	PUNCT
iajs-1845	102	13	r.	r.	PROPN
iajs-1845	102	14	timar	timar	PROPN
iajs-1845	102	15	;	;	PUNCT
iajs-1845	102	16	s.	s.	PROPN
iajs-1845	102	17	velciov	velciov	PROPN
iajs-1845	102	18	;	;	PUNCT
iajs-1845	102	19	i.	i.	PROPN
iajs-1845	102	20	ionita	ionita	PROPN
iajs-1845	102	21	;	;	PUNCT
iajs-1845	102	22	a.	a.	NOUN
iajs-1845	102	23	kaycsa	kaycsa	PROPN
iajs-1845	102	24	,	,	PUNCT
iajs-1845	102	25	and	and	CCONJ
iajs-1845	102	26	b.	b.	PROPN
iajs-1845	102	27	timar	timar	PROPN
iajs-1845	102	28	,	,	PUNCT
iajs-1845	102	29	urinary	urinary	ADJ
iajs-1845	102	30	biomarkers	biomarker	NOUN
iajs-1845	102	31	in	in	ADP
iajs-1845	102	32	the	the	DET
iajs-1845	102	33	assessment	assessment	NOUN
iajs-1845	102	34	of	of	ADP
iajs-1845	102	35	early	early	ADJ
iajs-1845	102	36	diabetic	diabetic	ADJ
iajs-1845	102	37	nephropathy	nephropathy	NOUN
iajs-1845	102	38	.	.	PUNCT
iajs-1845	103	1	journal	journal	NOUN
iajs-1845	103	2	of	of	ADP
iajs-1845	103	3	diabetes	diabetes	NOUN
iajs-1845	103	4	research	research	NOUN
iajs-1845	103	5	,	,	PUNCT
iajs-1845	103	6	1(1	1(1	NUM
iajs-1845	103	7	):	):	PUNCT
iajs-1845	103	8	1	1	NUM
iajs-1845	103	9	-	-	SYM
iajs-1845	103	10	13	13	NUM
iajs-1845	103	11	.	.	PUNCT
iajs-1845	103	12	2016	2016	NUM
iajs-1845	104	1	[	[	X
iajs-1845	104	2	6	6	NUM
iajs-1845	104	3	]	]	PUNCT
iajs-1845	104	4	w.	w.	NOUN
iajs-1845	104	5	song	song	PROPN
iajs-1845	104	6	;	;	PUNCT
iajs-1845	104	7	x.e	x.e	PROPN
iajs-1845	104	8	.	.	PROPN
iajs-1845	104	9	wang	wang	PROPN
iajs-1845	104	10	;	;	PUNCT
iajs-1845	104	11	y.	y.	PROPN
iajs-1845	104	12	tian	tian	PROPN
iajs-1845	104	13	;	;	PUNCT
iajs-1845	104	14	x.	x.	PROPN
iajs-1845	104	15	zhang;r	zhang;r	PROPN
iajs-1845	104	16	.	.	PUNCT
iajs-1845	105	1	lu	lu	PROPN
iajs-1845	105	2	,	,	PUNCT
iajs-1845	105	3	and	and	CCONJ
iajs-1845	105	4	h.	h.	PROPN
iajs-1845	105	5	meng	meng	PROPN
iajs-1845	105	6	,	,	PUNCT
iajs-1845	105	7	gc	gc	PROPN
iajs-1845	105	8	gene	gene	NOUN
iajs-1845	105	9	polymorphisms	polymorphism	NOUN
iajs-1845	105	10	and	and	CCONJ
iajs-1845	105	11	vitamin	vitamin	NOUN
iajs-1845	105	12	d	d	ADJ
iajs-1845	105	13	-	-	ADJ
iajs-1845	105	14	binding	bind	VERB
iajs-1845	105	15	protein	protein	NOUN
iajs-1845	105	16	levels	level	NOUN
iajs-1845	105	17	are	be	AUX
iajs-1845	105	18	related	relate	VERB
iajs-1845	105	19	to	to	ADP
iajs-1845	105	20	the	the	DET
iajs-1845	105	21	risk	risk	NOUN
iajs-1845	105	22	of	of	ADP
iajs-1845	105	23	generalized	generalized	ADJ
iajs-1845	105	24	aggressive	aggressive	ADJ
iajs-1845	105	25	periodontitis	periodontitis	NOUN
iajs-1845	105	26	.	.	PUNCT
iajs-1845	106	1	international	international	ADJ
iajs-1845	106	2	journal	journal	PROPN
iajs-1845	106	3	of	of	ADP
iajs-1845	106	4	endocrinology	endocrinology	NOUN
iajs-1845	106	5	,	,	PUNCT
iajs-1845	106	6	1(1	1(1	NUM
iajs-1845	106	7	):	):	PUNCT
iajs-1845	106	8	1	1	NUM
iajs-1845	106	9	-	-	SYM
iajs-1845	106	10	8	8	NUM
iajs-1845	106	11	.	.	PUNCT
iajs-1845	106	12	url	url	PROPN
iajs-1845	106	13	:	:	PUNCT
iajs-1845	106	14	http://dx.doi.org/10.1155/2016/5141089	http://dx.doi.org/10.1155/2016/5141089	NOUN
iajs-1845	106	15	.	.	PUNCT
iajs-1845	107	1	2016	2016	NUM
iajs-1845	108	1	[	[	X
iajs-1845	108	2	7	7	X
iajs-1845	108	3	]	]	X
iajs-1845	108	4	a.f	a.f	PROPN
iajs-1845	108	5	.	.	PROPN
iajs-1845	108	6	wookey	wookey	PROPN
iajs-1845	108	7	;	;	PUNCT
iajs-1845	108	8	t.	t.	PROPN
iajs-1845	108	9	chollangi	chollangi	PROPN
iajs-1845	108	10	;	;	PUNCT
iajs-1845	108	11	h.e	h.e	PROPN
iajs-1845	108	12	.	.	PROPN
iajs-1845	108	13	yong	yong	PROPN
iajs-1845	108	14	,	,	PUNCT
iajs-1845	108	15	b.	b.	PROPN
iajs-1845	108	16	kalionis	kalionis	PROPN
iajs-1845	108	17	;	;	PUNCT
iajs-1845	108	18	s.p	s.p	PROPN
iajs-1845	108	19	.	.	PROPN
iajs-1845	108	20	brennecke	brennecke	PROPN
iajs-1845	108	21	;	;	PUNCT
iajs-1845	108	22	p.	p.	NOUN
iajs-1845	108	23	murthi	murthi	NOUN
iajs-1845	108	24	,	,	PUNCT
iajs-1845	108	25	and	and	CCONJ
iajs-1845	108	26	h.m	h.m	PROPN
iajs-1845	108	27	.	.	PROPN
iajs-1845	108	28	georgiou	georgiou	PROPN
iajs-1845	108	29	,	,	PUNCT
iajs-1845	108	30	placental	placental	NOUN
iajs-1845	108	31	vitamin	vitamin	NOUN
iajs-1845	108	32	d	d	NOUN
iajs-1845	108	33	-	-	ADJ
iajs-1845	108	34	binding	bind	VERB
iajs-1845	108	35	protein	protein	NOUN
iajs-1845	108	36	expression	expression	NOUN
iajs-1845	108	37	in	in	ADP
iajs-1845	108	38	human	human	ADJ
iajs-1845	108	39	idiopathic	idiopathic	ADJ
iajs-1845	108	40	fetal	fetal	ADJ
iajs-1845	108	41	growth	growth	NOUN
iajs-1845	108	42	restriction	restriction	NOUN
iajs-1845	108	43	.	.	PUNCT
iajs-1845	109	1	journal	journal	NOUN
iajs-1845	109	2	of	of	ADP
iajs-1845	109	3	pregnancy	pregnancy	NOUN
iajs-1845	109	4	,	,	PUNCT
iajs-1845	109	5	2017	2017	NUM
iajs-1845	109	6	:	:	SYM
iajs-1845	109	7	1	1	NUM
iajs-1845	109	8	-	-	SYM
iajs-1845	109	9	5	5	NUM
iajs-1845	109	10	.	.	PUNCT
iajs-1845	110	1	[	[	X
iajs-1845	110	2	8	8	NUM
iajs-1845	110	3	]	]	PUNCT
iajs-1845	110	4	m.	m.	NOUN
iajs-1845	110	5	speeckaert	speeckaert	NOUN
iajs-1845	110	6	;	;	PUNCT
iajs-1845	110	7	g.	g.	PROPN
iajs-1845	110	8	huang	huang	PROPN
iajs-1845	110	9	;	;	PUNCT
iajs-1845	110	10	j.r	j.r	PROPN
iajs-1845	110	11	.	.	PROPN
iajs-1845	110	12	delanghe	delanghe	PROPN
iajs-1845	110	13	,	,	PUNCT
iajs-1845	110	14	and	and	CCONJ
iajs-1845	110	15	y.e	y.e	PROPN
iajs-1845	110	16	.	.	PROPN
iajs-1845	110	17	taes	taes	PROPN
iajs-1845	110	18	,	,	PUNCT
iajs-1845	110	19	biological	biological	ADJ
iajs-1845	110	20	and	and	CCONJ
iajs-1845	110	21	clinical	clinical	ADJ
iajs-1845	110	22	aspects	aspect	NOUN
iajs-1845	110	23	of	of	ADP
iajs-1845	110	24	the	the	DET
iajs-1845	110	25	vitamin	vitamin	NOUN
iajs-1845	110	26	d	d	NOUN
iajs-1845	110	27	binding	bind	VERB
iajs-1845	110	28	protein	protein	NOUN
iajs-1845	110	29	(	(	PUNCT
iajs-1845	110	30	gc	gc	PROPN
iajs-1845	110	31	-globulin	-globulin	PROPN
iajs-1845	110	32	)	)	PUNCT
iajs-1845	110	33	and	and	CCONJ
iajs-1845	110	34	its	its	PRON
iajs-1845	110	35	polymorphism	polymorphism	NOUN
iajs-1845	110	36	.	.	PUNCT
iajs-1845	111	1	clinicachimicaacta	clinicachimicaacta	PROPN
iajs-1845	111	2	,	,	PUNCT
iajs-1845	111	3	372(1	372(1	NUM
iajs-1845	111	4	)	)	PUNCT
iajs-1845	111	5	2006	2006	NUM
iajs-1845	111	6	:	:	PUNCT
iajs-1845	112	1	33	33	NUM
iajs-1845	112	2	-	-	SYM
iajs-1845	112	3	42	42	NUM
iajs-1845	112	4	.	.	PUNCT
iajs-1845	112	5	url	url	PROPN
iajs-1845	112	6	:	:	PUNCT
iajs-1845	113	1	https://doi.org/10.1016/j.cca.03.011.2006	https://doi.org/10.1016/j.cca.03.011.2006	PROPN
iajs-1845	113	2	[	[	X
iajs-1845	113	3	9	9	NUM
iajs-1845	113	4	]	]	X
iajs-1845	113	5	r.f	r.f	PROPN
iajs-1845	113	6	.	.	PROPN
iajs-1845	113	7	chun	chun	PROPN
iajs-1845	113	8	;	;	PUNCT
iajs-1845	113	9	b.e	b.e	PROPN
iajs-1845	113	10	.	.	PROPN
iajs-1845	113	11	peercy	peercy	PROPN
iajs-1845	113	12	;	;	PUNCT
iajs-1845	113	13	e.s	e.s	PROPN
iajs-1845	113	14	.	.	PROPN
iajs-1845	113	15	orwoll	orwoll	PROPN
iajs-1845	113	16	;	;	PUNCT
iajs-1845	113	17	c.m	c.m	PROPN
iajs-1845	113	18	.	.	PROPN
iajs-1845	113	19	nielson	nielson	PROPN
iajs-1845	113	20	;	;	PUNCT
iajs-1845	113	21	j.s	j.s	PROPN
iajs-1845	113	22	.	.	PROPN
iajs-1845	113	23	adams	adams	PROPN
iajs-1845	113	24	,	,	PUNCT
iajs-1845	113	25	and	and	CCONJ
iajs-1845	113	26	m.	m.	PROPN
iajs-1845	113	27	hewison	hewison	PROPN
iajs-1845	113	28	,	,	PUNCT
iajs-1845	113	29	vitamin	vitamin	NOUN
iajs-1845	113	30	d	d	NOUN
iajs-1845	113	31	and	and	CCONJ
iajs-1845	113	32	dbp	dbp	PROPN
iajs-1845	113	33	:	:	PUNCT
iajs-1845	113	34	the	the	DET
iajs-1845	113	35	free	free	ADJ
iajs-1845	113	36	hormone	hormone	NOUN
iajs-1845	113	37	hypothesis	hypothesis	NOUN
iajs-1845	113	38	revisited	revisit	VERB
iajs-1845	113	39	.	.	PUNCT
iajs-1845	114	1	the	the	DET
iajs-1845	114	2	journalof	journalof	ADJ
iajs-1845	114	3	steroid	steroid	NOUN
iajs-1845	114	4	biochemistry	biochemistry	NOUN
iajs-1845	114	5	and	and	CCONJ
iajs-1845	114	6	molecular	molecular	ADJ
iajs-1845	114	7	biology	biology	NOUN
iajs-1845	114	8	,	,	PUNCT
iajs-1845	114	9	144(1	144(1	NUM
iajs-1845	114	10	):	):	PUNCT
iajs-1845	114	11	132	132	NUM
iajs-1845	114	12	-	-	SYM
iajs-1845	114	13	137	137	NUM
iajs-1845	114	14	.	.	PUNCT
iajs-1845	114	15	2014	2014	NUM
iajs-1845	115	1	[	[	X
iajs-1845	115	2	10	10	NUM
iajs-1845	115	3	]	]	X
iajs-1845	115	4	a.j	a.j	PROPN
iajs-1845	115	5	.	.	PROPN
iajs-1845	115	6	brown	brown	PROPN
iajs-1845	115	7	,	,	PUNCT
iajs-1845	115	8	and	and	CCONJ
iajs-1845	115	9	d.w	d.w	PROPN
iajs-1845	115	10	.	.	PROPN
iajs-1845	115	11	coyne	coyne	PROPN
iajs-1845	115	12	,	,	PUNCT
iajs-1845	115	13	bioavailable	bioavailable	ADJ
iajs-1845	115	14	vitamin	vitamin	NOUN
iajs-1845	115	15	d	d	NOUN
iajs-1845	115	16	in	in	ADP
iajs-1845	115	17	chronic	chronic	ADJ
iajs-1845	115	18	kidney	kidney	NOUN
iajs-1845	115	19	disease	disease	NOUN
iajs-1845	115	20	.	.	PUNCT
iajs-1845	116	1	kidney	kidney	PROPN
iajs-1845	116	2	international	international	PROPN
iajs-1845	116	3	,	,	PUNCT
iajs-1845	116	4	82(1	82(1	NOUN
iajs-1845	116	5	)	)	PUNCT
iajs-1845	116	6	2012	2012	NUM
iajs-1845	116	7	:	:	PUNCT
iajs-1845	116	8	5	5	NUM
iajs-1845	116	9	-	-	SYM
iajs-1845	116	10	7	7	NUM
iajs-1845	116	11	.	.	PUNCT
iajs-1845	116	12	url	url	PROPN
iajs-1845	116	13	:	:	PUNCT
iajs-1845	116	14	https://doi.org/10.1038/ki.2012.135	https://doi.org/10.1038/ki.2012.135	PROPN
iajs-1845	117	1	[	[	X
iajs-1845	117	2	11	11	NUM
iajs-1845	117	3	]	]	X
iajs-1845	117	4	n.k	n.k	PROPN
iajs-1845	117	5	.	.	NOUN
iajs-1845	117	6	jassil	jassil	NOUN
iajs-1845	117	7	;	;	PUNCT
iajs-1845	117	8	a.	a.	NOUN
iajs-1845	117	9	sharma	sharma	PROPN
iajs-1845	117	10	;	;	PUNCT
iajs-1845	117	11	d.	d.	NOUN
iajs-1845	117	12	bikle	bikle	NOUN
iajs-1845	117	13	,	,	PUNCT
iajs-1845	117	14	and	and	CCONJ
iajs-1845	117	15	x.	x.	NOUN
iajs-1845	117	16	wang	wang	PROPN
iajs-1845	117	17	,	,	PUNCT
iajs-1845	117	18	vitamin	vitamin	NOUN
iajs-1845	117	19	d	d	NOUN
iajs-1845	117	20	binding	bind	VERB
iajs-1845	117	21	protein	protein	NOUN
iajs-1845	117	22	and	and	CCONJ
iajs-1845	117	23	25hydroxyvitamin	25hydroxyvitamin	NUM
iajs-1845	117	24	d	d	NOUN
iajs-1845	117	25	levels	level	NOUN
iajs-1845	117	26	:	:	PUNCT
iajs-1845	117	27	emerging	emerge	VERB
iajs-1845	117	28	clinical	clinical	ADJ
iajs-1845	117	29	applications	application	NOUN
iajs-1845	117	30	.	.	PUNCT
iajs-1845	118	1	endocrine	endocrine	ADJ
iajs-1845	118	2	practice	practice	NOUN
iajs-1845	118	3	,	,	PUNCT
iajs-1845	118	4	23(5	23(5	NUM
iajs-1845	118	5	):	):	PUNCT
iajs-1845	118	6	605	605	NUM
iajs-1845	118	7	-	-	SYM
iajs-1845	118	8	613	613	NUM
iajs-1845	118	9	.	.	PUNCT
iajs-1845	118	10	url	url	PROPN
iajs-1845	118	11	:	:	PUNCT
iajs-1845	118	12	https://doi.org/10.4158/ep161604.ra	https://doi.org/10.4158/ep161604.ra	PROPN
iajs-1845	118	13	.	.	NOUN
iajs-1845	118	14	2017	2017	NUM
iajs-1845	119	1	[	[	SYM
iajs-1845	119	2	12	12	NUM
iajs-1845	119	3	]	]	PUNCT
iajs-1845	119	4	b.	b.	PROPN
iajs-1845	119	5	satirapoj	satirapoj	PROPN
iajs-1845	119	6	,	,	PUNCT
iajs-1845	119	7	and	and	CCONJ
iajs-1845	119	8	s.g	s.g	PROPN
iajs-1845	119	9	.	.	PROPN
iajs-1845	119	10	adler	adler	PROPN
iajs-1845	119	11	,	,	PUNCT
iajs-1845	119	12	comprehensive	comprehensive	ADJ
iajs-1845	119	13	approach	approach	NOUN
iajs-1845	119	14	to	to	ADP
iajs-1845	119	15	diabetic	diabetic	ADJ
iajs-1845	119	16	nephropathy.kidney	nephropathy.kidney	NOUN
iajs-1845	119	17	research	research	NOUN
iajs-1845	119	18	and	and	CCONJ
iajs-1845	119	19	clinical	clinical	ADJ
iajs-1845	119	20	practice	practice	NOUN
iajs-1845	119	21	,	,	PUNCT
iajs-1845	119	22	33(3	33(3	NUM
iajs-1845	119	23	):	):	PUNCT
iajs-1845	119	24	121	121	NUM
iajs-1845	119	25	-	-	SYM
iajs-1845	119	26	131	131	NUM
iajs-1845	119	27	.	.	PUNCT
iajs-1845	119	28	url	url	PROPN
iajs-1845	119	29	:	:	PUNCT
iajs-1845	119	30	https://doi.org/10.1016/j.krcp.2014.08.001	https://doi.org/10.1016/j.krcp.2014.08.001	PROPN
iajs-1845	119	31	.	.	PUNCT
iajs-1845	119	32	2014	2014	NUM
iajs-1845	120	1	[	[	X
iajs-1845	120	2	13	13	NUM
iajs-1845	120	3	]	]	X
iajs-1845	120	4	j.l	j.l	PROPN
iajs-1845	120	5	.	.	PROPN
iajs-1845	120	6	fowlkes	fowlke	NOUN
iajs-1845	120	7	;	;	PUNCT
iajs-1845	120	8	r.c	r.c	PROPN
iajs-1845	120	9	.	.	PROPN
iajs-1845	120	10	bunn	bunn	PROPN
iajs-1845	120	11	;	;	PUNCT
iajs-1845	120	12	g.e	g.e	PROPN
iajs-1845	120	13	.	.	PROPN
iajs-1845	120	14	cockrell;l.m	cockrell;l.m	PROPN
iajs-1845	120	15	.	.	PUNCT
iajs-1845	121	1	clark	clark	PROPN
iajs-1845	121	2	;	;	PUNCT
iajs-1845	121	3	e.c	e.c	PROPN
iajs-1845	121	4	.	.	PROPN
iajs-1845	121	5	wahl	wahl	PROPN
iajs-1845	121	6	;	;	PUNCT
iajs-1845	121	7	c.k	c.k	PROPN
iajs-1845	121	8	.	.	PUNCT
iajs-1845	121	9	lumpkin	lumpkin	PROPN
iajs-1845	121	10	,	,	PUNCT
iajs-1845	121	11	and	and	CCONJ
iajs-1845	121	12	k.m	k.m	PROPN
iajs-1845	121	13	.	.	PROPN
iajs-1845	121	14	thrailkill	thrailkill	PROPN
iajs-1845	121	15	,	,	PUNCT
iajs-1845	121	16	dysregulation	dysregulation	NOUN
iajs-1845	121	17	of	of	ADP
iajs-1845	121	18	the	the	DET
iajs-1845	121	19	intrarenal	intrarenal	ADJ
iajs-1845	121	20	vitamin	vitamin	NOUN
iajs-1845	121	21	d	d	X
iajs-1845	121	22	endocytic	endocytic	ADJ
iajs-1845	121	23	pathway	pathway	NOUN
iajs-1845	121	24	in	in	ADP
iajs-1845	121	25	a	a	DET
iajs-1845	121	26	nephropathy	nephropathy	ADJ
iajs-1845	121	27	-	-	PUNCT
iajs-1845	121	28	prone	prone	ADJ
iajs-1845	121	29	mouse	mouse	NOUN
iajs-1845	121	30	model	model	NOUN
iajs-1845	121	31	of	of	ADP
iajs-1845	121	32	type	type	NOUN
iajs-1845	121	33	1	1	NUM
iajs-1845	121	34	diabetes	diabetes	NOUN
iajs-1845	121	35	.	.	PUNCT
iajs-1845	122	1	experimental	experimental	ADJ
iajs-1845	122	2	diabetes	diabetes	NOUN
iajs-1845	122	3	research	research	NOUN
iajs-1845	122	4	,	,	PUNCT
iajs-1845	122	5	2011	2011	NUM
iajs-1845	122	6	:	:	PUNCT
iajs-1845	122	7	1	1	NUM
iajs-1845	122	8	-	-	SYM
iajs-1845	122	9	7	7	NUM
iajs-1845	122	10	.	.	PUNCT
iajs-1845	122	11	url	url	NOUN
iajs-1845	122	12	:	:	PUNCT
iajs-1845	123	1	http://dx.doi.org/10.1155/2011/269378	http://dx.doi.org/10.1155/2011/269378	ADP
iajs-1845	123	2	[	[	X
iajs-1845	123	3	14	14	NUM
iajs-1845	123	4	]	]	X
iajs-1845	123	5	human	human	ADJ
iajs-1845	123	6	gesellschaftfür	gesellschaftfür	NOUN
iajs-1845	123	7	biochemica	biochemica	PROPN
iajs-1845	123	8	und	und	PROPN
iajs-1845	123	9	diagnosticambh	diagnosticambh	NOUN
iajs-1845	123	10	.	.	PUNCT
iajs-1845	124	1	protocol	protocol	NOUN
iajs-1845	124	2	of	of	ADP
iajs-1845	124	3	urine	urine	NOUN
iajs-1845	124	4	test	test	NOUN
iajs-1845	124	5	strips	strip	NOUN
iajs-1845	124	6	for	for	ADP
iajs-1845	124	7	visual	visual	ADJ
iajs-1845	124	8	reading	reading	NOUN
iajs-1845	124	9	or	or	CCONJ
iajs-1845	124	10	with	with	ADP
iajs-1845	124	11	combilyzer13	combilyzer13	NOUN
iajs-1845	124	12	,	,	PUNCT
iajs-1845	124	13	germany	germany	PROPN
iajs-1845	124	14	.	.	PUNCT
iajs-1845	125	1	https://www.human.de/fileadmin/content/flyer/en/981142_urinalysis_system_line__e	https://www.human.de/fileadmin/content/flyer/en/981142_urinalysis_system_line__e	PROPN
iajs-1845	125	2	n.pdf	n.pdf	NOUN
iajs-1845	125	3	(	(	PUNCT
iajs-1845	125	4	accessed	access	VERB
iajs-1845	125	5	12.03.17	12.03.17	NUM
iajs-1845	125	6	)	)	PUNCT
iajs-1845	125	7	.	.	PUNCT
iajs-1845	126	1	2016	2016	NUM
iajs-1845	126	2	  	  	SPACE
iajs-1845	126	3	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	ADJ
iajs-1845	126	4	biology	biology	NOUN
iajs-1845	126	5	|	|	ADV
iajs-1845	126	6	21	21	NUM
iajs-1845	126	7	2018)عام	2018)عام	NUM
iajs-1845	126	8	1العدد	1العدد	NUM
iajs-1845	126	9	(	(	PUNCT
iajs-1845	126	10	31لمجلد	31لمجلد	NUM
iajs-1845	126	11	ا	ا	INTJ
iajs-1845	126	12	مجلة	مجلة	NOUN
iajs-1845	126	13	إبن	إبن	VERB
iajs-1845	126	14	الهيثم	الهيثم	ADJ
iajs-1845	126	15	للعلوم	للعلوم	NOUN
iajs-1845	126	16	الصرفة	الصرفة	NOUN
iajs-1845	126	17	والتطبيقية	والتطبيقية	VERB
iajs-1845	126	18	ibn	ibn	PROPN
iajs-1845	126	19	al	al	PROPN
iajs-1845	126	20	-	-	PUNCT
iajs-1845	126	21	haitham	haitham	PROPN
iajs-1845	126	22	jour	jour	X
iajs-1845	126	23	.	.	PROPN
iajs-1845	126	24	for	for	ADP
iajs-1845	126	25	pure	pure	ADJ
iajs-1845	126	26	&	&	CCONJ
iajs-1845	126	27	appl	appl	PROPN
iajs-1845	126	28	.	.	PUNCT
iajs-1845	127	1	sci	sci	PROPN
iajs-1845	127	2	.	.	PUNCT
iajs-1845	127	3	vol	vol	NOUN
iajs-1845	127	4	.	.	PROPN
iajs-1845	128	1	31	31	NUM
iajs-1845	128	2	(	(	PUNCT
iajs-1845	128	3	1	1	NUM
iajs-1845	128	4	)	)	PUNCT
iajs-1845	128	5	2018	2018	NUM
iajs-1845	128	6	[	[	X
iajs-1845	128	7	15	15	NUM
iajs-1845	128	8	]	]	X
iajs-1845	128	9	mybiosource	mybiosource	PROPN
iajs-1845	128	10	co.	co.	PROPN
iajs-1845	128	11	,	,	PUNCT
iajs-1845	128	12	gc	gc	PROPN
iajs-1845	128	13	elisa	elisa	PROPN
iajs-1845	128	14	kit	kit	PROPN
iajs-1845	128	15	/	/	SYM
iajs-1845	128	16	human	human	ADJ
iajs-1845	128	17	vitamin	vitamin	NOUN
iajs-1845	128	18	-	-	PUNCT
iajs-1845	128	19	d	d	NOUN
iajs-1845	128	20	binding	bind	VERB
iajs-1845	128	21	protein	protein	NOUN
iajs-1845	128	22	elisa	elisa	NOUN
iajs-1845	128	23	kit	kit	PROPN
iajs-1845	128	24	,	,	PUNCT
iajs-1845	128	25	usa	usa	PROPN
iajs-1845	128	26	.	.	PROPN
iajs-1845	128	27	https://www.mybiosource.com/prods/elisa-kit/human/vitamin-d-bindingprotein/gc/datasheet.php?products_id=763939	https://www.mybiosource.com/prods/elisa-kit/human/vitamin-d-bindingprotein/gc/datasheet.php?products_id=763939	PROPN
iajs-1845	128	28	(	(	PUNCT
iajs-1845	128	29	accessed	access	VERB
iajs-1845	128	30	12.05.17	12.05.17	NOUN
iajs-1845	128	31	)	)	PUNCT
iajs-1845	128	32	.	.	PUNCT
iajs-1845	129	1	i.	i.	PROPN
iajs-1845	129	2	2017	2017	NUM
iajs-1845	130	1	[	[	X
iajs-1845	130	2	16	16	NUM
iajs-1845	130	3	]	]	X
iajs-1845	130	4	infopia	infopia	PROPN
iajs-1845	130	5	co.	co.	PROPN
iajs-1845	130	6	ltd	ltd	PROPN
iajs-1845	130	7	.	.	PROPN
iajs-1845	130	8	,	,	PUNCT
iajs-1845	130	9	clover	clover	PROPN
iajs-1845	130	10	a1cself	a1cself	PRON
iajs-1845	130	11	analyzer	analyzer	NOUN
iajs-1845	130	12	.	.	PUNCT
iajs-1845	131	1	korea	korea	PROPN
iajs-1845	131	2	http://www.infopia21.com/upload/downloadmanual/[ce]clovera1c_self_analyzer	http://www.infopia21.com/upload/downloadmanual/[ce]clovera1c_self_analyzer	PROPN
iajs-1845	132	1	_	_	PUNCT
iajs-1845	132	2	manual_(140519).pdf	manual_(140519).pdf	PROPN
iajs-1845	132	3	(	(	PUNCT
iajs-1845	132	4	accessed	access	VERB
iajs-1845	132	5	12.03.17	12.03.17	NUM
iajs-1845	132	6	)	)	PUNCT
iajs-1845	132	7	.	.	PUNCT
iajs-1845	133	1	2014	2014	NUM
iajs-1845	134	1	[	[	X
iajs-1845	134	2	17	17	NUM
iajs-1845	134	3	]	]	X
iajs-1845	134	4	y.	y.	NOUN
iajs-1845	134	5	bentata	bentata	PROPN
iajs-1845	134	6	,	,	PUNCT
iajs-1845	134	7	and	and	CCONJ
iajs-1845	134	8	r.	r.	PROPN
iajs-1845	134	9	abouqal	abouqal	PROPN
iajs-1845	134	10	,	,	PUNCT
iajs-1845	134	11	albuminuria	albuminuria	NOUN
iajs-1845	134	12	in	in	ADP
iajs-1845	134	13	patients	patient	NOUN
iajs-1845	134	14	with	with	ADP
iajs-1845	134	15	young	young	ADJ
iajs-1845	134	16	onset	onset	NOUN
iajs-1845	134	17	type	type	NOUN
iajs-1845	134	18	2	2	NUM
iajs-1845	134	19	diabetes	diabetes	NOUN
iajs-1845	134	20	.	.	PUNCT
iajs-1845	135	1	journal	journal	NOUN
iajs-1845	135	2	of	of	ADP
iajs-1845	135	3	nephropharmacology	nephropharmacology	NOUN
iajs-1845	135	4	,	,	PUNCT
iajs-1845	135	5	6(2	6(2	NUM
iajs-1845	135	6	):	):	PUNCT
iajs-1845	135	7	110	110	NUM
iajs-1845	135	8	-	-	SYM
iajs-1845	135	9	113	113	NUM
iajs-1845	135	10	.	.	PUNCT
iajs-1845	136	1	url	url	PROPN
iajs-1845	136	2	:	:	PUNCT
iajs-1845	136	3	http://dx.doi.org/10.1155/2016/4626125	http://dx.doi.org/10.1155/2016/4626125	PROPN
iajs-1845	136	4	.	.	PUNCT
iajs-1845	137	1	2017	2017	NUM
iajs-1845	138	1	[	[	SYM
iajs-1845	138	2	18	18	NUM
iajs-1845	138	3	]	]	X
iajs-1845	138	4	m.a	m.a	PROPN
iajs-1845	138	5	.	.	PROPN
iajs-1845	138	6	omar	omar	PROPN
iajs-1845	138	7	;	;	PUNCT
iajs-1845	138	8	m.m	m.m	PROPN
iajs-1845	138	9	.	.	PROPN
iajs-1845	138	10	rezk	rezk	PROPN
iajs-1845	138	11	;	;	PUNCT
iajs-1845	138	12	a.a	a.a	PROPN
iajs-1845	138	13	.	.	PROPN
iajs-1845	138	14	el	el	PROPN
iajs-1845	138	15	-	-	PUNCT
iajs-1845	138	16	kafoury	kafoury	PROPN
iajs-1845	138	17	,	,	PUNCT
iajs-1845	138	18	and	and	CCONJ
iajs-1845	138	19	m.s	m.s	PROPN
iajs-1845	138	20	.	.	PROPN
iajs-1845	138	21	kandil	kandil	PROPN
iajs-1845	138	22	.	.	PUNCT
iajs-1845	139	1	microalbuminuria	microalbuminuria	PROPN
iajs-1845	139	2	and	and	CCONJ
iajs-1845	139	3	glycated	glycate	VERB
iajs-1845	139	4	hemoglobin	hemoglobin	NOUN
iajs-1845	139	5	in	in	ADP
iajs-1845	139	6	children	child	NOUN
iajs-1845	139	7	with	with	ADP
iajs-1845	139	8	type	type	NOUN
iajs-1845	139	9	1	1	NUM
iajs-1845	139	10	diabetes	diabetes	NOUN
iajs-1845	139	11	mellitus	mellitus	NOUN
iajs-1845	139	12	,	,	PUNCT
iajs-1845	139	13	alexandria	alexandria	PROPN
iajs-1845	139	14	journal	journal	PROPN
iajs-1845	139	15	of	of	ADP
iajs-1845	139	16	medicine	medicine	NOUN
iajs-1845	139	17	,	,	PUNCT
iajs-1845	139	18	51(1	51(1	NUM
iajs-1845	139	19	)	)	PUNCT
iajs-1845	139	20	2015	2015	NUM
iajs-1845	139	21	:	:	PUNCT
iajs-1845	139	22	83	83	NUM
iajs-1845	139	23	-	-	SYM
iajs-1845	139	24	88	88	NUM
iajs-1845	139	25	.	.	PUNCT
iajs-1845	139	26	url	url	PROPN
iajs-1845	139	27	:	:	PUNCT
iajs-1845	139	28	https://doi.org/10.1016/j.ajme.2014.04.005	https://doi.org/10.1016/j.ajme.2014.04.005	PROPN
iajs-1845	140	1	[	[	X
iajs-1845	140	2	19	19	NUM
iajs-1845	140	3	]	]	X
iajs-1845	140	4	c.	c.	PROPN
iajs-1845	140	5	ufuoma	ufuoma	PROPN
iajs-1845	140	6	,	,	PUNCT
iajs-1845	140	7	j.c	j.c	PROPN
iajs-1845	140	8	.	.	PROPN
iajs-1845	140	9	ngozi	ngozi	PROPN
iajs-1845	140	10	,	,	PUNCT
iajs-1845	140	11	a.d	a.d	PROPN
iajs-1845	140	12	.	.	PROPN
iajs-1845	140	13	kester	kester	PROPN
iajs-1845	140	14	and	and	CCONJ
iajs-1845	140	15	y.d	y.d	PROPN
iajs-1845	140	16	.	.	PROPN
iajs-1845	140	17	godwin	godwin	PROPN
iajs-1845	140	18	.	.	PUNCT
iajs-1845	141	1	prevalence	prevalence	NOUN
iajs-1845	141	2	and	and	CCONJ
iajs-1845	141	3	risk	risk	NOUN
iajs-1845	141	4	factors	factor	NOUN
iajs-1845	141	5	of	of	ADP
iajs-1845	141	6	microalbuminuria	microalbuminuria	PROPN
iajs-1845	141	7	among	among	ADP
iajs-1845	141	8	type	type	NOUN
iajs-1845	141	9	2	2	NUM
iajs-1845	141	10	diabetes	diabetes	NOUN
iajs-1845	141	11	mellitus	mellitus	NOUN
iajs-1845	141	12	:	:	PUNCT
iajs-1845	141	13	a	a	DET
iajs-1845	141	14	hospital	hospital	NOUN
iajs-1845	141	15	-	-	PUNCT
iajs-1845	141	16	based	base	VERB
iajs-1845	141	17	study	study	NOUN
iajs-1845	141	18	from	from	ADP
iajs-1845	141	19	,	,	PUNCT
iajs-1845	141	20	warri	warri	PROPN
iajs-1845	141	21	,	,	PUNCT
iajs-1845	141	22	nigeria	nigeria	PROPN
iajs-1845	141	23	.	.	PUNCT
iajs-1845	142	1	sahel	sahel	PROPN
iajs-1845	142	2	medical	medical	PROPN
iajs-1845	142	3	journal	journal	PROPN
iajs-1845	142	4	,	,	PUNCT
iajs-1845	142	5	19(1	19(1	NUM
iajs-1845	142	6	):	):	PUNCT
iajs-1845	142	7	16	16	NUM
iajs-1845	142	8	-	-	SYM
iajs-1845	142	9	20	20	NUM
iajs-1845	142	10	.	.	PUNCT
iajs-1845	143	1	url	url	PROPN
iajs-1845	143	2	:	:	PUNCT
iajs-1845	143	3	http://www.smjonline.org/text.asp?2016/19/1/16/181889	http://www.smjonline.org/text.asp?2016/19/1/16/181889	NOUN
iajs-1845	143	4	.	.	PUNCT
iajs-1845	143	5	2016	2016	NUM
iajs-1845	144	1	[	[	X
iajs-1845	144	2	20	20	NUM
iajs-1845	144	3	]	]	SYM
iajs-1845	144	4	a.a	a.a	PROPN
iajs-1845	144	5	.	.	PROPN
iajs-1845	144	6	al	al	PROPN
iajs-1845	144	7	-	-	PUNCT
iajs-1845	144	8	eisa	eisa	NOUN
iajs-1845	144	9	,	,	PUNCT
iajs-1845	144	10	a.	a.	PROPN
iajs-1845	144	11	al	al	PROPN
iajs-1845	144	12	-	-	PUNCT
iajs-1845	144	13	hajri	hajri	PROPN
iajs-1845	144	14	,	,	PUNCT
iajs-1845	144	15	s.	s.	PROPN
iajs-1845	144	16	al	al	PROPN
iajs-1845	144	17	-	-	PUNCT
iajs-1845	144	18	shuaib	shuaib	PROPN
iajs-1845	144	19	,	,	PUNCT
iajs-1845	144	20	d.m.a.a	d.m.a.a	PROPN
iajs-1845	144	21	.	.	PROPN
iajs-1845	144	22	razzak	razzak	PROPN
iajs-1845	144	23	and	and	CCONJ
iajs-1845	144	24	i.	i.	PROPN
iajs-1845	144	25	al	al	PROPN
iajs-1845	144	26	-	-	PUNCT
iajs-1845	144	27	basiri	basiri	PROPN
iajs-1845	144	28	.	.	PUNCT
iajs-1845	145	1	earlyonset	earlyonset	PROPN
iajs-1845	145	2	microalbuminuria	microalbuminuria	PROPN
iajs-1845	145	3	in	in	ADP
iajs-1845	145	4	children	child	NOUN
iajs-1845	145	5	with	with	ADP
iajs-1845	145	6	type	type	NOUN
iajs-1845	145	7	1	1	NUM
iajs-1845	145	8	diabetes	diabetes	NOUN
iajs-1845	145	9	in	in	ADP
iajs-1845	145	10	kuwait	kuwait	PROPN
iajs-1845	145	11	.	.	PUNCT
iajs-1845	146	1	current	current	ADJ
iajs-1845	146	2	pediatric	pediatric	ADJ
iajs-1845	146	3	research	research	NOUN
iajs-1845	146	4	,	,	PUNCT
iajs-1845	146	5	21(2	21(2	NUM
iajs-1845	146	6	):	):	PUNCT
iajs-1845	146	7	254	254	NUM
iajs-1845	146	8	-	-	SYM
iajs-1845	146	9	259	259	NUM
iajs-1845	146	10	.	.	NOUN
iajs-1845	146	11	2017	2017	NUM
iajs-1845	147	1	[	[	X
iajs-1845	147	2	21	21	NUM
iajs-1845	147	3	]	]	PUNCT
iajs-1845	147	4	a.	a.	PROPN
iajs-1845	147	5	basu	basu	PROPN
iajs-1845	147	6	and	and	CCONJ
iajs-1845	147	7	j.s	j.s	PROPN
iajs-1845	147	8	.	.	PUNCT
iajs-1845	148	1	jhala	jhala	NOUN
iajs-1845	148	2	.	.	PUNCT
iajs-1845	149	1	correlation	correlation	NOUN
iajs-1845	149	2	between	between	ADP
iajs-1845	149	3	serum	serum	NOUN
iajs-1845	149	4	lipid	lipid	NOUN
iajs-1845	149	5	profile	profile	NOUN
iajs-1845	149	6	and	and	CCONJ
iajs-1845	149	7	albuminuria	albuminuria	NOUN
iajs-1845	149	8	in	in	ADP
iajs-1845	149	9	normotensive	normotensive	ADJ
iajs-1845	149	10	diabetic	diabetic	ADJ
iajs-1845	149	11	subjects	subject	NOUN
iajs-1845	149	12	.	.	PUNCT
iajs-1845	150	1	education	education	NOUN
iajs-1845	150	2	(	(	PUNCT
iajs-1845	150	3	asme	asme	PROPN
iajs-1845	150	4	)	)	PUNCT
iajs-1845	150	5	,	,	PUNCT
iajs-1845	150	6	1(4	1(4	NUM
iajs-1845	150	7	):	):	PUNCT
iajs-1845	150	8	202	202	NUM
iajs-1845	150	9	-	-	SYM
iajs-1845	150	10	210	210	NUM
iajs-1845	150	11	.	.	PUNCT
iajs-1845	150	12	2014	2014	NUM
iajs-1845	151	1	[	[	X
iajs-1845	151	2	22	22	NUM
iajs-1845	151	3	]	]	PUNCT
iajs-1845	151	4	r.	r.	PROPN
iajs-1845	151	5	nielsen	nielsen	PROPN
iajs-1845	151	6	,	,	PUNCT
iajs-1845	151	7	e.i	e.i	PROPN
iajs-1845	151	8	.	.	PROPN
iajs-1845	151	9	christensen	christensen	PROPN
iajs-1845	151	10	and	and	CCONJ
iajs-1845	151	11	h.	h.	PROPN
iajs-1845	151	12	birn	birn	PROPN
iajs-1845	151	13	.	.	PUNCT
iajs-1845	152	1	megalin	megalin	PROPN
iajs-1845	152	2	and	and	CCONJ
iajs-1845	152	3	cubilin	cubilin	NOUN
iajs-1845	152	4	in	in	ADP
iajs-1845	152	5	proximal	proximal	ADJ
iajs-1845	152	6	tubule	tubule	NOUN
iajs-1845	152	7	protein	protein	NOUN
iajs-1845	152	8	reabsorption	reabsorption	NOUN
iajs-1845	152	9	:	:	PUNCT
iajs-1845	152	10	from	from	ADP
iajs-1845	152	11	experimental	experimental	ADJ
iajs-1845	152	12	models	model	NOUN
iajs-1845	152	13	to	to	ADP
iajs-1845	152	14	human	human	ADJ
iajs-1845	152	15	disease	disease	NOUN
iajs-1845	152	16	.	.	PUNCT
iajs-1845	153	1	kidney	kidney	PROPN
iajs-1845	153	2	international	international	PROPN
iajs-1845	153	3	,	,	PUNCT
iajs-1845	153	4	89(1	89(1	NUM
iajs-1845	153	5	)	)	PUNCT
iajs-1845	153	6	2016	2016	NUM
iajs-1845	153	7	:	:	PUNCT
iajs-1845	154	1	58	58	NUM
iajs-1845	154	2	-	-	SYM
iajs-1845	154	3	67	67	NUM
iajs-1845	154	4	.	.	PUNCT
iajs-1845	154	5	url	url	PROPN
iajs-1845	154	6	:	:	PUNCT
iajs-1845	155	1	http://dx.doi.org/10.1016/j.kint.2015.11.007	http://dx.doi.org/10.1016/j.kint.2015.11.007	PROPN
iajs-1845	155	2	[	[	X
iajs-1845	155	3	23	23	NUM
iajs-1845	155	4	]	]	X
iajs-1845	155	5	k.m	k.m	PROPN
iajs-1845	155	6	.	.	PROPN
iajs-1845	155	7	thrailkill	thrailkill	PROPN
iajs-1845	155	8	,	,	PUNCT
iajs-1845	156	1	c.h	c.h	PROPN
iajs-1845	156	2	.	.	PROPN
iajs-1845	156	3	jo	jo	PROPN
iajs-1845	156	4	,	,	PUNCT
iajs-1845	156	5	g.e	g.e	PROPN
iajs-1845	156	6	.	.	PROPN
iajs-1845	156	7	cockrell	cockrell	PROPN
iajs-1845	156	8	,	,	PUNCT
iajs-1845	156	9	c.s	c.s	PROPN
iajs-1845	156	10	.	.	PROPN
iajs-1845	156	11	moreau	moreau	PROPN
iajs-1845	156	12	and	and	CCONJ
iajs-1845	156	13	j.l	j.l	PROPN
iajs-1845	156	14	.	.	PROPN
iajs-1845	156	15	fowlkes	fowlke	NOUN
iajs-1845	156	16	.	.	PUNCT
iajs-1845	157	1	enhanced	enhance	VERB
iajs-1845	157	2	excretion	excretion	NOUN
iajs-1845	157	3	of	of	ADP
iajs-1845	157	4	vitamin	vitamin	NOUN
iajs-1845	157	5	d	d	NOUN
iajs-1845	157	6	binding	bind	VERB
iajs-1845	157	7	protein	protein	NOUN
iajs-1845	157	8	in	in	ADP
iajs-1845	157	9	type	type	NOUN
iajs-1845	157	10	1	1	NUM
iajs-1845	157	11	diabetes	diabete	NOUN
iajs-1845	157	12	:	:	PUNCT
iajs-1845	157	13	a	a	DET
iajs-1845	157	14	role	role	NOUN
iajs-1845	157	15	in	in	ADP
iajs-1845	157	16	vitamin	vitamin	NOUN
iajs-1845	157	17	d	d	NOUN
iajs-1845	157	18	deficiency	deficiency	NOUN
iajs-1845	157	19	.	.	PUNCT
iajs-1845	158	1	the	the	DET
iajs-1845	158	2	journal	journal	NOUN
iajs-1845	158	3	of	of	ADP
iajs-1845	158	4	clinical	clinical	ADJ
iajs-1845	158	5	endocrinology	endocrinology	NOUN
iajs-1845	158	6	&	&	CCONJ
iajs-1845	158	7	metabolism	metabolism	NOUN
iajs-1845	158	8	,	,	PUNCT
iajs-1845	158	9	96(1	96(1	NUM
iajs-1845	158	10	):	):	PUNCT
iajs-1845	158	11	142	142	NUM
iajs-1845	158	12	-	-	SYM
iajs-1845	158	13	149	149	NUM
iajs-1845	158	14	.	.	PUNCT
iajs-1845	158	15	url	url	PROPN
iajs-1845	158	16	:	:	PUNCT
iajs-1845	158	17	https://doi.org/10.1210/jc.2010-0980	https://doi.org/10.1210/jc.2010-0980	NOUN
iajs-1845	158	18	.	.	PUNCT
iajs-1845	159	1	2011	2011	NUM
iajs-1845	160	1	[	[	X
iajs-1845	160	2	24	24	NUM
iajs-1845	160	3	]	]	X
iajs-1845	160	4	x.q	x.q	PROPN
iajs-1845	160	5	.	.	PROPN
iajs-1845	160	6	tian	tian	PROPN
iajs-1845	160	7	,	,	PUNCT
iajs-1845	160	8	l.m	l.m	PROPN
iajs-1845	160	9	.	.	PROPN
iajs-1845	160	10	zhao	zhao	PROPN
iajs-1845	160	11	,	,	PUNCT
iajs-1845	160	12	j.p	j.p	PROPN
iajs-1845	160	13	.	.	PROPN
iajs-1845	160	14	ge	ge	PROPN
iajs-1845	160	15	,	,	PUNCT
iajs-1845	160	16	y.	y.	PROPN
iajs-1845	160	17	zhang	zhang	PROPN
iajs-1845	160	18	and	and	CCONJ
iajs-1845	160	19	y.c	y.c	PROPN
iajs-1845	160	20	.	.	PROPN
iajs-1845	160	21	xu	xu	PROPN
iajs-1845	160	22	.	.	PUNCT
iajs-1845	161	1	elevated	elevated	ADJ
iajs-1845	161	2	urinary	urinary	ADJ
iajs-1845	161	3	level	level	NOUN
iajs-1845	161	4	of	of	ADP
iajs-1845	161	5	vitamin	vitamin	NOUN
iajs-1845	161	6	d	d	NOUN
iajs-1845	161	7	-	-	ADJ
iajs-1845	161	8	binding	bind	VERB
iajs-1845	161	9	protein	protein	NOUN
iajs-1845	161	10	as	as	ADP
iajs-1845	161	11	a	a	DET
iajs-1845	161	12	novel	novel	NOUN
iajs-1845	161	13	biomarker	biomarker	NOUN
iajs-1845	161	14	for	for	ADP
iajs-1845	161	15	diabetic	diabetic	ADJ
iajs-1845	161	16	nephropathy	nephropathy	NOUN
iajs-1845	161	17	.	.	PUNCT
iajs-1845	162	1	experimental	experimental	ADJ
iajs-1845	162	2	and	and	CCONJ
iajs-1845	162	3	therapeutic	therapeutic	ADJ
iajs-1845	162	4	medicine	medicine	NOUN
iajs-1845	162	5	,	,	PUNCT
iajs-1845	162	6	7(2	7(2	NUM
iajs-1845	162	7	)	)	PUNCT
iajs-1845	162	8	2014	2014	NUM
iajs-1845	162	9	:	:	PUNCT
iajs-1845	162	10	411	411	NUM
iajs-1845	162	11	-	-	SYM
iajs-1845	162	12	416	416	NUM
iajs-1845	162	13	.	.	PUNCT
iajs-1845	163	1	[	[	X
iajs-1845	163	2	25	25	NUM
iajs-1845	163	3	]	]	PUNCT
iajs-1845	163	4	k.	k.	PROPN
iajs-1845	163	5	mirković	mirković	PROPN
iajs-1845	163	6	,	,	PUNCT
iajs-1845	163	7	c.r	c.r	PROPN
iajs-1845	163	8	.	.	PROPN
iajs-1845	163	9	doorenbos	doorenbos	PROPN
iajs-1845	163	10	,	,	PUNCT
iajs-1845	163	11	w.a	w.a	PROPN
iajs-1845	163	12	.	.	PROPN
iajs-1845	163	13	dam	dam	PROPN
iajs-1845	163	14	,	,	PUNCT
iajs-1845	163	15	h.j.l	h.j.l	PROPN
iajs-1845	163	16	.	.	PROPN
iajs-1845	163	17	heerspink	heerspink	PROPN
iajs-1845	163	18	,	,	PUNCT
iajs-1845	163	19	m.c	m.c	PROPN
iajs-1845	163	20	.	.	PROPN
iajs-1845	163	21	slagman	slagman	PROPN
iajs-1845	163	22	,	,	PUNCT
iajs-1845	163	23	f.l	f.l	PROPN
iajs-1845	163	24	.	.	PROPN
iajs-1845	163	25	nauta	nauta	PROPN
iajs-1845	163	26	,	,	PUNCT
iajs-1845	163	27	a.b	a.b	PROPN
iajs-1845	163	28	.	.	PROPN
iajs-1845	163	29	kramer	kramer	PROPN
iajs-1845	163	30	,	,	PUNCT
iajs-1845	163	31	r.t	r.t	PROPN
iajs-1845	163	32	.	.	PROPN
iajs-1845	163	33	gansevoort	gansevoort	PROPN
iajs-1845	163	34	,	,	PUNCT
iajs-1845	163	35	j.	j.	PROPN
iajs-1845	163	36	van	van	PROPN
iajs-1845	163	37	den	den	PROPN
iajs-1845	163	38	born	bear	VERB
iajs-1845	163	39	,	,	PUNCT
iajs-1845	163	40	g.	g.	PROPN
iajs-1845	163	41	navis	navis	PROPN
iajs-1845	163	42	and	and	CCONJ
iajs-1845	163	43	m.h	m.h	PROPN
iajs-1845	163	44	.	.	PROPN
iajs-1845	163	45	de	de	X
iajs-1845	163	46	borst	borst	PROPN
iajs-1845	163	47	.	.	PUNCT
iajs-1845	164	1	urinary	urinary	ADJ
iajs-1845	164	2	vitamin	vitamin	NOUN
iajs-1845	164	3	d	d	NOUN
iajs-1845	164	4	binding	bind	VERB
iajs-1845	164	5	protein	protein	NOUN
iajs-1845	164	6	:	:	PUNCT
iajs-1845	164	7	a	a	DET
iajs-1845	164	8	potential	potential	ADJ
iajs-1845	164	9	novel	novel	ADJ
iajs-1845	164	10	marker	marker	NOUN
iajs-1845	164	11	of	of	ADP
iajs-1845	164	12	renal	renal	ADJ
iajs-1845	164	13	interstitial	interstitial	ADJ
iajs-1845	164	14	inflammation	inflammation	NOUN
iajs-1845	164	15	and	and	CCONJ
iajs-1845	164	16	fibrosis	fibrosis	NOUN
iajs-1845	164	17	.	.	PUNCT
iajs-1845	165	1	plos	plos	PROPN
iajs-1845	165	2	one	one	NUM
iajs-1845	165	3	,	,	PUNCT
iajs-1845	165	4	8(2	8(2	NUM
iajs-1845	165	5	):	):	PUNCT
iajs-1845	165	6	1	1	NUM
iajs-1845	165	7	-	-	SYM
iajs-1845	165	8	9	9	NUM
iajs-1845	165	9	.	.	NUM
iajs-1845	165	10	2013	2013	NUM
iajs-1845	166	1	[	[	X
iajs-1845	166	2	26	26	NUM
iajs-1845	166	3	]	]	X
iajs-1845	166	4	a.s	a.s	PROPN
iajs-1845	166	5	.	.	PROPN
iajs-1845	166	6	mohamed	mohamed	PROPN
iajs-1845	166	7	.	.	PROPN
iajs-1845	167	1	elevated	elevated	ADJ
iajs-1845	167	2	urinary	urinary	ADJ
iajs-1845	167	3	level	level	NOUN
iajs-1845	167	4	of	of	ADP
iajs-1845	167	5	vitamin	vitamin	NOUN
iajs-1845	167	6	d	d	NOUN
iajs-1845	167	7	binding	bind	VERB
iajs-1845	167	8	protein	protein	NOUN
iajs-1845	167	9	as	as	ADP
iajs-1845	167	10	a	a	DET
iajs-1845	167	11	biomarker	biomarker	NOUN
iajs-1845	167	12	for	for	ADP
iajs-1845	167	13	diabetic	diabetic	ADJ
iajs-1845	167	14	nephropathy	nephropathy	NOUN
iajs-1845	167	15	,	,	PUNCT
iajs-1845	167	16	published	publish	VERB
iajs-1845	167	17	master	master	NOUN
iajs-1845	167	18	thesis	thesis	NOUN
iajs-1845	167	19	,	,	PUNCT
iajs-1845	167	20	faculty	faculty	NOUN
iajs-1845	167	21	of	of	ADP
iajs-1845	167	22	medicine	medicine	NOUN
iajs-1845	167	23	,	,	PUNCT
iajs-1845	167	24	ain	ain	PROPN
iajs-1845	167	25	shams	shams	PROPN
iajs-1845	167	26	university	university	PROPN
iajs-1845	167	27	,	,	PUNCT
iajs-1845	167	28	egypt	egypt	PROPN
iajs-1845	167	29	,	,	PUNCT
iajs-1845	167	30	2016	2016	NUM
iajs-1845	167	31	.	.	PUNCT
iajs-1845	168	1	url	url	PROPN
iajs-1845	168	2	:	:	PUNCT
iajs-1845	168	3	http://srv4.eulc.edu.eg/eulc_v5/libraries/	http://srv4.eulc.edu.eg/eulc_v5/libraries/	NOUN
iajs-1845	168	4	thesis	thesis	NOUN
iajs-1845	168	5	/	/	SYM
iajs-1845	168	6	browsethesispages.aspx	browsethesispages.aspx	NUM
iajs-1845	168	7	?	?	PUNCT
iajs-1845	168	8	fn	fn	NOUN
iajs-1845	169	1	=	=	NOUN
iajs-1845	169	2	publicdrawthesis&bibid=12280766	publicdrawthesis&bibid=12280766	NOUN
iajs-1845	169	3	[	[	X
iajs-1845	169	4	27	27	NUM
iajs-1845	169	5	]	]	PUNCT
iajs-1845	169	6	a.	a.	NOUN
iajs-1845	169	7	shoukry	shoukry	NOUN
iajs-1845	169	8	,	,	PUNCT
iajs-1845	169	9	s.e.a	s.e.a	NOUN
iajs-1845	169	10	.	.	PUNCT
iajs-1845	169	11	bdeer	bdeer	NOUN
iajs-1845	169	12	and	and	CCONJ
iajs-1845	169	13	r.h	r.h	PROPN
iajs-1845	169	14	.	.	PROPN
iajs-1845	169	15	el	el	PROPN
iajs-1845	169	16	-	-	PUNCT
iajs-1845	169	17	sokkary	sokkary	NOUN
iajs-1845	169	18	.	.	PUNCT
iajs-1845	170	1	urinary	urinary	ADJ
iajs-1845	170	2	monocyte	monocyte	PROPN
iajs-1845	170	3	chemoattractant	chemoattractant	PROPN
iajs-1845	170	4	protein-1	protein-1	PROPN
iajs-1845	170	5	and	and	CCONJ
iajs-1845	170	6	vitamin	vitamin	NOUN
iajs-1845	170	7	d	d	ADJ
iajs-1845	170	8	-	-	ADJ
iajs-1845	170	9	binding	bind	VERB
iajs-1845	170	10	protein	protein	NOUN
iajs-1845	170	11	as	as	ADP
iajs-1845	170	12	biomarkers	biomarker	NOUN
iajs-1845	170	13	for	for	ADP
iajs-1845	170	14	early	early	ADJ
iajs-1845	170	15	detection	detection	NOUN
iajs-1845	170	16	of	of	ADP
iajs-1845	170	17	diabetic	diabetic	ADJ
iajs-1845	170	18	nephropathy	nephropathy	NOUN
iajs-1845	170	19	in	in	ADP
iajs-1845	170	20	type	type	NOUN
iajs-1845	170	21	2	2	NUM
iajs-1845	170	22	diabetes	diabetes	NOUN
iajs-1845	170	23	mellitus	mellitus	NOUN
iajs-1845	170	24	.	.	PUNCT
iajs-1845	171	1	molecular	molecular	ADJ
iajs-1845	171	2	and	and	CCONJ
iajs-1845	171	3	cellular	cellular	ADJ
iajs-1845	171	4	biochemistry	biochemistry	NOUN
iajs-1845	171	5	,	,	PUNCT
iajs-1845	171	6	408(1	408(1	NUM
iajs-1845	171	7	-	-	SYM
iajs-1845	171	8	2	2	NUM
iajs-1845	171	9	)	)	PUNCT
iajs-1845	171	10	2015	2015	NUM
iajs-1845	171	11	:	:	PUNCT
iajs-1845	172	1	25	25	NUM
iajs-1845	172	2	-	-	SYM
iajs-1845	172	3	35	35	NUM
iajs-1845	172	4	.	.	PUNCT
iajs-1845	172	5	url	url	PROPN
iajs-1845	172	6	:	:	PUNCT
iajs-1845	172	7	https://doi.org/10.1007/s1101	https://doi.org/10.1007/s1101	NUM
iajs-1845	172	8	[	[	X
iajs-1845	172	9	28	28	NUM
iajs-1845	172	10	]	]	X
iajs-1845	172	11	m.j	m.j	PROPN
iajs-1845	172	12	.	.	PROPN
iajs-1845	172	13	kim	kim	PROPN
iajs-1845	172	14	,	,	PUNCT
iajs-1845	172	15	a.h	a.h	PROPN
iajs-1845	172	16	.	.	PROPN
iajs-1845	172	17	frankel	frankel	PROPN
iajs-1845	172	18	,	,	PUNCT
iajs-1845	172	19	m.	m.	PROPN
iajs-1845	172	20	donaldson	donaldson	PROPN
iajs-1845	172	21	,	,	PUNCT
iajs-1845	172	22	s.j	s.j	PROPN
iajs-1845	172	23	.	.	PROPN
iajs-1845	172	24	darch	darch	PROPN
iajs-1845	172	25	,	,	PUNCT
iajs-1845	172	26	c.d	c.d	PROPN
iajs-1845	172	27	.	.	PROPN
iajs-1845	172	28	pusey	pusey	PROPN
iajs-1845	172	29	,	,	PUNCT
iajs-1845	172	30	p.d	p.d	PROPN
iajs-1845	172	31	.	.	PROPN
iajs-1845	172	32	hill	hill	PROPN
iajs-1845	172	33	,	,	PUNCT
iajs-1845	172	34	m.	m.	NOUN
iajs-1845	172	35	mayr	mayr	PROPN
iajs-1845	172	36	and	and	CCONJ
iajs-1845	172	37	f.w	f.w	PROPN
iajs-1845	172	38	.	.	PROPN
iajs-1845	172	39	tam	tam	PROPN
iajs-1845	172	40	.	.	PROPN
iajs-1845	172	41	oral	oral	ADJ
iajs-1845	172	42	cholecalciferol	cholecalciferol	NOUN
iajs-1845	172	43	decreases	decrease	VERB
iajs-1845	172	44	albuminuria	albuminuria	ADV
iajs-1845	172	45	and	and	CCONJ
iajs-1845	172	46	urinary	urinary	PROPN
iajs-1845	172	47	tgf	tgf	PROPN
iajs-1845	172	48	-	-	PUNCT
iajs-1845	172	49	β1	β1	PROPN
iajs-1845	172	50	in	in	ADP
iajs-1845	172	51	patients	patient	NOUN
iajs-1845	172	52	with	with	ADP
iajs-1845	172	53	type	type	NOUN
iajs-1845	172	54	2	2	NUM
iajs-1845	172	55	diabetic	diabetic	ADJ
iajs-1845	172	56	nephropathy	nephropathy	NOUN
iajs-1845	172	57	on	on	ADP
iajs-1845	172	58	established	establish	VERB
iajs-1845	172	59	renin	renin	ADJ
iajs-1845	172	60	–	–	PUNCT
iajs-1845	172	61	angiotensin	angiotensin	NOUN
iajs-1845	172	62	–	–	PUNCT
iajs-1845	172	63	aldosterone	aldosterone	NOUN
iajs-1845	172	64	system	system	NOUN
iajs-1845	172	65	inhibition	inhibition	NOUN
iajs-1845	172	66	.	.	PUNCT
iajs-1845	173	1	kidney	kidney	PROPN
iajs-1845	173	2	international	international	ADJ
iajs-1845	173	3	,	,	PUNCT
iajs-1845	173	4	80(8	80(8	NOUN
iajs-1845	173	5	)	)	PUNCT
iajs-1845	173	6	2011	2011	NUM
iajs-1845	173	7	:	:	PUNCT
iajs-1845	173	8	851	851	NUM
iajs-1845	173	9	-	-	SYM
iajs-1845	173	10	860	860	NUM
iajs-1845	173	11	.	.	PUNCT
iajs-1845	174	1	[	[	X
iajs-1845	174	2	29	29	NUM
iajs-1845	174	3	]	]	X
iajs-1845	174	4	s.a	s.a	PROPN
iajs-1845	174	5	.	.	PROPN
iajs-1845	174	6	khodeir	khodeir	PROPN
iajs-1845	174	7	,	,	PUNCT
iajs-1845	174	8	n.m	n.m	PROPN
iajs-1845	174	9	.	.	PROPN
iajs-1845	174	10	kotb	kotb	PROPN
iajs-1845	174	11	,	,	PUNCT
iajs-1845	174	12	k.m	k.m	PROPN
iajs-1845	174	13	.	.	PROPN
iajs-1845	174	14	okasha	okasha	PROPN
iajs-1845	174	15	,	,	PUNCT
iajs-1845	174	16	k.a	k.a	PROPN
iajs-1845	174	17	.	.	PROPN
iajs-1845	174	18	ahmed	ahmed	PROPN
iajs-1845	174	19	and	and	CCONJ
iajs-1845	174	20	h.m	h.m	PROPN
iajs-1845	174	21	.	.	PROPN
iajs-1845	174	22	nagy	nagy	PROPN
iajs-1845	174	23	.	.	PUNCT
iajs-1845	175	1	urinary	urinary	ADJ
iajs-1845	175	2	level	level	NOUN
iajs-1845	175	3	of	of	ADP
iajs-1845	175	4	vitamin	vitamin	NOUN
iajs-1845	175	5	d	d	NOUN
iajs-1845	175	6	-	-	ADJ
iajs-1845	175	7	binding	bind	VERB
iajs-1845	175	8	protein	protein	NOUN
iajs-1845	175	9	as	as	ADP
iajs-1845	175	10	a	a	DET
iajs-1845	175	11	new	new	ADJ
iajs-1845	175	12	biomarker	biomarker	NOUN
iajs-1845	175	13	for	for	ADP
iajs-1845	175	14	diabetic	diabetic	ADJ
iajs-1845	175	15	nephropathy	nephropathy	NOUN
iajs-1845	175	16	.	.	PUNCT
iajs-1845	176	1	journal	journal	NOUN
iajs-1845	176	2	of	of	ADP
iajs-1845	176	3	  	  	SPACE
iajs-1845	176	4	https://doi.org/10.30526/31.1.845	https://doi.org/10.30526/31.1.845	ADJ
iajs-1845	176	5	biology	biology	NOUN
iajs-1845	176	6	|	|	ADV
iajs-1845	176	7	22	22	NUM
iajs-1845	176	8	2018)عام	2018)عام	NUM
iajs-1845	176	9	1العدد	1العدد	NUM
iajs-1845	176	10	(	(	PUNCT
iajs-1845	176	11	31لمجلد	31لمجلد	NUM
iajs-1845	176	12	ا	ا	INTJ
iajs-1845	176	13	مجلة	مجلة	NOUN
iajs-1845	176	14	إبن	إبن	VERB
iajs-1845	176	15	الهيثم	الهيثم	ADJ
iajs-1845	176	16	للعلوم	للعلوم	NOUN
iajs-1845	176	17	الصرفة	الصرفة	NOUN
iajs-1845	176	18	والتطبيقية	والتطبيقية	VERB
iajs-1845	176	19	ibn	ibn	PROPN
iajs-1845	176	20	al	al	PROPN
iajs-1845	176	21	-	-	PUNCT
iajs-1845	176	22	haitham	haitham	PROPN
iajs-1845	176	23	jour	jour	X
iajs-1845	176	24	.	.	PROPN
iajs-1845	177	1	for	for	ADP
iajs-1845	177	2	pure	pure	ADJ
iajs-1845	177	3	&	&	CCONJ
iajs-1845	177	4	appl	appl	PROPN
iajs-1845	177	5	.	.	PUNCT
iajs-1845	178	1	sci	sci	PROPN
iajs-1845	178	2	.	.	PUNCT
iajs-1845	178	3	vol	vol	NOUN
iajs-1845	178	4	.	.	PROPN
iajs-1845	179	1	31	31	NUM
iajs-1845	179	2	(	(	PUNCT
iajs-1845	179	3	1	1	NUM
iajs-1845	179	4	)	)	PUNCT
iajs-1845	179	5	2018	2018	NUM
iajs-1845	179	6	the	the	DET
iajs-1845	179	7	egyptian	egyptian	ADJ
iajs-1845	179	8	society	society	NOUN
iajs-1845	179	9	of	of	ADP
iajs-1845	179	10	nephrology	nephrology	NOUN
iajs-1845	179	11	and	and	CCONJ
iajs-1845	179	12	transplantation	transplantation	NOUN
iajs-1845	179	13	,	,	PUNCT
iajs-1845	179	14	16(1	16(1	NUM
iajs-1845	179	15	)	)	PUNCT
iajs-1845	179	16	2016	2016	NUM
iajs-1845	179	17	:	:	PUNCT
iajs-1845	179	18	32	32	NUM
iajs-1845	179	19	-	-	SYM
iajs-1845	179	20	38	38	NUM
iajs-1845	179	21	url	url	NOUN
iajs-1845	179	22	:	:	PUNCT
iajs-1845	179	23	http://www.jesnt.eg.net/text.asp?2016/16/1/32/179210	http://www.jesnt.eg.net/text.asp?2016/16/1/32/179210	NOUN
iajs-1845	180	1	[	[	X
iajs-1845	180	2	30	30	NUM
iajs-1845	180	3	]	]	X
iajs-1845	180	4	x.q	x.q	PROPN
iajs-1845	180	5	.	.	PROPN
iajs-1845	180	6	tian	tian	PROPN
iajs-1845	180	7	,	,	PUNCT
iajs-1845	180	8	l.m	l.m	PROPN
iajs-1845	180	9	.	.	PROPN
iajs-1845	180	10	zhao	zhao	PROPN
iajs-1845	180	11	,	,	PUNCT
iajs-1845	180	12	j.p	j.p	PROPN
iajs-1845	180	13	.	.	PROPN
iajs-1845	180	14	ge	ge	PROPN
iajs-1845	180	15	,	,	PUNCT
iajs-1845	180	16	y.	y.	PROPN
iajs-1845	180	17	zhang	zhang	PROPN
iajs-1845	180	18	and	and	CCONJ
iajs-1845	180	19	y.c	y.c	PROPN
iajs-1845	180	20	.	.	PROPN
iajs-1845	180	21	xu	xu	PROPN
iajs-1845	180	22	.	.	PUNCT
iajs-1845	181	1	elevated	elevated	ADJ
iajs-1845	181	2	urinary	urinary	ADJ
iajs-1845	181	3	level	level	NOUN
iajs-1845	181	4	of	of	ADP
iajs-1845	181	5	vitamin	vitamin	NOUN
iajs-1845	181	6	d	d	NOUN
iajs-1845	181	7	-	-	ADJ
iajs-1845	181	8	binding	bind	VERB
iajs-1845	181	9	protein	protein	NOUN
iajs-1845	181	10	as	as	ADP
iajs-1845	181	11	a	a	DET
iajs-1845	181	12	novel	novel	NOUN
iajs-1845	181	13	biomarker	biomarker	NOUN
iajs-1845	181	14	for	for	ADP
iajs-1845	181	15	diabetic	diabetic	ADJ
iajs-1845	181	16	nephropathy	nephropathy	NOUN
iajs-1845	181	17	.	.	PUNCT
iajs-1845	182	1	experimental	experimental	ADJ
iajs-1845	182	2	and	and	CCONJ
iajs-1845	182	3	therapeutic	therapeutic	ADJ
iajs-1845	182	4	medicine	medicine	NOUN
iajs-1845	182	5	,	,	PUNCT
iajs-1845	182	6	7(2	7(2	NUM
iajs-1845	182	7	):	):	PUNCT
iajs-1845	182	8	411	411	NUM
iajs-1845	182	9	-	-	SYM
iajs-1845	182	10	416	416	NUM
iajs-1845	182	11	.	.	PUNCT
iajs-1845	183	1	url	url	PROPN
iajs-1845	183	2	:	:	PUNCT
iajs-1845	183	3	https://doi.org/10.3892/etm.2013.1426	https://doi.org/10.3892/etm.2013.1426	NOUN
iajs-1845	183	4	.	.	PUNCT
iajs-1845	184	1	2014	2014	NUM
iajs-1845	184	2	  	  	SPACE